EXPLORING MOLECULAR PATHOGENESIS OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) USING SOD1 AND TDP43 by LIM LIANG ZHONG
EXPLORING MOLECULAR PATHOGENESIS
OF AMYOTROPHIC LATERAL SCLEROSIS
(ALS) USING SOD1 AND TDP43
. LIM LIANG ZHONG
. (B.Sci.(Hons.), NTU, Singapore)
A THESIS SUBMITTED FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
DEPARTMENT OF BIOLOGICAL SCIENCES
FACULTY OF SCIENCE
NATIONAL UNIVERSITY OF SINGAPORE
2016
Declaration of Authorship
I hereby declare that this thesis is my original work and it has been written by me in
its entirety. I have duly acknowledged all the sources of information which have been
used in the thesis. I have acknowledged all main sources of help. Where the thesis is
based on work done by myself jointly with others, I have made clear exactly what was
done by others and what I have contributed myself.





First, I am grateful to Prof. Song Jianxing for: his encouragement to enroll into the
NUS-PhD program, his insightful suggestions and discussion pertaining to the research
on hand, sharing his philosophical research approaches, his concerns in the future of his
students, and his personal arrangements in research matters. Without his illuminating
exchanges, this PhD journey would be somewhat lacking.
Second, I will like to thank the TAC members: Prof. Jayaraman Sivaraman and
Assoc. Prof. Ganesh Srinivasan Anand for their guidance over the later half of this
PhD program.
Third, I am also grateful to the past and present lab members for without their assis-
tance and guidance, I would not have learnt, grown and done as much: Lua Shixiong,
Ng Huiqi, Qin Haina, Garvita Gupta, Miao Linlin, Shaveta Gopta, Wang Wei, Yew
Hongmeng, Lee Xiaowen, Lu Yimei, Wei Yuanyuan, and other lab members whom I
may have missed out (Sorry!). I will like to thank the other members along the ex-
structural biology corridor for their timely assistance and discussion on the projects at
hand. I would like to thank also Dr. Fan Jingsong for his help in the NMR experiments
and training.
Fourth, I would like to thank and acknowledge National University of Singapore and
Ministry of Education (Singapore) for the research scholarship and stipends.
Fifth, I like to thank my friends who had shared concerns and comforting words over
this journey.
Sixth, I am grateful and indebted to my parents and family in their unwavering support.
Lastly, I am indebted to Providence for the unexpected arrangements in all matters.
ii
Summary
Amyotrophic Lateral Sclerosis (ALS) is a major motor neurodegenerative disorder that
affect people regardless of their gender, race or genetics. Proteinaceous insoluble ag-
gregates is the perennial hallmark of ALS patients. While it is widely believed ALS
mutations render these ALS proteins more aggregation prone, there is no consensus on
the ALS molecular pathogenesis. Here, we explored plausible ALS molecular mecha-
nisms using SOD1 (ROS-reducing enzyme) and TDP43 (DNA/RNA binding protein);
their common neurotoxicity cause is their ability to perturb membrane integrity of
membrane-bound organelles such as mitochondrial and endoplasmic reticulum.
We found unstructured wild-type (WT) and truncated mutant (L126Z) of SOD1 can
adopt amphiphilic α-helices in phospholipid environment which is mimic by dode-
cylphosphocholine (DPC) except for the zinc binding loop. Through MD simulation,
we found the highly hydrophilic zinc-binding loop meditate extensive and transient
hydrogen bonds with DPC, which is also supported by the lack of NMR conforma-
tional exchange in this zinc-binding loop. These results indicate the zinc-binding loop
serves two roles in SOD1 interaction with phospholipids: zinc-binding loop anchor
the unfolded amphiphilic regions of SOD1 to the phospholipid interface, while the
unfolded amphiphilic regions formed α-helices; zinc-binding loop of membrane-bound
SOD1 recruit other cytoplasmic proteins or SOD1 onto the membrane surface. We
had provided some biophysical evidence for this SOD1 ALS-pathogenesis where exten-
sive membrane-remodeling due to unstructured SOD1 may accelerate motor neuron
apoptosis.
We showed for the first time that Fe2+ triggered the folding of unfolded WT SOD1 to a
similar extent like Zn2+. Through NMR, we found the ferric ion in Fe2+-bound SOD1
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is less likely to be replaced by Zn2+ despite excess Zn2+ supplementation. Thus Fe2+-
bound SOD1 may reduce or inhibit the proper maturation of wild-type and mutant
SOD1. Furthermore, as ALS severity increases, ferric ion may increase in ALS patients,
and our results suggest such ALS phenomenon may increase amount of Fe2+-bound
SOD1 and oxidative stress due to ‘aberrant’ Fenton’s chemistry. Our findings support
a novel SOD1-dependent, ALS molecular pathogenesis.
C-terminus of TDP43 (TDP43prion) is a prion-like domain which form dynamic oligomers
with other DNA/RNA binding protein. Interestingly this prion domain is home to
most ALS-causing mutations in TDP43. We showed the membrane-interacting do-
main of TDP43prion consists of only the hydrophobic region of TDP43prion and the
upstream irregularly shaped Ω-loop (upstream M311-Q343). In bicelle system, the
self-oligomerization of three TDP43prion ALS mutants (A315E, Q331K and M337V) is
faster and formed irreversible β-amyloid fibers; TDP43prion WT in bicelle remained a
clear but viscous hydrogel.
We found TDP43prion three ALS mutants self-oligomerize faster than WT but they
all formed β-rich amyloid oligomers or fibrils at neutral pH (pH6.8). Interestingly,
the three ALS mutants again formed irreversible aggregates but the WT remained
a clear hydrogel. Interestingly, the three ALS mutants require lesser ssDNA molar
ratio to aggregate as compared to WT. For self-oligomerization processes at neutral
pH and ssDNA titration, TDP43prion WT showed important structural differences in
its β-rich oligomers as compared to the three ALS mutants. These results suggested
TDP43prion has a folding energy landscape in which the WT can fold into dynamic and
functional oligomers, but ALS mutations remodel this landscape to favor irreversible
aggregation of TDP43prion oligomers. These findings provide novel insights on how
molecular behavior of TDP43prion is affected in the context of ALS mutations that
had not been described before in the literature.
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This project focuses on using in-vitro biophysical methods to study some plausible
molecular mechanisms in amyotrophic lateral sclerosis (ALS) pathogenesis using two
ALS proteins: SOD1 and TDP43prion. The flow in this brief biology introduction is
as follow: ALS, SOD1, TDP43prion, and the proposed ALS molecular pathogenesis in
context of these two proteins. The final section covers the project aims.
1.1.2 Amyotrophic lateral sclerosis (ALS)
ALS is a group of genetic disorders that result in the progressive loss of both the upper
and lower motor neurons, regardless of ethnicity, genetics or gender. Because of the
gradual denervation of neuromuscular system, the ambient neuronal signaling to the
respiratory system is gradually lost till respiratory failure occurs that resulted in death
1
Introduction 2
(Ferraiuolo et al., 2011; Andersen & Al-Chalabi, 2011). The average age onset of ALS
is between 55 and 60 years old, with an expected life expectancy of 3-5 years after the
onset of ALS symptoms. However the age range for ALS onset spans from 9 years to 93
years (Ferraiuolo et al., 2011; Andersen & Al-Chalabi, 2011). ALS is subclassified into
2 categories: inheritable, familial ALS (FALS) and sporadic ALS (SALS) (Andersen
& Al-Chalabi, 2011). Between 5% and 10% of all ALS cases are FALS patients who
genetically inherited the mutated ALS genes, while the remaining are SALS which
occur seemingly randomly (Ferraiuolo et al., 2011; Andersen & Al-Chalabi, 2011).
Thus it is perplexing to ascertain between these 2 sub-categories clinically because
they share the same clinical symptoms and genetic mutations.
As of date, there are 13 ALS-associated genes with each gene being assigned a subtype
(Ferraiuolo et al., 2011; Andersen & Al-Chalabi, 2011) (Table.1.1). Although it was
believed there are hot spots (mutations sites) in these ALS-associated genes (which
can be used to predict ALS severity), this correlation does not hold (Andersen & Al-
Chalabi, 2011). Several ALS-associated genes are mutated throughout the entire gene
sequence and have no direct correspondence with the ALS severity (Andersen & Al-
Chalabi, 2011). For instance, although many mutations found in superoxide dimutase-1
(SOD1) enzyme (ALS1/FALS) in a Mendelian dominance, there is no clear correlation
between ALS severity and the different SOD1 mutations (Andersen & Al-Chalabi,
2011). On the other hand, the accepted view of SALS occurrence is the combination of
multiple genetic variations of the genes in the kindred of ALS-genes and environmental
risk factors: smoking (Armon, 2009), agricultural chemicals and heavy metal exposure
(Furby et al., 2010; Sutedja et al., 2009).
The multi-factorial causes of ALS prevent accurate and precise diagnosis for susceptible-
ALS patients (Fig.1.1). Furthermore, the neurodegenerative process in ALS patients
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Table 1.1: List of familial ALS type (FALS) and the associated causative gene,
which is adapted from Robberecht & Philips (2013)
.
ALS Type (chromosome Number) Gene FALS(%)
ALS1 (21Q22.1) SOD1 20%
ALS2 (2q33.2) ALS2 ≪1%
ALS3 (18q2.1) Not Identified
ALS4 (9q34) SETX Unknown
ALS5 (15q21.1) SPG11 Unknown
ALS6(16q11.2) FUS 1-5%
ALS7 (20p13) Not Identified
ALS8 (20q13.3) VAPB ≪1%
ALS9 (14q11.2) ANG ≪1%
ALS10 (1p36.2) TARDBP 1-5%
ALS11 (6q21) FIG4 Unknown
ALS12 (10p15-p14) OPTN ≪ 1%
ALS13 (12q24) ATXN2 ≪1%
ALS14 (9p13.3) VCP ≪1%
ALS15 (Xp11.23-p11.1) UBQLN2 5-10%
ALS16 (9p13.3) SIGMAR1 5-10%
ALS17 (3p11) CHMP2B 5-10%
ALS18 (17p13.3) PFN1 5-10%
ALS-FTD (9p21.2) C9orf72 5-10%
may involve other molecular origins that show non-ALS clinical phenotypes such as cog-
nitive impairment, cereballar ataxia, glaucoma, dementia, muscular atrophy, pyschosis
etc; such genes in non-ALS neurodegenerative processes are also mutated in ALS pa-
tients and may precede months to years before the actual onset of ALS symptoms
(Andersen & Al-Chalabi, 2011; Robberecht & Philips, 2013). Interestingly, recent
breakthroughs in ALS research implicate molecular links between ALS with other
non-ALS neurodegenerative diseases such as frontotemporal lobar dementia (FTLD),
myotonic dystrophy, inclusion body of myositis etc (Robberecht & Philips, 2013).
1.1.3 Superoxide dismutase (SOD)
Mutations in human superoxide dismutase-1 (hSOD1) make up about 20% of all famil-
ial ALS cases (FALS) in ALS1 (Ferraiuolo et al., 2011; Robberecht & Philips, 2013).
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Figure 1.1: Many complex and inter-related molecular mechanisms in ALS that
are triggered in the motor neurons, adapted from Ferraiuolo et al. (2011). Neu-
rodegeneration could be a combination of proteinopathy, ribonucleopathy (impaired
processing of DNA intron and RNA splicing), oxidative damage from free radicals,
impaired organelles functions (such as mitochondria, the endoplasmic reticulum [ER],
Golgi), cellular toxicity from excessive glutamate excitation; neuroinflammation from
activation of astrocytes, glial cells.
While SOD1 is 153 amino acid long protein, it has more than 180 genetic mutations dis-
covered till date (http://alsod.iiop.kcl.ac.uk/Als/Index.aspx). Despite several decades
of research into ALS1, molecular causes for ALS onset in ALS1 remains elusive. Fur-
thermore, impairment of the wild-type (WT) SOD1 SOD1WT is linked to aging and
ALS1 (Murakami et al., 2011), which implicate SOD1WT having some roles in ALS
pathogenesis. In general, the family of eukaryotic SOD enzymes in human consists of
three isoforms (Rotunno & Bosco, 2013):
SOD1 is a homo-dimer found in the cytoplasm (predominantly), mitochondria inner
membrane space (IMS), perioxisomes and nucleus.
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SOD2 is a homo-tetramer found in the mitochondria matrix.
SOD3 is a homo-tetramer found in the extracellular matrix.
1.1.3.1 Reactive Oxygen Species (ROS) and SOD1
Reactive oxygen species (ROS): oxygen (O2), hydrogen peroxide (H2O2), peroxide
(•O2−2 ), hydroxyl radical (•OH), hydroxyl ion (OH
−) and superanion oxide (•O−2 ) are
generated from the inevitable, cellular aerobic metabolism of glucose. Small amounts
of ROS are essential in cellular signaling, gene expression and inflammation activation
(Ho¨hn et al., 2013), and moderate concentration of cellular ROS is needed for cellular
proliferation and survival (Parakh et al., 2013). The main sources of ubiquitous su-
peroxide anion are due to ATP generation from mitochondria electron-transport chain
and nicotinamide-adenine dinucleotide phosphate oxidases (NADPH).
Though the abundant superoxide anion has lower oxidative reactivity than hydrogen
peroxide, superoxide anion may be converted to first hydrogen peroxide, and then ex-
tremely active hydroxyl radical (•OH) by various transition metal ions such as Fe2+,
Mn2+, Ni2+, which are found within organelle stores or cytoplasm (Ho¨hn et al., 2013).
Furthermore, superoxide anions can react (to a lesser degree) with NO to more reac-
tive nitrogen species (RNS) such as peroxynitrite (ONOO−) and nitroperoxycarbonate
(NOOCO2−) (Ho¨hn et al., 2013). Protein, being the most abundant species inside the
cells, inevitably become the main targets for the ROS, RNS and their derivative prod-
ucts; these reactive chemical species either attack and cause the fragmentation of the
protein backbone or oxidize amino acid side-chains such as phenylalanine, tyrosine,
tryptophan, histidine, leucine, methionine and cysteine (Ho¨hn et al., 2013). As such,
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motor neurons may be more susceptible to damage by excessive ROS because they con-
sume more oxygen than other types of cells and thus generating significantly higher
amount of cellular ROS (Parakh et al., 2013).
SOD in general catalyzes the reduction of superanion oxide (•O2−) into O2 and H2O2,
which is epitomized by the general mechanism of SOD below (Fridovich, 1995):
1. •O2− + Cu2+-SOD → O2 + Cu
+-SOD1
2. •O2− + 2H+ + Cu+-SOD → H2O2 + Cu
2+-SOD
1.1.3.2 Structure of human SOD1 (hSOD1)
Figure 1.2: Topological representation of SOD1. (A) Numbering of the eight β-
strands and the loops are based on order of appearance, starting from the N-terminus
(Parge et al., 1992). (B) The crystal structure of dimeric SOD1WT (1SPD) with one
Cu2+ (orange) and Zn2+ (blue) per monomer. Protomer 1 is colored as cyan and
protomer 2 as magenta. (Parge et al., 1992). (C) The four cysteines in a monomeric
SOD1, with native disulfide bridge formed between Cys57 and Cys146.
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hSOD1 is a homo-dimeric enzyme (Fig.1.2B) with each monomer having 153 residues
and a molecular weight of 16 kDa. There are 4 cysteines in which two are free (C6 and
C111), and the other two are in an intra-disulfide bridge (C57 and C146) (Fig.1.2C). Its
folded architecture is a β-barrel with eight anti-parallel β strands in which β1-3 and β6
are connected together to form the characteristic Greek key motif (Fig.1.2A), and two
loop regions: the electrostatic loop (loop VII: residue 121-141) and the Zn2+-binding
loop (loop IV: residue 49-84) (Fig.1.2A). The electrostatic loop does not participate
directly in the catalysis process but contains a number of charged residues. The elec-
trostatic loop becomes ordered upon Zn2+ binding and forms a narrow channel above
the active site to select for superoxide anions (Strange et al., 2003; Kayatekin et al.,
2008). Interestingly mutations along this loop may affect the catalytic rate of hSOD1
(Rakhit, 2009).
1.1.3.3 Cu2+, Zn2+ and the maturation of hSOD1
Figure 1.3: Metal-binding sites and the coordinating residues in monomeric hSOD1
(1SPD). Zn2+-binding residues: His63, His71, His80 and Asp83. Cu2+-binding
residues: His46, His48, His63 and His120.
hSOD1 uses the solvent exposed copper ion for its catalytic activities. There is a
specific copper chaperone for hSOD1 (hCCS) which loads the Cu ion into pre-folded
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Zn-bounded SOD1 (Culotta et al., 1997; Schmidt et al., 2000). Although there are
other sources to account Cu loading (such as reduced glutathione) into SOD1 (Carroll
et al., 2004), these alternative sources are believed to be ineffective (Wong et al., 2000).
Zn2+ is buried deep inside the β-barrel of SOD1 which is necessary for maintaining
the correct conformation of SOD1 (Furukawa et al., 2004; Furukawa & O’Halloran,
2005) (Fig.1.3). In addition, Zn2+ initiates or catalyzes the folding of unstructured
hSOD1 (Leinartaite et al., 2010), which is necessary for immature SOD1 to interact
with hCCS (Furukawa et al., 2004; Furukawa & O’Halloran, 2005). Without Zn2+ ions
supplement, motor neurons of hSOD1 ALS mice model underwent faster apoptosis
probably due to lack of cytosolic, functional hSOD1 (Este´vez et al., 1999). These
experimental observation underscore the quintessential role of Zn2+ in the maturation
of hSOD1 in-vivo.
After hCCS inserts one Cu2+ ion into the monomeric Zn2+-bounded partially-folded
hSOD1, hCCS catalyzes the formation of disulfide bond between C57 and C146 (Banci
et al., 2003; Furukawa et al., 2004). The Cu2+ is further stabilized by coordinate
bonding from His46, His48, His63, His120, and the Zn2+ ion is stabilized by coordinate
bonding with His63, His71, His80 and Asp83 (Fig.1.3, Parge et al. (1992)). His63 acts
as a bridge between the Cu and Zn binding site and further stabilizes the structure
of the hSOD1 (Fig.1.3). In addition, Asp124 plays an important stability role where
it is hydrogen bonded to His46 and His71. In fact, hSOD1 mutant of Asp124 showed
dramatic reduction in Zn2+ affinity and partial unfolding (Rakhit et al., 2002).
After the monomeric hSOD1 matures, it is released from hCCS where it dimerizes
with another matured, monomeric hSOD1. The dimerization interface contains hy-
drophobic and hydrophilic interactions and hydrogen bonding that contribute to the
enhanced structural stability of hSOD1 (Getzoff et al., 1989). For example, though the
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monomeric E.coli SOD is highly homologous to the dimeric hSOD1, it has a lower melt-
ing point and its active site is easier to be denatured than the hSOD1 (Johnston et al.,
2000). Indeed, the structural stability of hSOD1WT is remarkable: it can withstand
high temperature (above 80◦C) (Lepock et al., 1990), 4% SDS (Forman & Fridovich,
1973) and 10M urea (Marklund et al., 1997). Enzymatic activity of fully matured,
dimeric hSOD1 is stable over a large range of pH 6-11 (Senoo et al., 1988) and its
catalytic activity lifetime can be maintained even for several centuries (Weser et al.,
1989). These experimental findings imply that the dimerization of hSOD1 enhanced
its structural and thus enzymatic stability.
Removing Zn2+ and Cu2+ from hSOD1 causes it to unfold and become monomeric
in-vivo and in-vitro (Nordlund & Oliveberg, 2006; Shaw et al., 2006), as the disul-
fide bridge in unfolded hSOD1WT is susceptible to reduction in the cytoplasm (Kay-
atekin, 2010). In addition, loops IV and VII in hSOD1 becomes highly disordered
upon removing Zn2+ and Cu2+ from hSOD1 (Strange et al., 2003), which may in-
crease the propensity of its native disulphide bond being reduced (Kayatekin et al.,
2010). Mutations disrupting the coordinate bonding of hSOD1 to the Zn2+ and Cu2+
such as H43R causes hSOD1 to be folded differently from hSOD1WT , which makes
these hSOD1 mutants a nucleus for unfolding and/or aggregation of other functional
hSOD1WT (Christie & Turnley, 2012; Fujimaki et al., 2013). Thus only fully matured
hSOD1WT is resistant to disulfide reduction as the intra-molecular disulfide bond is
protected from the highly reducing cytosolic environment.
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1.1.4 Trans-active response (TAR) DNA-binding protein (TDP43)
Trans-active response (TAR) DNA-binding protein (TDP43) is a 43-kDa protein (Fig.1.4A)
which was first discovered as a transcription activator that repressed human immun-
odeficiency virus (HIV)-I transcription (Ou et al., 1995). Subsequently, TDP43 was
found to be involved in a myriad of RNA metabolism where it regulates RNA tran-
scription, RNA splicing and miRNA processing (Verma & Tandan, 2013; Da Cruz &
Cleveland, 2011; Udan & Baloh, 2011). TDP-43 is also part of the heterogeneous nu-
clear ribonucleoprotein (hnRNP) family which comprises of well-known RNA splicing
modulators (Hasegawa et al., 2011; Wang et al., 2012; King et al., 2012; Ling et al.,
2013; Lee et al., 2012; Polymenidou & Cleveland, 2011). Through its association with
different binding protein partners, it shuttles between the nucleus and cytoplasm to
perform its RNA metabolic roles (Verma & Tandan, 2013). TDP43 has a long list of
RNA targets and absence of its control in some of these RNA targets are implicated in
its ALS-pathogenesis such as the expression and splicing regulation of the Tau protein
(Da Cruz & Cleveland, 2011).
While TDP43 forms a smaller complex of 300-400kDa in the nucleus, TDP43 forms
a larger complex of ≥ 1MDa in the cytoplasm (Da Cruz & Cleveland, 2011). Inter-
estingly, insoluble TDP43 aggregates are found in approximately 97% ALS and 45%
of FTD patients regardless of genetics inheritance or sporadic mutations (Ling et al.,
2013). It was clinically found Alzheimer’s patients with these TDP43 insoluble inclu-
sions suffer from enhanced cognitive impairment (Josephs et al., 2014). While TDP43
is aggregation prone because of the necessary reversible oligomerization for its physi-
ological functions (Wang et al., 2012, 2002), ALS pathogenesis of TDP43 may begin
after its reversible oligomerization becomes irreversible.
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1.1.4.1 Topology of TDP43
Figure 1.4: Structural properties of TDP43. (A) The domain architecture of TDP43
which contains a nuclear localization signal (NLS), nuclear export signal (NES) and
4 domains: N’, two RNA recognition motif domain, and C’-prion like domain which
is the nexus of ALS and FTLD mutations (Da Cruz & Cleveland, 2011). (B) Hy-
drophobicity of prion-like domain from Lys262 to Met414; hydrophobicity scale used
is Kyte-Dolittle. The blue box indicate the hydrophobic region, which is also helical
from Ala321 to Ser347. (C) Hydrophobic moment measures amphiphilicity, in which
a helix alternates between a hydrophobic and hydrophilic residue. The cutoff (hori-
zontal line) for amphiphilic region is 0.35 and scale used is n-octanol scale (Wimley
et al., 1996).
TDP43 is a 414 amino acid protein which contains a nuclear localization signal (NLS),
nuclear export signal (NES), and four structural domains (Fig.1.4A). Previously, the
structure of N’ domain was not known because it has severe aggregation problems
(Chang et al., 2012). The structure of N’ domain was recently solved and found to
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contain both structured and unstructured conformational states (Qin et al., 2014).
There are two RRM domain contains the RNA recognition motifs, which can bind to
single-stranded RNA, and their crystal structures had been solved by X-ray crystal-
lography (Kuo et al., 2009).
1.1.4.2 Prion-like domain in TDP43
Sup35 (a yeast protein) epitomizes prion-like protein in which its N-terminus (Q/N-rich
region) undergo a self-propagating amyloid formation under stressful condition (Udan
& Baloh, 2011). While not all Q/N-rich domains can undergo self-propagation of
amyloid, these Q/N-rich domains are usually disordered and have a strong propensity
to self-aggregate.
In TDP43, the C’ domain is known as Gly-rich region because of high content of glycine
(Fig.1.4A) and is also known as prion-like domain (TDP43prion) because of its richness
in Gln(Q), Asn(N) and Ser(S) residues (approximately 32%) (Udan & Baloh, 2011).
These residues are enriched in the prion protein (Stahl et al., 1993). Out of the 44 ALS
and FTLD mutations discovered for TDP43, about 40 of them are located in the C’
prion-like domain (Da Cruz & Cleveland, 2011) (Fig.1.4A). Interestingly, TDP43prion is
highly hydrophobic (Fig.1.4B) and is believed to be the membrane-interacting fragment
responsible for TDP43 neurotoxicity in ALS (Liu et al., 2013; Jiang et al., 2013a;
Zhu et al., 2014). This TDP43prion contains no nucleic acid binding motifs, but it
meditated TDP43 binding to other heterogeneous ribonucleoproteins (hnRNPs) for




1.1.5 Molecular pathogenesis in ALS
1.1.5.1 The link between protein aggregation and ALS
Insoluble protein aggregates (amyloid fibers) in neuronal cells is one perennial hall-
mark of neurodegenerative diseases; protein aggregates are also found in other human
diseases (systemic amyloidose) such as type II diabetics (mutation of IAPP), lysozyme
amyloidosis (mutation of lysozyme 130 α+β), cataract (mutation of γ-Crystallins)
(Chiti & Dobson, 2006). These insoluble proteinaceous inclusion are typically fibril-
liar, spherical, ubiquitinated, and found primarily in motor neurons of spinal cord and
brain stem of ALS patients (Per, 2011). Such mutant ALS proteins in these inclusion
bodies are typically assumed to be misfolded, partially unfolded or unable to fold.
These insoluble proteins aggregates may also elicit extensive neuro-inflammation re-
sponses from both astroyctes and microglia which could speed up the apoptotic signal
in neighboring neuronal cells (Philips & Robberecht, 2011).
In-vivo and in-vitro aggregates of hSOD1 monomers are usually apo form and disulfide
reduced (Furukawa & O’Halloran, 2005; Furukawa et al., 2008; Chattopadhyay et al.,
2008). Through partial-unfolding or misfolding, hSOD1 aggregates into β-amyloid
aggregates (Banci et al., 2008; Furukawa et al., 2008), or are cross-linked between the
exposed cysteines of apo monomeric hSOD1 mutant (Furukawa et al., 2006; Niwa et al.,
2007). Although numerous X-ray crystals of various SOD1 ALS mutants are similar in
structure, solution NMR showed several regions of fully-matured hSOD1 ALS mutants
have elevated dynamics or partial unfolding in their electrostatic loop, Zn2+-binding
loop and β 3-4, which showed ALS mutations enhance the partial unfolding of hSOD1
that contributed to its enhanced aggregation propensity (Rotunno & Bosco, 2013).
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Recent findings implicate TDP43 mutants in the pathogenesis of FALS, SALS, and
frontotemporal lobar degeneration (FTLD) (Da Cruz & Cleveland, 2011; Verma &
Tandan, 2013). Although TDP43 is a nuclear protein, TDP43 insoluble aggregates in
ALS patients were consistently found in the cytoplasm of both motor and frontotem-
poral lobar neurons (Verma & Tandan, 2013; Da Cruz & Cleveland, 2011; Udan &
Baloh, 2011; Lee et al., 2012). Increasing number of experimental results show TDP43
ALS mutants have enhanced post-translational modifications (PTM) which trigger the
formation of such insoluble, cytoplasmic TDP43 aggregates, and such PTM include
acetylation (Cohen et al., 2015), phosphorylation (Nonaka et al., 2009) and ubiquiti-
nation (Nonaka et al., 2009) .
1.1.5.2 Protein aggregates inhibits the proteasome pathway
Overwhelming increase of cytosolic, insoluble protein aggregates may inhibit the pro-
teasomal pathway and trigger apoptotic signal in neuronal cells (Hyun et al., 2003;
Wilde et al., 2011). Several studies using the neuronal cells showed hSOD1 mutants or
DTT-treated holo hSOD1 formed extensive insoluble protein aggregates, overwhelmed
the cellular proteasome capacity and triggered the apoptotic signal (Stieber et al., 2000;
Hyun et al., 2003; Urushitani et al., 2002; Basso et al., 2006; Niwa et al., 2007). Post-
translation modification (PTM) of TDP43 such as acetylation (Cohen et al., 2015),
phosphorylation (Nonaka et al., 2009) and ubiquitination (Nonaka et al., 2009) increase
the formation of insoluble PTM TDP43 aggregates and may enhance the inactivation
of proteasome pathway which trigger the apoptotic pathway.
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1.1.5.3 Endoplasmic reticulum (ER) and elevated unfolded protein re-
sponse (UPR) of protein aggregates
The endoplasmic reticulum (ER) is the cellular center for translation, folding and
post-translation of protein and is associated with other cellular organelles such as the
nucleus, Golgi apparatus, the mitochondria. Misfolded protein or protein aggregates
within the lumen of ER triggers the unfolded protein response (UPR) to salvage the
unfolded or misfolded proteins (Walker & Atkin, 2011). In the motor neurons of
transgenic mutant FALS models, ER stress (UPR) gene are typically up-regulated
prior to the onset of ALS symptoms (Saxena et al., 2009; Thompson et al., 2013; Prell
et al., 2012).
One important UPR target is a UPR-induced chaperone (PDI) which regulates the for-
mation of disulfide bonds and controls the redox conditions of ER. The redox regulation
of PDI is compromised in the ALS patients because of elevated protein aggregates in
the ER (Akhtar et al., 2012). The ever-increasing amount of unfolded proteins in
the ER lumen also enhanced the activation of apoptotic signal as intracellular stores
of Ca2+ in ER are poured into the cytosol which activates the caspases that trigger
apoptotic signal in these neuronal cell (Gong et al., 2007). Recent evidence support
this notion as the early accumulation of ‘misfolded’ SOD1 on the ER membrane en-
hance the activation of ER stress or UPR extensively in motor neurons (Sun et al.,
2015). Furthermore, the prolonged activation of UPR can also compromise its in-vivo
functions, as the elevated activation of UPR is correlated with increased association of
SOD1 aggregates (Bergemalm et al., 2010; Basso et al., 2009) and TDP43 aggregates
(Suzuki & Matsuoka, 2012; Walker et al., 2013) with UPR proteins and other resi-




1.1.5.4 Loss of function due to protein aggregation?
The notion that protein aggregation initiates and perpetuates neurodegeneration dis-
eases has had gained wide acceptance over the years. Formation of these insoluble
protein inclusions may capture other cellular proteins to prevent their normal cellu-
lar functions, and thus leading to the abnormal cellular physiology and activation of
cellular apoptosis (Ferraiuolo et al., 2011; Andersen & Al-Chalabi, 2011).
The abundant cytosolic SOD1 removes ROS, and mutant hSOD1 are associated with
increased amount of oxidized bio-macromolecules (lipid, DNA and proteins) in spinal
cord tissue of both SALS and FALS patients (Shibata et al., 2001; Ferrante et al., 1997;
Saccon et al., 2013). This association led to the speculation the loss of functional SOD1
generates a massive buildup of superoxide anion that causes the massive oxidative
damage to the various cellular components (Shibata et al., 2001; Ferrante et al., 1997;
Saccon et al., 2013). However, this hypothesis have been widely disregarded, and
another hypothesis (aberrant redox chemistry) is favored where the partial unfolding of
hSOD1 exposes the narrow channel to the active site which allow non-native substrate
to enter and become converted to more potent ROS/RNS (Este´vez et al., 1999). Several
evidence support this “aberrant redox chemistry” hypothesis: partially unfolded, WT-
like hSOD1 mutants do have some level of oxidase activities (Liochev & Fridovich,
2000); increased conversion of nitric oxide to more potent peroxynitrite upon Zn2+
depletion (Este´vez et al., 1999); other transition metal ions such as Mn2+ bind to the
active site and partakes in the aberrant redox chemistry (Este´vez et al., 1999); H2O2
may interact with Cu+ in SOD1 to produce more potent hydroxyl radical (• OH)
(Wiedau-Pazos et al., 1996). However, this “aberrant redox chemistry” theory is not
widely accepted as the main cause for ALS1-meditated neurodegeneration.
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TDP43 is involved in a wide spectrum of RNA metabolism such as RNA transcription,
RNA splicing and miRNA processing (Verma & Tandan, 2013; Da Cruz & Cleveland,
2011; Udan & Baloh, 2011). However cytoplasmic, insoluble TDP43 aggregates may
recruit and cause the aggregation of functional nuclear TDP43 into the cytoplasm (Lee
et al., 2012). This gradual depletion of functional, nuclear TDP43 may lead to aberrant
cellular RNA splicing control and inhibition of other essential TDP43 physiological
functions that accelerate apoptosis onset (Lee et al., 2012). However there is no clear
conclusive evidence to support the loss of TDP43 native function as a principal ALS
molecular pathogenesis (Lee et al., 2012).
1.1.5.5 Protein aggregation as a protective mechanism?
Recent research suggests protein aggregates may be a cellular protection against the
cytotoxic effects of partially-unfolded proteins (Rotunno & Bosco, 2013; Cragnaz et al.,
2014; Mompea´n et al., 2014); partially-unfolded proteins aggregated into insoluble ag-
gregates which allow certain adapter proteins to bind and activate proteosome machin-
ery like autophagosomes to degrade these insoluble protein aggregates (Bjørkøy et al.,
2005; Tyedmers et al., 2010).
Although partially unfolded or misfolded of hSOD1 WT and mutants are implicated in
ALS pathogenesis as these proteins are found extensively in inclusion bodies for both
SALS and FALS patients, it is increasingly believed that the soluble, partially-unfolded
of hSOD1 may be chiefly responsible for the cytotoxic effects of ALS1 (Rotunno &
Bosco, 2013). hSOD1WT is implicated in pathogenesis of ALS as it is found in inclusion
bodies and aggregates in post-mortem studies of spinal cords of SALS and FALS pa-
tients (Rotunno & Bosco, 2013). Antibodies had identified partially unfolded regions
of hSOD1WT implicated in the ALS pathogenesis: residue 2-20 (β1-2) and residue
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133-153 (the dimer interface) (Rotunno & Bosco, 2013), and these SOD1 unfolded
regions were increasingly detected as astrocytes continually express mutant hSOD1
isolated from human SALS patients (Haidet-Phillips et al., 2011). Though there is no
clear demonstration that hSOD1WT causes SALS, these experimental evidence suggest
the partially unfolded hSOD1WT may contribute the vicious cycle of deregulation of
cellular machinery, and aggregation of the soluble and unfolded hSOD1WT may be
protective for the neuronal cell.
Functional self-oligomerization of full-length TDP43WT is essential for its function and
is non-neurotoxic (Da Cruz & Cleveland, 2011). Several in-vitro studies had identified a
membrane-interacting motif in TDP43prion responsible for TDP43 neurotoxicity in ALS
(Liu et al., 2013; Jiang et al., 2013a; Zhu et al., 2014). Such specific self-oligomerization
of TDP43 may bury certain motifs which prevent neurotoxic effects of these motifs
(Cragnaz et al., 2014; Mompea´n et al., 2014) such as membrane perturbation of the
membrane-bound organelle or vesicles.
1.1.5.6 Aggregation-prone or aggregated proteins perturbing membrane-
bound organelles or vesicles
Interestingly, a number of aggregation-prone proteins involved in different neurode-
generative diseases are found to interact with the plasma membrane (Elfrink et al.,
2008; Nanga et al., 2009). Such aggregation-prone proteins are found to interact with
phospholipids mimetics, such as: MSPV APBP56S in ALS8 (Papiani et al., 2012; Qin et al.,
2013b), α-synuclein in Parkinson’s disease (Auluck et al., 2010), N’ of Huntington
in Huntingtin’s disease (Suopanki et al., 2006). These experimental results suggest
aggregation-prone proteins can generally interact and perturb the membrane integrity
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of membrane-bound organelles or vesicles and eventually triggering apoptosis in vul-
nerable neurons. An alternative view is the plasma membrane surface may serve as a
nucleation center for these aggregation-prone proteins.
The β-strands and edges of hSOD1 are filled with solvent-exposed charged residues,
which are proposed to prevent the aggregation of holo, hSOD1WT (Richardson &
Richardson, 2002; Nordlund & Oliveberg, 2006). While the hydrophobic residues are
typically buried within the hydrophobic core, the buried regions in these β-strands
may be amphiphilic (Richardson & Richardson, 2002). Mutations may cause proteins
to expose these amphiphilic sequences and allow these amphiphilic regions to interact
with membrane-bound organelle or vesicles. Indeed, hSOD1 WT-like mutants have
showed increased exposure of these amphiphilic regions that makes up the β-barrel:β4
(residues 42-50) and β7 (residues 109-123) (Karch & Borchelt, 2010a). Furthermore,
aggregates of hSOD1 mutants interacted and caused the leakage of liposomes (mem-
brane mimetics), and this interaction is attributed to the amphiphilic nature of lipid
and exposed β-sheet regions in these hSOD1 mutants (Choi et al., 2011a,b). Golgi
apparatus are often found fragmented in the presence of hSOD1 mutant aggregates
(Stieber et al., 2000) and UPR is upregulated as a result of unfolded hSOD1 associ-
ation to the ER surface (Sun et al., 2015). Recent research demonstrated partially
unfolded, WT and mutant hSOD1 affect primarily the mitochondria of motor neurons
cells (Son & Elliott, 2014) and because motor neurons in general have greater longevity,
the accumulation of partially unfolded hSOD1 over time enhances membrane pertur-
bation of mitochondria (for a comprehensive review see: (Son & Elliott, 2014)). In
addition, unfolded, immature SOD1WT are transported to the inter-membrane space
of mitochondria (Kawamata & Manfredi, 2010), which suggested unfolded hSOD1 has
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an intrinsic affinity for the mitochondria. These experimental results illustrate the in-
trinsic proclivity of hSOD1 to interact with lipid membrane and disrupt the membrane
integrity of membrane-bound organelles or vesicles.
While there is no obvious amphiphilic region in TDP43prion, it contains a highly hy-
drophobic region (Fig.1.4B). Recent experimental studies show TDP43 protein aggre-
gates disrupt cellular vesicle transport which could be through perturbing or impairing
membrane dynamics of membrane-bound organelles such as ER (Stoica et al., 2014;
Soo et al., 2015), Golgi apparatus (Fujita et al., 2008; Soo et al., 2015) and mitochon-
dria (Wang et al., 2013; Magrane´ et al., 2013). Interestingly, peptides based on the
sequence of TDP43prion have the ability to perturb membrane dynamics and cause
the leakage of membrane-bound liposomes (Liu et al., 2013; Sun et al., 2014). These
experimental results illustrate TDP43prion also has the intrinsic ability to interact
with phospholipids and perturb the membrane integrity of these membrane-bound or-
ganelles, similar to hSOD1.
1.2 Methodology
1.2.1 Circular dichroism spectroscopy
Circular dichroism (CD) is the dichroism of circularly polarized light, which is the
differences in light adsorption between left-handed and right-handed circular polarized
light when they passed through a optically-active sample such as proteins in solu-
tion. At the other end of the CD machine, the left-handed and right-handed circular
polarized light are combined and an elliptical wave is obtained if the sample is optically-
active. Proteins in solution are optically-active because of their structural asymmetry.
CD has had been routinely to study the protein conformations within the far-UV range
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(190nm-260nm). CD spectrum in the near-UV (250nm-300nm) range are mainly from
aromatic residues such as Trp, Tyr, Phe, while CD spectrum in the UV-visible range
(300nm-750nm) is due to the presence of chromophores.
CD spectrum in the far-UV range can monitor changes to the protein conformation
when additives or other molecules are added. But as the CD spectrum is a reflection of
the overall structural content in the solution, the CD spectra of other molecules have
to be determined prior to making concluding interpretation. Unstructured proteins
have negative ellipticity between 190nm and 210nm. Proteins with predominant α-
helix conformation have one positive elliptical peak between 190nm and 200nm and
two negative elliptical minima between 200nm and 240nm. Proteins with predominant
β-sheet conformation have one positive elliptical peak between 190nm and 205nm and
one negative elliptical peak between 205nm and 230nm.
1.2.2 Fluorescence spectroscopy
Fluorescence occurs as excited electrons return to ground state with emitted photons
having a longer wavelength than its excited wavelength (Lakowicz, 2013). Fluores-
cence spectroscopy in protein science comes from aromatic residues which behaves like
intrinsic fluorophore: tyrosine (Tyr), phenylalanine (Phe), and especially tryptophan
(Trp) which has the highest quantum yield or highest amount of emitted photons per
excitation (Lakowicz, 2013). Trp is typically excited between 280nm and 295nm, and
its fluorescence emission spectrum is collected between 300nm and 400nm. This emis-
sion spectrum is highly sensitive to chemical environment which may influence the
fluorescence properties of Trp, and thus this emission spectrum can reflect changes in
the tertiary packing or structure of protein; if solvent exposed Trp becomes buried into
the hydrophobic core of either protein aggregates or globular proteins, the maxima of
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emission spectra will shift and the fluorescence intensity will also change (Lakowicz,
2013).
Extrinsic fluorescent probes are routinely used in protein science as their fluorescence
properties changed after binding to solvent accessible, hydrophobic pockets of protein
aggregates or globular protein; such probes include congo red, ThS (Thioflavin-S),
ThT (Thioflavin-T), ANS (8-Anilino-1-naphthalenesulfonic acid) which are known to
bind to β-rich aggregates (Nilsson, 2004; Shukla et al., 2004; Guptasarma, 2008; Chan
et al., 2013; del Mercato et al., 2007; Westermark et al., 2000). A popular probe used
here is ThT, where its emission spectra is collected between 450nm and 650nm after
being excited between 440nm and 450nm. Only in the presence of β-rich aggregates,
the maximum of emission spectra will significantly increase and is dependent on the
amount of β-rich aggregates formed, but the maximum may decrease overtime as the
β-rich aggregates may form larger aggregates with less accessible hydrophobic pockets
(Nilsson, 2004; Shukla et al., 2004; Guptasarma, 2008; Chan et al., 2013; del Mercato
et al., 2007; Westermark et al., 2000).
In addition, a recent discovery demonstrated β-rich protein fibrils have intrinsic visible
fluorescence (emission spectrum is collected from 390nm to 650nm with excitation
wavelength between 370nm and 380nm), and the maximum of this emission spectrum
increase as the richness of β-sheets increases during the aggregation of β-rich protein
such as tau protein, lysozyme, amyloid-β protein fragments (1-40, 1-42) (Guptasarma,
2008; Chan et al., 2013; del Mercato et al., 2007). This intrinsic fluorescence of β-rich
protein is independent of aromatic sidechains such as Tyr, Phe and Trp; instead it is
thought that the electron delocalization gradually becomes extensive as the β-richness
increases in these β-rich fibrils, and permits lower energy electronic transitions for
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excited electrons to return to ground state and thus giving rise to this intrinsic visible
fluorescence (Guptasarma, 2008; Chan et al., 2013; del Mercato et al., 2007).
1.2.3 Nuclear magnetic resonance
Modern nuclear magnetic resonance (NMR) spectroscopy used in protein science in-
cludes: structure determination, functional dynamics, ligand-binding properties, and
etc. Nucleons particles like neutrons and protons have an intrinsic quantum property
called spin, which means these particles are constantly rotating around a fixed axis and
the spin quantum number (I) determines its overall spin. NMR utilizes the intrinsic
spin property of a particular atomic nuclei to be studied. Nuclei with even number of
protons and neutrons such as 12C, 16O and 32S have an overall zero spin quantum num-
ber as the spins of protons and neutrons are paired and thus canceling the magnetic
moment of the other spins.
On the other hand, the most commonly used isotopes or spin-active nuclei in protein
NMR studies are those with odd number of protons and neutrons viz. 1H, 13C and
15N. Such spin-active nuclei have an overall non-zero spin quantum number as there
are unpaired protons or neutrons and thus an intrinsic magnetic moment (µ), which
allow these nuclei to behave like small magnets and become aligned to an external
applied magnetic field (Bext or B0) in the NMR machine.
1H, 13C and 15N have spin
quantum number of 12 , which makes analysis of these nuclei straightforward. Nuclei
with spin quantum number of 12 can adopt 2 possible spin states in Bext: α (+
1
2) which
is aligned to Bext and β (−
1
2) which is aligned against Bext. The energy difference
between the 2 spin states (∆E) is given by γhB02π , where γ is the constant gyromagnetic
ratio of a particular nuclei, and B0 is the strength of the magnetic field. The detected
NMR signals of these spin-active nuclei reflect the ∆E between the two spin states.
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Thus the higher the magnetic field of the NMR machine, the larger ∆E is and the
better NMR signal becomes. 1H has the highest gyromagnetic ratio, while 1H/13C is
about 4 and 1H/15N is about 10 (Wuthrich, 1986).
Figure 1.5: The precession of net magnetization vector in an external magnetic field
(Bext). µ1 illustrates the precession path of an earlier net magnetization vector, while
µ2 illustrates the precession path of the same net magnetization vector at a later time.
For a simple illustration of how NMR works, let’s assume all the same spin-active
nuclei type in the protein are approximated to a macroscopic magnetization vector or
commonly referred as the net magnetization vector. In the presence of only external
magnetic field (Bext or B0), this net magnetization vector (µ) is aligned to the Bext in
the z-axis direction. Bext exerts a torque force on the net magnetization vector which
has an intrinsic angular moment moving at an angle to the Bext. The derivative of this
torque force gives the angular velocity frequency or the Larmor frequency (ω0), which
is defined as ω0 = γB0.
A small radio frequency (RF) pulse (B1) is applied to excite the spin-active nuclei by
pushing the previously aligned net magnetization vector (to z-axis) onto the x-y plane
(Fig.1.5). However in order for the RF pulse to push the net magnetization vector
onto the x-y plane flatly, the frequency of RF pulse should be exactly at ω0 frequency.
In the past, the right frequency is determined by scanning through a range of RF
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frequencies, which is also called continuous wave. In modern NMR, a pulse of broad
RF frequency range is used to simultaneously excite all nuclei, and are analyzed using
Fourier transform (FT) technique.
After exciting the net magnetization vector (by pushing it onto the x-y plane), the net
magnetization vector will gradually precesses back to equilibrium at the z-axis (µ1 to
µ2) (Fig.1.5). The precession of the net magnetization vector back to equilibrium (z-
axis) is commonly referred as relaxation. Throughout the relaxation process, the net
magnetization vector is projected into 2 components: x-y plane and z-plane. These x-y
plane and z-plane components of the net magnetization vector induces a small current
in the various receiver coils placed at different orientations in the NMR machine: x,
y, z and etc, which are then recorded as a free-induction decay (FID) signal. The FID
signal intensities decrease with time as the net magnetization vector precesses back to
the z-axis. The FID signal is fourier transformed into a spectrum of unique frequencies
(1H, 13C and/or 15N) of the studied molecular system.
1.2.3.1 Chemical Shifts
Each unique spin-active nuclei spin in a molecule has an unique NMR resonance fre-
quency which depends on its surrounding chemical environment. The NMR resonance
frequency is a reflection of its surrounding chemical environment such as solvent effects,
electronegative neighboring atoms influencing its electron density, the presence of para-
magnetic atoms or ions which resulted in anisotropic induced magnetic field effects,
shielding and deshielding magnetic effects from the electrons in the adjacent bonds
and atoms which generate induced magnetic fields after these electrons interact with
the primary or external NMR magnetic field (Bext or B0) (Wuthrich, 1986). However
the location of this resonance signal depends on the magnetic field strength and the
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RF frequency, and thus various reference standards or compounds (deuterium oxide
[D2O], TMS [tetramethylsilane], etc) are used to remove the variability of resonance
signal location by converting the NMR resonance frequency into a NMR parameter





Chemical shift index (CSI) is a quick way to assess secondary structure of proteins
where CSI is the random coil adjusted Cα and/or Cβ chemical shifts of residues in the
studied protein; corresponding Cα and/or Cβ chemical shifts of residues are subtracted
from the corresponding chemical shifts from a database of proteins with predominant
random coils (Wishart & Sykes, 1994). The enhanced difference of ∆Cα - ∆Cβ (CSI)
per residue allow the determination of which residue are α-helical (CSI > +3ppm),
β-sheet (CSI < -1.48ppm), or random coil (approximately -1ppm ≤ CSI ≤ +1ppm)
(Wishart & Sykes, 1994).
1.2.3.2 J-Coupling
Because neighboring magnetic moments (from neighboring nuclei) interact with the
studied nuclei, electrons in the chemical (scalar) bonds between the two nuclei become
polarized, and thus resulting in the splitting of NMR resonance lines in the NMR
spectrum. This effect is called J- or scalar coupling, and this J-coupling is limited to
nuclei being bonded to less than 5 bonds. J-coupling is routinely in used in multidi-
mensional NMR correlation experiments (2D, 3D, 4D) to provide information about
the conformation properties of amino acid backbone and sidechain, and help identify
spin systems that are connected that are larger than one bond.
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1.2.3.3 Nuclear overhauser effects (NOE)
Nuclear overhauser effects (NOE) is a cross-relaxation of coupled spins which are cou-
pled by dipoles. NOE is the magnetization transfer amongst nuclei that in close prox-
imity, and the effectiveness of this magnetization transfer scales with r−6, where r is
the distance between spin-active nuclei in A˚. Thus observable NOE are for nuclei which
are in close proximity of up to 5A˚. NOE intensities are divided accordingly into three
distance categories: NOEs with strong intensity have distance range between 1.8A˚ and
2.8A˚; NOEs with medium intensity have distance range between 1.8A˚ and 3.5A˚; NOEs
with weak intensity have distance range between 1.8A˚ and 5.0A˚ (Wuthrich, 1986).
1.2.3.4 Dynamics in the ps-ns time range
T1 is referred as longitudinal relaxation where the spin nuclei exchange their irradi-
ated energy (RF) to the surrounding (lattice); there is an eventual lost of energy. T1
is also the rate of repeating any NMR sequence. T2 is referred as transverse relaxation
where the spin nuclei loses phase coherence with the neighboring nuclei; there is no
lost in energy. T2 is inversely proportional to the peak width of a particular resonance.
T2 is also sensitive to conformational exchanges and molecular size of protein, where
T2 values in larger proteins are smaller and thus their NMR spectra lines are broad-






) and heterogeneous NOE
(hnNOE) probes the intra-molecular motion between the pico-second (ps) and nano-
second (ns). These NMR relaxation parameters are related to the dynamics of bond
vector of hydrogen attached to either 15N or 13C (X), through their spectral density
J(ω) function in these equations ((Kleckner & Foster, 2011):
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(dipolar interactions) , cX =
ωX∆σ
31/2
, rXH is the X-H bond
length, µ0 is the permeability of free space, γH is the gyromagnetic ratios of
1H, γX is
gyromagnetic ratios of X spin (X=13C or 15N), ωH is the Larmor frequencies of
1H spin,
ωX is the Larmor frequencies of X spin, ∆σ is the chemical shift anisotropy of the X
spin. The J(ω) is the Fourier transformation of the auto-correlation function Crot(τ),
where τ is the rotational correlation time. Crot(τ) is physically defined as Crot(τ).ν0
. ν(τ), where ν is the orientation vector of bond X-H. This equation establishes the
relationship of J(ω) to the dynamics of bond vector (X-H). However the analytical form
of Crot(τ) depends on the definition of diffusion tensor or the assumption of protein
physical dimensions: either isotropic (spherical protein) or anisotropic (non-spherical
protein) (Kleckner & Foster, 2011).
1.2.3.5 Chemical exchange: Dynamics in the µs-ms time range
Chemical exchange refers to intra-molecular or inter-molecular events that cause spin-
active nuclei to be in two or more chemical environment, or commonly referred to as
conformation states. Although there could be multiple conformational states in the
studied protein, only the two-state conformational exchange is widely used (Kleckner
& Foster, 2011). The chemical exchange regime occurs in the µs-ms of NMR timescale,
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where there is rapid inter-conversion of transient, intermediary conformations. Intra-
molecular conformational exchange correlates to movement of protein side-chains dur-
ing unfolding or folding, conformation equilibria. Inter-molecular conformational ex-
change correlates to ligand binding, isotopic exchange (HDX) and enzymatic catalysis
processes.
Rex or its inverse (Kex) is the conformation exchange rate in the µs-ms of NMR
timescale. Two popular NMR experiments to derive Rex are Carr-Purcell- Meiboom-
Gill (CPMG) experiment and rotating-frame relaxation (R1ρ) experiment. CPMG is a
NMR pulse sequence that uses a series of varying spin-echo delays or CPMG frequen-
cies (τcpmg) (Kleckner & Foster, 2011). Rotating-frame relaxation (R1ρ) uses a series
of ‘spin-lock’ RF pulses with different effective field strength, ωeff ; R1ρ measures the
relaxation of the magnetization vector along a smaller field B1 (the RF field), and RF
field is static in the rotating frame (Kleckner & Foster, 2011). These 2 experiments
provides a relaxation dispersion curve where the intensity of observed R2 is plotted to
establish the relationship between the line-broadening due to chemical exchange and
(τcpmg) or ωeff .
If the exchange rate Kex occurs faster than the chemical exchange rate (µs-ms), the
line-shape of the NMR spectrum is an average of the two or more conformations. If
the exchange rate Kex occurs slower than the chemical exchange rate (µs-ms), the
line-shape of the NMR spectrum will show two or more conformations. However as
the frequency differences between the two conformation states is dependent on external
magnetic field strength (B0), it is recommended to use multiple magnetic field strengths
(B0) to derive the exchange parameters of the two conformational states such as kinetics





Figure 1.6: Illustration of 1D-1H NMR spectrum. The blue line indicates the
approximate range for each particular type of protons (1H). SC indicates sidechains.
1D-1HNMR provides important structural information about protein structure. Figure
1.6 shows the proton peaks between -1ppm and 12ppm in the 1D-1H NMR spectrum.
As proteins contain a large number of protons, this 1D-1H NMR spectrum is usually
overcrowded, and 1H peaks of several residues overlap with each other. The position of
each 1H peak correlates to an unique type of proton, which are labeled in Figure 1.6.
Typically, the backbone amide protons of unfolded proteins has a narrow distribution
range of 1ppm unlike folded protein which typically spreads beyond 1.5ppm. One
important use of 1D-1H NMR is to detect subtle structural changes that cannot be
captured by the less sensitive 2D-HSQC. The upfield peaks are found between -1ppm
and 0.7ppm, and these peaks indicate methyl protons are interacting with aromatic
sidechain in a stacking fashion. It also reflects tertiary packing of several secondary
structure elements in the protein.
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1.2.3.7 NMR structure determination
Figure 1.7: Cβ and Cα connectivities of G37-F45 in SOD1L126Z in DPC. This figure
only shows the HNCACB strips of each residue.
There are several steps in protein structure determination. First is obtaining the
isotopic-labeled protein samples. E.coli containing the plasmid with the sequence of
the recombinant protein is grown in medium enriched with 15N, 13C and/or 2H iso-
topic salts. 13C-labeled proteins are obtained by growing E.coli cells in 13C glucose,
and 15N-labeled proteins are obtained by growing E.coli cells in 15N ammonium sul-
phate. 1H is naturally occurring with a high abundance of 99.9% (Wuthrich, 1986).
The purified protein solution is dissolved in phosphate buffer or milli-Q water contain-
ing between 5% and 10% D2O. Concentration of protein ranges from 40µM (normal
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titration experiments) to 500µM (for structure determination). Optimizing the exper-
imental conditions such as temperature, pH, ionic salt strength, and other additives
are typically done before 3D-NMR experiments; these optimization experiments are
done with 2D-HSQC to assess the stability of protein over a course of several days.
Second after the experimental conditions optimization, a series of 3D or 4D-NMR
hetero-nuclear experiments are done to obtain chemical shifts assignments of the amino
acids (1H, 15N, 13C) and distance restraints assignments. Such typical 3D-NMR
experiments include: 13C-edited HNCACB, 13C-edited HCC(CO)NNH, 13C-edited
CBCB(CO)NH, 15N-edited HSQC-TOCSY, 15N-edited HSQC-NOESY. For this project,
only 3D-NMR experiments are collected. The starting step is to do backbone assign-
ment of backbone amide of all residues in the HSQC spectrum. It is done with a simple
strategy of identifying the 13C chemical shifts: Cα, Cβ, Cγ and etc of the preceding
and the current residue (using13C-edited HNCACB), and matching with 13C chem-
ical shifts of only preceding residue (using13C-edited CBCA(CO)HN). This strategy
is illustrated in Figure 1.7 which shows the sequential assignment for a stretch of 9
residues (G37-F45) in SOD1L126Z in DPC, but CBCA(CO)HN spectra has been omit-
ted for clarity. After the backbone amide (NH) of all assignable peaks are done, the
different types protons (1H) are assigned using 15N-edited HSQC-TOCSY. 15N-edited
HSQC-NOESY are used for NOE assignment: sequential, short and long-range.
Third after the 1H, 15N, 13C chemical shifts are obtained for all assignable amino acid,
these chemical shifts are converted into backbone dihedral restraints using Talos+
(Shen et al., 2009) or some other software. The NOE assignment are then converted
into distance restraints. With the backbone dihedral and NOE distance restraints,
the NMR structure can be calculated using software like CNS (Bru¨nger et al., 1998)
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or Cyana (Gu¨ntert, 2004a). Several rounds are done to improve score of the calcu-
lated structures, before the final structures are energy minimized (EM) by forcefield
parameters like Amber (Lindorff-Larsen et al., 2010) or Charmm (Patel & Brooks,
2004). Finally, the quality of the EM NMR structures are checked by software like
Procheck (Laskowski et al., 1993) which gives the distribution area of dihedral angle,
and show whether the dihedral angles are in the allowed regions or disallowed region
in the ramanchandran plot.
1.2.4 Molecular dynamics (MD) simulation
Physical chemistry of molecules are modeled in a slew of equations, to which molecular
dynamics (MD) simulation aims to utilize these equations to study the physical chem-
istry of molecules in various chemical milieu such as water, methanol, non-polar solvent.
The dynamic behavior of molecules are elucidated after the analysis of MD simulation
data. However, the conclusions from these analyses are limited to the physical chem-
istry models being used. Various parameters are devised to describe the physical
chemistry of molecules: non-bonded energy terms (electrostatics and van-der-waals)
and bonded energy terms (bonding, dihedral angles, bond-angles). Typically, these
parameters are collated into a force-field, and there are various brands of force-fields
which differs in the empirical fitting to experimental values. Collectively, force-field
parameters of all molecules in the studied system yield the potential energy of the
system.
Classical Newtonian MD simulation begins by initializing the position and velocity
vectors of all atoms in the simulated system. At every new time step of MD integration,
the forces acting on all atoms are computed. The force is defined as the derivative of
the potential energy of all atoms in the simulated system, Fi=
dV
dr⃗i
where Fi is the force
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on atom i, dV
dr⃗i
is the derivative of potential energy at a function of coordinate vector r⃗i
of atom i (Hess et al., 2008). Time-trajectories of all atoms are determined by solving
the Newton’s equation with the force derived from the potential energy calculated from




= Fi, i = 1...N




where mi is the mass of atom i,
∂2ri
∂t2
is the acceleration of atom i, r⃗i is the coordinate
vector of atom i, v⃗i is the velocity of atom i. This MD integration process will con-
tinue until the stipulated time duration. There are different flavors in MD simulation:
fully-atomistic, monte-Carlos (which generates random trajectories), coarse-gaining
(which sacrifice atomistic details for computation speed), hybrid QM/MM and etc.
Fully-atomistic MD simulation with classical Newtonian mechanism is selected for this
project as the computation speed is not too costly and the simulated time scale can de-
cently match the timescale of NMR experiments done on SOD1. However, drawbacks
of classical Newtonian MD simulations include the following: limited time scale acces-
sible (between ns and µs), which inversely scales with the size of the studied system;
the general lack of polarization effects treatment in force-fields; cut-offs to limit the
computation efforts of determining interaction between molecules; quantum mechanics
effects of electron and protons are not captured.
1.3 Project aims
Recent research churned out contrasting evidence and questioned whether protein ag-
gregates are neurotoxic or the loss of function due to aggregation is solely responsible
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for neuronal degeneration (see Fig.1.1 for more details). Neurodegeneration may be a
constellation of molecular mechanisms which enhanced the apoptosis of motor neurons
(Ferraiuolo et al., 2011; Robberecht & Philips, 2013). Furthermore, the heterogeneity
in genetic and molecular causes of ALS complicates ALS diagnosis (Ferraiuolo et al.,
2011; Robberecht & Philips, 2013). However multiple molecular causation can provide
more opportunities and approaches to treat ALS and improve its prognosis.
While SOD1 and TDP43 represent a major slice of ALS research done, there is no
consensus on their proposed ALS molecular mechanisms. Each of these proposed
mechanisms may be the next neuronal apoptotic flash-point. We aim to employ various
complementary biophysical studies in understanding how these two proteins contribute
to ALS molecular pathogenesis:
1. We like to understand how these two ALS-relevant proteins differ in their interac-
tion with phospholipids, and the molecular implications behind their differences
in phospholipid interaction. SOD1 contains a highly hydrophilic Zn2+-binding
lop and several amphiphilic regions. On the other hand, TDP43 contains only a
hydrophobic region.
2. Besides Zn2+ and Cu2+, other heavy metal ions are found to be enriched in
especially in SOD1 aggregates (Ayton et al., 2013; Oba et al., 1993; Ignjatovic´
et al., 2013). Thus we like to assess how such heavy metals affects the structural
properties of SOD1. The results can shed light on the in-vivo maturation inhibi-
tion of SOD1 in the presence of cytosolic accumulation of heavy metals, which is




3. TDP43 requires self-oligomerization or oligomerization with other hnRNPs for
its physiological functions (Hasegawa et al., 2011; Wang et al., 2012; King et al.,
2012; Ling et al., 2013; Lee et al., 2012; Polymenidou & Cleveland, 2011). As
most of ALS mutations of TDP43 are localized at the prion-like domain (Ling
et al., 2013), we like to assess the relevance of these ALS-mutants in the self-
oligomerization process of TDP43prion, and whether such ALS mutations changes




2.1 Protein samples production
The author would like to thank and acknowledge the help from students (Wei Yuanyuan,
Lu Yimei, Lee Xiaowen, Tan Yanming) and research staffs (Yew Hongmeng, Miao Lin-
lin) who contributed to the production of the lyophilized protein samples. TDP43prion
WT and mutants had 6 His residues at C’-terminus. SOD1 WT and mutants used
for SOD1 interaction with lipids had N’ His-tag, while SOD1 WT and mutants used
in SOD1 interaction with metal ions had no His-tag. In general, these recombinant
proteins were found in insoluble inclusion bodies and resuspended in 8M urea at pH
8.5, before being purified using reverse-phase HPLC. The HPLC elute were lyophilized
for at least one day before use.
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2.2 Sample preparation for experiments
Lyophilized protein samples were first dissolved with milli-Q water and the concentra-
tion of these samples were determined with their absorbance at 280nm using 8M urea;
their pH ranges from 2.6 to 4.4, which depends on the trace amount of TFA (Tri-fluoro
acetic acid) from the HPLC purification. The CD samples were prepared by diluting
from the stock solution accordingly to reach about 15µM to 25µM in concentration.
NMR samples were prepared by diluting from the stock solution accordingly to reach
about 50µM (for NMR titration experiments) to 500µM (for 3D-NMR experiments)
in concentration.
2.3 Bicelle preparation
One limitation of using DPC micelle is its physical curvature imparts conformational
strains on the protein to be studied. Bicelle mimics the flat bilayer to a certain de-
gree which were used for CD and NMR titrations. Bicelle were constructed with
DMPC (long-chain; 1,2-dimyristoyl-sn-glycero-3-phosphocholine) and DHPC (short-
chain; 1,2-dihexanoyl-sn-glycero-3-phosphocholine) with a molar ratio of 4:1; this lipid
composition mix of DMPC and DHPC is common for solution NMR and CD studies,
though varying the ratio of DMPC to DHPC gives different bicelle diameters (Prosser
et al., 2006). Furthermore, the bicelle comprising of 4x DMPC to 1x DHPC can mimic
the bilayer membrane (Durr et al., 2012).
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2.4 CD experiments
CD experiments were performed on a Jasco J-810 spectropolarimeter at 25◦C, using a
cuvette with 1mm pathlength. The data spectral resolution is set at 0.1nm, and three
independent scans were averaged to yield the final CD graph. The estimated structural
contents of the CD spectra is done by deconvoluting these CD spectra with the CDPro
software suite (Sreerama & Woody, 2000).
2.5 NMR experiments
NMR experiments were done on a 800 MHz Bruker Avance spectrometer which has a
cryoprobe and pulse field gradient units. About 5% of total sample volume is D2O.
For structure determination, 13C-edited triple resonance experiments like HNCACB,
CBCA(CO)NH, (CCC)CONH were used to obtain the carbon chemical shifts; 15N-
edited HSQC-TOCSY and HSQC-NOESY were used to obtain the NOE restraints.
The chemical shifts were converted to dihedral restraints with Talos+ (Shen et al.,
2009), and the NMR structures were calculated using Cyana (Gu¨ntert, 2004a). Between
five and ten NMR structures with the lowest target-function value from CYANA were
further refinement with GROMACS version 4.5.3 (Hess et al., 2008) using Amber99sb-
ildn force field (Lindorff-Larsen et al., 2010); these NMR structures have no NOE
violation greater than 0.4A˚ and dihedral angle violation greater than 4◦. The refined
structures were further checked with PROCHECK-NMR (Laskowski et al., 1993) before
data submission. Secondary structural propensity (SSP) score of a residue uses its
∆Cα,∆Cβ ,∆Hα to compute its secondary structure propensity (Marsh et al., 2006).
Backbone dynamics of protein in the ps-ns timescale regime was obtained from 1H-15N
steady-state NOEs (heterogeneous NOEs) either with or without 1H pre-saturation of
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3s and a relaxation delay of 6s. Backbone dynamics of protein in the µs-ms timescale
regime was obtained from 15N transverse relaxation dispersion experiments with a
constant time delay of τCP at 50 ms), and a series of CPMG frequencies which ranges
from 40Hz to 960Hz. A reference spectrum (without the CPMG block) was obtained
to derive the effective transverse relaxation rate (R2eff ) using this equation:
R2eff = −lnI(vCPMG)/I0/TCP ,
where I(vCPMG) is the peak intensity at each unique CPMG frequency and I0 is the
peak intensity in the reference spectrum.
The solvent accessibility of protein residues in solvent or phospholipid milieu was
assessed either with gradual titration of paramagnetic manganese (Mn2+) chloride
or gadodiamide (Gd3+-5,8 bis(carboxylatomethyl)-2-[2-(methylamino)-2-oxoethyl]-10-
oxo-2,5,8,11- tetraazadodecane-1-carboxylate hydrate).
2.6 Fluorescence spectral measurements
All fluorescence spectra measurements were done with a RF-5301 PC spectropho-
tometer (Shimadzu, Japan) at 25◦C. The pathlength dimension of fluorescence quartz
cuvette is 10mm x 10mm. The general spectrophotometer settings used were: data
resolution set at 0.2nm, medium scan speed (about 250nm/min), PMT voltage set at
low sensitivity. The emission spectra of intrinsic UV fluorescence was measured with
the excitation wavelength set at 280nm, with excitation slit width of 5nm and emission
slit width of 10nm. The emission spectra of intrinsic visible fluorescence was measured
with the excitation wavelength set at 375nm, with excitation slit width of 20nm and
emission slit width of 10nm.
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The emission spectra of thioflavin-T (ThT) binding was done in triplicates with ex-
citation wavelength at 442nm and excitation slit width of 5nm and emission slit of
10nm. A ThT stock solution of 2mM was initially prepared by dissolving ThT pow-
der into milli-Q water. This solution was filtered through a 0.22µm Millipore filter to
remove any undissolved ThT powder. By diluting accordingly the ThT stock into 1
mM phosphate buffer of pH6.8, the working ThT solution was obtained with final ThT
concentration at 50µM. 10µl aliquot of protein or buffer (as control) was mixed with
the working ThT solution and incubated in the dark for 10 mins before obtaining the
emission spectrum.
2.7 Transmission electron microscopy (TEM) imaging
A TEM microscope (Jeol Jem 2010f Hrtem, Japan) with accelerating voltage of 200
kV was used to image the protein samples. 5µl of protein solutions was dropped onto
Cu grids, which are 3mm in diameter, have 150 meshes and are coated with carbon
film. Negative staining was done with 5µl of 2% neutral, phosphotungstic acid (PTA).
This solution mixture was incubated for 30 sec before the excess fluid was drained.
Subsequently, the Cu grid was air-dried for 15 mins before being imaged.
2.8 Molecular dynamics (MD) simulation
The forcefield parameters of proteins were described using Amber99sb-ildn force field
(Lindorff-Larsen et al., 2010), while the forcefield parameters describing DPC molecules
are obtained from Abel et al. (2012). The MD simulation was performed using GRO-
MACS version 4.5.3 (Hess et al., 2008). To generate unstructured peptides, Pymol was
first used to generate a fully extended peptide; the N’ is capped with acetyl and C’ is
41
Material and methods 42
capped with N-methyl to avoid the artificial charged-termini effect. Thereafter, a short
MD simulation of 100ps was applied with temperature of 350K to derive the initial
structure of unstructured peptides in which sidechains residues were not in close prox-
imity, and the backbone were sufficient extended. The initial structure of SOD1L126Z
with the lowest target-function from CYANA is not capped. The MD simulation of
peptides with DPC was done with the peptide being centered in the simulation box and
65 DPC molecules randomly positioned throughout the box; the length of cubic box
is about 70A˚. The MD simulation of SOD1L126Z with DPC was done with SOD1L126Z
being centered in the simulation box and 150 DPC molecules randomly positioned
throughout the box; the length of cubic box is about 100A˚. The molecular system is
then immersed with water molecules; the water molecules were described with TIP3P
water model (Jorgensen et al., 1983). Counter-salt ions (Na+ or Cl−) were used to
neutralize the charge from the protein.
The protocol for MD simulation of proteins with DPC was adapted from Abel et al.
(2012). The starting molecular system were first energy minimized (EM) using the
steepest descent algorithm that terminates when the energy score of the system is
lower than -1000 kJ mol−1 nm−1. Then, two equilibration phases were done for each
EM molecular system. Protein, DPC, counter salt ions and water molecules were
coupled separately to thermostatic baths. During the two equilibration, heavy atoms
of protein and DPC molecules were restrained harmonically with a force constant of
1000kJ mol−1 nm2. The first equilibration was in the NVT ensemble for 200ps using
the Berendsen thermostat with τT of 0.1 ps at 300K. The second equilibration was
in the NPT ensemble for 300 ps using Nose-Hoover thermostat with τT of 0.1ps at
300K and the Parrinello-Rahman barostat with τP of 3.0ps at pressure of 1.015 bar
and a pressure compressibility of 45x10−6 bar−1. The equilibrated molecular system
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was subsequently simulated without restraints for 200ns in the NPT ensemble using
Nose-Hoover thermostat with τT of 0.3ps at 300K and the Parrinello-Rahman barostat
with τP of 1.0ps at pressure of 1.015 bar and a pressure compressibility of 45x10
−6
bar−1. Throughout the MD simulation, the periodic boundary conditions was set up
with electrostatic interactions being described with the particle-mesh Ewald method
(Essmann et al., 1995). 10A˚was the cutoff for non-bonded interactions. A 2fs timestep
was used to integrate the MD equations of motions, and the neighbor pair list was
updated every 10ps. Trajectories were captured every 2ps. Analysis were done using




3.1 SOD1 interaction with phospholipids
3.1.1 Introduction
Figure 3.1: Primary sequence of SOD1L126Z and SOD1WT . The full primary se-
quence of SOD1WT (A1-Q153) is shown. The black horizontal line denotes the pri-
mary sequence of truncated SOD1L126Z , which is terminated at the 125th residue.
Most SOD1 mutants are found in proteinaceous, insoluble aggregates in ALS patients
(Stieber et al., 2000; Cheroni et al., 2005; Basso et al., 2006). If the unfolded aggregates
of SOD1 mutants cannot be salvaged, these aggregates are tagged with ubiquitin and
degraded by ubiquitin-targeting proteasome (Stieber et al., 2000; Cheroni et al., 2005;
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Basso et al., 2006). But the continuous accumulation of these SOD1 aggregates can
overwhelm proteasomal machinery and allow these SOD1 aggregates to capture other
proteins and also explore other cytotoxic or neurotoxic effects (Stieber et al., 2000;
Cheroni et al., 2005; Basso et al., 2006). Interestingly, soluble and insoluble SOD1
aggregates were found to associate and cause the dysfunction of membrane-bound
organelles: mitochondria (Liu et al., 2004; Jonsson et al., 2004; Velde et al., 2008;
Israelson et al., 2010), endoplasmic reticulum (ER) (Atkin et al., 2014; Homma et al.,
2013), Golgi apparatus (Urushitani et al., 2008) and peroxisomes near the mitochondria
(Urushitani et al., 2002). More importantly, recent evidence points out soluble SOD1
mutants may be more cytotoxic than the insoluble form (Rotunno & Bosco, 2013;
Zetterstro¨m et al., 2007; Brotherton et al., 2013). Instead, formation of insoluble
SOD1 aggregates may be a cellular protection mechanism against further cytotoxicity
(Rotunno & Bosco, 2013), which is seen in other neurodegenerative diseases (Auluck
et al., 2010; Bodner et al., 2006).
Naturally occurring mutations of SOD1 include several C’-truncated versions: a stop
codon in SOD1L126Z (Fig.3.1) (Zu et al., 1997) and SOD1G141Z (Nakamura et al., 2015)
or nucleotide insertion which encodes a stop codon in SOD1G127insTGGG (Jonsson et al.,
2004). These C’-truncated mutants cannot dimerize because they lack the last β-strand
that makes up dimer interface, and rationalize their increased aggregation propensity
and cellular turnover as compared to SOD1 WT-like mutants (Wang et al., 2003;
Ghadge et al., 2006). While transgenic mice model with these C’-truncated SOD1
mutants consistently showed upregulation of small-heat shock proteins (chaperones)
such as αB-crystallin, (Wang et al., 2005; Karch & Borchelt, 2010b), these cellular
response may not ameliorate the aggregation and ALS severity of SOD1L126Z (Karch &
Borchelt, 2010b). Interestingly, SOD1L126Z aggregates are found almost exclusively in
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detergent-insoluble (SDS) fractions unlike aggregates of other SOD1 WT-like mutants
which can be found in both soluble and detergent-insoluble factions (Wang et al., 2005).
In this section, both unstructured, SOD1WT and truncated C’ SOD1 mutant (SOD1L126Z)
were found to interact with DPC (a lipid mimetic) and regions of previous SOD1 β-
strands adopted amphiphilic α-helices. These amphiphilic α-helices maximize positive
energetics through forming α-helical hydrogen bonds, which offsets the negative ener-
getics due to being immersed into the hydrophobic environment of the lipid environ-
ment (White & Wimley, 1999; Ladokhin & White, 1999). Through MD simulation, we
found the highly hydrophilic Zn2+-binding loop engaged extensive but transient hydro-
gen bonds with the DPC micelles either through its backbone or sidechain atoms. This
transient interaction of Zn2+-binding loop with DPC is reflected experimentally by the
lack of its conformational exchange and its rather low hnNOE values which reflects
unconstrained motion. These observations imply Zn2+-binding loop may transiently
assist in anchoring the unfolded amphiphilic regions of SOD1 to the phospholipid in-
terface, where these unfolded region start to form amphiphilic helices. In addition, the
molecular size of SOD1L126Z in DPC may be smaller than SOD1WT which can help
rationalize SOD1L126Z enhanced neurotoxicity in-vivo (Karch & Borchelt, 2010b).
3.1.2 Bio-informatics analysis
3.1.2.1 Disordered propensity of SOD1L126Z and SOD1WT
Disorder analyses were done on the sequence of SOD1L126Z and SOD1WT . Although
different software uses combinations of different criteria to assess the disorder propen-
sity of proteins, these criteria generally include low sequence complexity, less hydropho-
bicity, secondary structure propensity, and etc (Su et al., 2006; He et al., 2009). Figure
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Figure 3.2: Disordered prediction done for the sequence of SOD1L126Z (red) and
SOD1WT (black). (A) Disorder prediction of SOD1L126Z and SOD1WT using the
software Ipad. The horizontal line is set at 0.27 which is Ipad threshold for disorder-
ness. Difference protein sequence may have different threshold values for disorderness.
(B) Disorder prediction of SOD1L126Z and SOD1WT using the software Iupred. The
horizontal line is at 0.5, which is Iupred threshold for disorderness. (C) Disorder
prediction of SOD1L126Z and SOD1WT using the software pondrfit. The horizontal
line is at 0.5, which is pondrfit threshold for disorderness.
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3.2 shows the predicted disordered region of SOD1L126Z and SOD1WT using different
bio-informatics programs.
iPad (Su et al., 2006) predicted disordered regions of SOD1L126Z is at the N’ (A1-
G12), Zn2+-binding loop regions (G61-E78), and C’ (R115-D125); for SOD1WT , the
N’ and Zn2+-binding loop region is the same as SOD1L126Z except for the C’ disordered
region, which is A123-Q153 (Fig.3.2A). For Iupred, the predicted disordered regions
of SOD1L126Z is at the N’ (A1-V7), Zn2+-binding loop regions (G61-V87), C’ (K122-
D125); for SOD1WT , the main differences are in the C’ disordered region: K128-
G138 and G147-Q153 (Fig.3.2B). For Pondrfit, the predicted disordered regions of
SOD1L126Z is at the N’ (A1-G12), Zn2+-binding loop regions (R69-D92), C’ (G114-
D125); for SOD1WT , the main differences are in the C’ disordered region: D124-N139
and G150-Q153 (Fig.3.2C).
While there are variations in the length of predicted disordered regions, the general
consensus of disordered regions are the first (N’) and last ten (C’) residues of SOD1,
the zinc binding loop and electrostatic loop (Fig.3.2). The general consensus of non-
disordered region in SOD1WT and SOD1L126Z are β-strand regions: E14-G61 (N’) and
D92-K123 (C’) (Fig.3.2).
3.1.2.2 Hydrophobicity propensity analysis of SOD1WT
Many propensity scales for amino acids were developed for the bio-informatics analyses
of primary sequences of protein such as hydrophobicity, hydration potential, α-helices
and β-sheets propensities and etc. As these calculated values (based on propensity
scales) are dependent only on the primary sequence, there will be little difference in
the calculated hydrophobicity and amphiphilicity between a truncated SOD1L126Z and
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Figure 3.3: Hydrophobicity propensity analysis on the primary sequence of
SOD1WT . (A) Hydrophobicity values with a window size of 7 residues, using the
Kyte-Dolittle’s hydrophobicity scale (Kyte & Doolittle, 1982). Negative values means
hydrophilic regions, and positive values mean hydrophobic regions. (B) Amphiphilic-
ity or hydrophobic moment calculated using Mpex Octanol Hydrophobic scale (Wim-
ley et al., 1996). The window size of 7 residues were used.
SOD1WT . Therefore only the calculated hydrophobicity and hydrophobic moments (a
measure of amphiphilicity) of SOD1WT are presented in Figure 3.3.
Regions with relative high hydrophobicity are β-stranded regions: A4-L9, Q15-N19,
E100-H120 and L144-G150 (Fig.3.3A), and regions with high amphiphilicity are also
β-regions: N26-H46, D93-S105 and E121-K136 (Fig.3.3B). It is clear that the Zn2+-
binding loop is highly hydrophilic (Fig.3.3A) and lacks the amphiphilicity seen in other
regions of SOD1 (Fig.3.3B). With the exception of the Zn2+-binding loop, the other
regions of SOD1WT at the N’ and C’ generally alternate between hydrophobicity/hy-
drophilicity and amphiphilicity.
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While canonical trans-membrane (TM) regions of proteins typically have high hy-
drophobicity (White & Wimley, 1999; Cramer et al., 1992), several studies have also
demonstrated amphiphilic helices are able to interact with the membrane bilayer with-
out the requirement for a sequential stretch of hydrophobic residues like the canonical
TM regions (Brown et al., 1980; Vogel, 1981; von Heijne, 1986; Ulmer et al., 2005; Xiao
et al., 2012). The bioinformatics analysis here suggests alternating stretches of am-
phiphilicity and hydrophobicity, as well as the predicted disordered regions may enable
unfolded SOD1WT to uniquely interact with the lipid membrane unlike a canonical TM
or typical amphiphilic protein.
3.1.3 Experimental results
3.1.3.1 CD and NMR studies of SOD1L126Z and SOD1WT
At pH3.5 and minimal salt concentration, SOD1L126Z showed a typical unstructured,
random coil conformation in the CD spectra with the characteristic negative elliptical
value between 190nm and 200nm (Fig.3.4A). In contrast, the matured hSOD1WT (pur-
chased from Sigma-Adrich) showed a characteristic β-sheet conformation (Fig.3.4A).
To evaluate the membrane interaction of SOD1L126Z and SOD1WT , phospholipid
mimetic dodecylphosphocholine (DPC) was used. The addition of DPC pushed the un-
structured SOD1L126Z to adopt a helical conformation (Fig.3.4B), which started at 80x
DPC and became saturated between 150x DPC and 200x DPC. In contrast, addition of
DPC had no significant effect on matured hSOD1WT (purchased from Sigma-Adrich)
as there was no significant structural perturbation of β-conformation (Fig.3.4C). Even
after heating matured hSOD1WT to 90◦C and adding 3mM EDTA (to chelate the
Zn2+ ion), DPC titration had little effect on the β-conformation of matured SOD1WT
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Figure 3.4: Far-UV CD spectra characterization of SOD1L126Z and SOD1WT .
(A) Far UV spectra of 20µM native SOD1WT in milliQ water, purified from hu-
man erythrocytes (purchased from Sigma Aldrich) (black), and 20µM SOD1L126Z in
milliQ water at pH3.5 and minimal salt concentration (red). (B) 20µM SOD1L126Z
(black) with DPC titration of various molar ratios to protein: 50x(red), 100x(blue),
150x(green), 200x(cyan), 400x(magenta). (C) 20µM native SOD1WT in milliQ wa-
ter with DPC titration of 100x (red) and 400x (blue). Another sample of native
SOD1WT was heated to 90◦C and 3mM EDTA was added (green), and after cooling,
400xDPC was added (cyan.) (D) 20µM SOD1WT without Zn2+ and disulfide bridge
(black) with DPC titration of various molar ratios to protein: 50x(red), 100x(blue),
150x(green), 200x(cyan), 400x(magenta).
(Fig.3.4C). These observations attest to the remarkable structural stability of matured,
dimeric SOD1WT after undergoing all the necessary maturation steps.
The addition of DPC to unstructured SOD1WT (demetallated and no disulfide bridge)
also had the same effect of pushing SOD1WT to form a helical conformation (Fig.3.4D)
and similar to SOD1L126Z , the helical conformation transition of the unfolded SOD1WT
was saturated between 150x and 200x DPC. We used 2D-HSQC NMR to character-
ize the binding of phospholipid mimetics (DPC) to both SOD1L126Z (Fig.3.5A) and
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Figure 3.5: 2D-HSQC spectrum of SOD1L126Z (A) and SOD1WT (B) in solution
(black) and 200x DPC (red).
SOD1WT (Fig.3.5B), and found significant many peaks shifts. These results indi-
cate phospholipids interact with unstructured SOD1 and imply that without proper
maturation, both SOD1 WT and other ALS mutants have the ability to interact with
phospholipids and perturb the membrane integrity of membrane-bound organelles (Liu
et al., 2004; Jonsson et al., 2004; Velde et al., 2008; Israelson et al., 2010), or disrupt
vesicles in both intracellular and extracellular transport system (Atkin et al., 2014;
Homma et al., 2013; Urushitani et al., 2002, 2008).
3.1.3.2 Backbone assignment of SOD1L126Z : free and in DPC
The backbone assignment of SOD1L126Z in solution and 200x DPC were done at pH3.5,
25◦C, using 500µM of double-labeled SOD1L126Z (15N and 13C) with a pair of triple
resonance experiments: HNCACB and CBCA(CO)HN. Figure 3.5A shows the 2D-
HSQC NMR spectra for SOD1L126Z in solution and 200x DPC which shows a narrow
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Figure 3.6: CSI comparison between SOD1L126Z in solution (black) and 200x DPC
(red). (A) Carbon CSI of (∆Cα - ∆Cβ) of SOD1L126Z in solution and 200x DPC.
(B) Proton CSI (∆Hα) of SOD1L126Z in solution and 200x DPC. ∆Cα,∆Cβ,∆Hα
are random coil adjusted chemical shifts of each residue (Wishart et al., 1995).
dispersion for the backbone amides, and thus indicates at 200x DPC, SOD1L126Z is
still unable to have any tertiary structure packing.
Figure 3.6 shows the chemical shift index (CSI) deviation of SOD1L126Z in solution
and 200x DPC. The CSI of SOD1L126Z in solution indicates it is a highly unstructured
protein with no tertiary packing, but it has regions with weak helical propensity: R79-
A87 and D92-E98 (Fig.3.6A-B); these small regions with weak helical propensity are
evident with the α-helical NOEs detected: dαN(i,i+2) and dαN(i,i+3) (Fig.3.7A).
The CSI of SOD1L126Z in 200x DPC showed a high population of α-helices where the
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Figure 3.7: NOE sequential plot of SOD1L126Z in (A) solution and (B) 200x DPC.
NOEs includes intra, sequential (i,i+1) and short-range NOEs (i,i+2 → i+4).
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Figure 3.8: Number of NOEs per residue for SOD1L126Z in (A) solution and (B)
200x DPC, using Cyana. White box denotes intra-NOEs, 20%-gray denotes sequential
NOEs (i,i+1) and dark gray denotes short-range NOEs (i, i+2 → i+4).
prominent helical regions are: V14-K23, V29-H43, D96-S107 and D109-V119 (Fig.3.6A-
B). NOEs for a typical α}-helix are also seen in these areas: dαNN(i, i+2), dαNN(i,
i+3) and dαNN(i, i+4) (Fig.3.7B).
For SOD1L126Z in solution, a total of 420 assigned NOEs were found: 261 intra-NOEs,
110 sequential NOEs (i, i+1) and 49 short-range NOEs (i, i+2 → i+4) (Fig.3.8A).
For SOD1L126Z in 200x DPC, there were a total of 951 assigned NOEs: 343 intra-
NOEs, 296 sequential NOEs and 312 short-range NOEs (Fig.3.8B). Although there
were several unassigned NOEs for SOD1L126Z in DPC because of proton ambiguities,
no long-range NOEs could be found or ascertain for SOD1L126Z in DPC. Furthermore
1H of all backbone amides of SOD1L126Z in DPC are distributed between 7.75 ppm
and 8.75 ppm (Fig 3.5A), which indicate SOD1L126Z in DPC had no tertiary packing.
This scenario means SOD1L126Z is not inserted deep into the membrane environment
like unfolded VAPBMSPP56S (ALS8 protein) in DPC (Qin et al., 2013a), which suggest
more opportunities for SOD1L126Z to remodel the membrane dynamics at the plasma
membrane peripheral where there are more vesicular budding and fusion.
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3.1.3.3 Backbone assignment of SOD1WT : free and in DPC
Figure 3.9: CSI comparison between SOD1WT in solution (black) and 200x DPC
(red). (A) Carbon CSI of (∆Cα - ∆Cβ) of free SOD1WT in solution and in molar
ratio of 200x DPC. (B) Proton CSI (∆Hα) of SOD1WT in solution and in molar
ratio of 200x DPC. ∆Cα,∆Cβ∆Hα are random coil adjusted chemical shifts of each
residue (Wishart et al., 1995).
Backbone assignment experiments (HNCACB, CBCA(CO)HN) of SOD1WT in solution
and 200x DPC were done at pH3.5, 25◦C with 600µM, double-labeled of SOD1WT (15N
and 13C). These two 2D-HSQC NMR spectra of demetallated, immature SOD1WT in
solution and DPC (Fig.3.5B) show a narrow 1H dispersion of the backbone amides,
similar to SOD1L126Z in DPC (Fig.3.5A). Furthermore, visible aggregates of SOD1WT
were observed within 3 hours upon addition of 10mM phosphate buffer in 200x DPC,
similar to SOD1L126Z . These observations indicate without Zn2+ and native disulfide
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Figure 3.10: NOE sequential plot of SOD1WT in (A) solution and (B) 200x DPC.
NOEs includes intra, sequential (i,i+1) and short-range NOEs (i,i+2 → i+4).
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Figure 3.11: Number of NOEs per residue for SOD1WT in (A) solution and (B)
200x DPC using Cyana. White box denotes intra-NOEs, 20%-gray denotes sequential
NOEs (i,i+1) and dark gray denotes short-range NOEs (i, i+2 → i+4).
bridge, SOD1WT can interact with phospholipids and is unable to adopt any tertiary
structure packing.
Figure 3.9 shows the CSI of SOD1WT in solution and DPC. The CSI of SOD1WT
in solution (Fig.3.9A) indicates SOD1WT is predominantly an unstructured protein
which has several regions with weak helical propensity: G83-E98 and L124-K126 as
it shows some short-range NOEs characteristics of α-helix: dαN (i,i+2) and dαN (i,i+3)
(Fig.3.10A). The CSI of SOD1WT in DPC showed several regions with prominent he-
lical conformations which are almost identical to those in SODL126Z in 200x DPC
(Fig.3.7B): V14-K23, V29-H43, D96-S107 and D109-V119. In addition, R143-V148
forms an amphiphilic helix in SOD1WT (Fig.3.9B). These helical regions of SOD1WT in
DPC show typical α-helical NOEs: dαN (i, i+2), dαN (i,i+3) and dαN (i,i+4) (Fig.3.10B).
Figure 3.11 shows the number of assigned NOEs for SOD1WT in solution and DPC.
For SOD1WT in solution, there were a total of 857 assigned NOEs: 371 intra-NOEs,
345 sequential NOEs (i,i+1) and 141 short-range NOEs (i, i+2 → i+4) (Fig.3.11A).
For SOD1WT in 200x DPC, there were a total of 1153 assigned NOEs: 442 intra-NOEs,
422 sequential NOEs and 289 short-range NOEs (Fig.3.11B). Similar to SOD1L126Z in
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DPC, the 1H of backbone amide of all residues in SOD1WT in DPC are distributed
in a narrow width between 7.75 ppm and 8.75 ppm (Fig 3.5B), which indicate no
prominent tertiary structural packing. Although there were several ambiguous NOEs
not assigned for SOD1WT in DPC, these ambiguous NOEs are not likely long-range
NOEs because of the narrow dispersed backbone amides.
3.1.3.4 NMR structure of SOD1L126Z in DPC













Distance violation > 0.5A˚ 0
Angle violation >5.0◦ 0
CYANA target function 15.63
Deviations from ideal geometry
Bond length 0.019 ± 0.005A˚
Angles 2.047 ± 0.855 ◦






For the structure calculation of SOD1L126Z in 200x DPC, 106 dihedral angle constraints
and 951 distance restraints were used. Figure 3.12A shows 5 structures of SOD1L126Z in
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Figure 3.12: Calculated NMR structures of SOD1L126Z in 200x DPC using Cyana
(Gu¨ntert, 2004a). (A) Five structures (with the lowest target function) calculated
from Cyana (Gu¨ntert, 2004a). Green, cyan, magenta, yellow and pink correspond
from calculated structures in the order of lowest target function value. (B) Anno-
tated helices of the calculated structure with the lowest target function. (C) Vacuum
electrostatics map of calculated structure with the lowest target function (with 180◦
rotated view). Color code for electrostatic surface: red is negatively charged, blue is
positively charged and white is hydrophobic or uncharged.
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DPC with the lowest Cyana target function values (Gu¨ntert, 2004a), and their statis-
tics are listed in Table.3.1. Because there was no long-range NOEs, the calculated
structures show great variety in their topologies, but the α-helical regions remained
consistent for all the calculated structures. Conformational heterogeneity are also ob-
served for other NMR proteins structures in DPC which lack long-range NOEs such as
amyloid precursor protein’s transmembrane domain (2LLM; Nadezhdin et al. (2011)),
Integrin-β3 subunit (2KV9; Metcalf et al. (2010)), transmembrane and cytoplasmic
domains of human CD4 (2KLU; Wittlich et al. (2010)), and human apolipoprotein C-
II (1SOH; citemacraild2004nmrApolipoprotein). Figure 3.12B illustrates the α-helical
regions of SOD1L126Z formed under the lipid environment mimic by DPC.
Figure 3.12C illustrates the vacuum electrostatic potential map for SOD1L126Z in DPC,
which shows the amphiphilic regions of the four α-helices formed in SOD1L126Z in DPC
(Fig.3.12B); these amphiphilic α-helices show a relatively polar surface on one side and
hydrophobic surface on the other side. Such amphiphilic α-helices are formed to max-
imize the positive energetics from the α-helical hydrogen bonds, which can offset the
negative energetics from being immersed into the hydrophobic phase of the phospho-
lipid membrane (White & Wimley, 1999; Ladokhin & White, 1999). These amphiphilic
α-helices of SOD1L126Z are able to partition to the interface of the phospholipids,
where the hydrophobic part of these amphiphilic regions interact with hydrophobic
hydrocarbon chain of the phospholipids, and the polar surface of amphiphilic regions
interact with either the phosphate or polar headgroup of the phosphocholine. Inter-
estingly, the surface of first half (towards the N’) of SOD1L126Z is largely positively-
charged, while the surface of second half (towards the N’) is largely negatively-charged
(Fig.3.12B); this electrostatic surface uniqueness may determine the membrane speci-
ficity of SOD1L126Z .
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3.1.3.5 NMR structure of SOD1WT in DPC













Distance violation > 0.5 A˚ 0
Angle violation >5.0 ◦ 0
CYANA target function 24.13
Deviations from ideal geometry
Bond 0.019 ± 0.006 ◦
Angles 2.035 ± 0.834 ◦






NMR structure of SOD1WT in DPC was calculated with 156 dihedral angle constraints
(78 residues) and 1153 distance restraints. Figure 3.13A shows 5 structures of SOD1WT
in DPC with the lowest Cyana (Gu¨ntert, 2004a) target function values, and their
statistics are listed in Table.3.2. Similar to SOD1L126Z in 200x DPC (Fig.3.12A),
these helical regions of SOD1WT in DPC had varying topologies but their secondary
structures remained consistent in all the calculated structures. This conformational
heterogeneity are also observed for other NMR proteins structures in DPC which lack
long-range NOEs such as amyloid precursor protein’s transmembrane domain (2LLM;
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Figure 3.13: Calculated NMR structures of SOD1WT in 200x DPC using Cyana
(Gu¨ntert, 2004a). (A) Five structures (with the lowest target function) calculated
from Cyana (Gu¨ntert, 2004a). Green, cyan, magenta, yellow and pink correspond
from calculated structures in the order of lowest target function value. (B) Anno-
tated helices of the calculated structure with the lowest target function. (C) Vacuum
electrostatics map of calculated structure with the lowest target function (with 180◦
rotated view). Color code for electrostatic surface: red is negatively charged, blue is
positively charged and white is hydrophobic or uncharged
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Nadezhdin et al. (2011)), Integrin-β3 subunit (2KV9; Metcalf et al. (2010)), trans-
membrane and cytoplasmic domains of human CD4 (2KLU; Wittlich et al. (2010)),
and human apolipoprotein C-II (1SOH; citemacraild2004nmrApolipoprotein).
Figure 3.13B illustrates the α-helical regions of SOD1WT that are formed in DPC, and
their corresponding amphiphilic surface are shown in Figure 3.13C. The amphiphilic
helical regions of SOD1WT in DPC (Fig.3.13B) are quite similar to that of SOD1L126Z
in DPC (Fig.3.12B), but there is an additional amphiphilic helix (R143-A152) at the
C’ of SOD1WT , and is preceded by the unstructured electrostatic loop (K136-R143) in
DPC (Fig.3.9).
3.1.3.6 NMR dynamics studies on SOD1L126Z and SOD1WT
NMR dynamics experiments and analysis can provide conclusive insights on which
residues of SOD1L126Z and SOD1WT in DPC are dynamic at different time scale.
Thus 400µM of single-labeled (15N) SOD1L126Z and SOD1WT were used for the NMR
dynamic experiments. Heterogeneous nuclear NOE (hnNOE) is a sensitive meter for
backbone amide motion in the ns-ps time scale regime. Figure 3.14A indicates sub-
stantial hnNOE differences of SOD1L126Z in solution and DPC. SOD1L126Z in solution
showed a narrow band of hnNOE distribution where the averaged hnNOE is -0.16 (for
the negative hnNOE) and 0.13 (for positive hnNOE), which indicates the backbone
amides of SOD1L126Z in solution is highly unconstrained; however for SOD1L126Z in
DPC, the averaged hnNOE value of many residues is larger than 0.50, which indi-
cates the backbone amides are largely constrained by the lipid environment of DPC in
the ps-ns time scale regime. The residues between E49 and D90 (Zn2+-binding loop)
of SOD1L126Z remained unconstrained by the lipid environment of DPC (Fig.3.14A),
which suggest Zn2+-binding loop may only be transiently associated with surface of
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Figure 3.14: NMR dynamic studies of SOD1L126Z in solution and 200x DPC. (A)
Heterogeneous-nuclear NOE (hnNOE) barplot for SOD1L126Z in solution (black) and
with 200x DPC (red). The error bars are illustrated on the top of each bar. (B)
Per residue CPMG differences of R2(τcp) at 80Hz and 960Hz, SOD1
L126Z in DPC
(gray). The gray curve is set at 1.5, which is an arbitrary indicator for significant
conformation exchanges in the µs-ms. The small insert shows the CPMG curve of
residues with significant conformation exchanges.
lipid membrane. The chemical (conformation) exchange measures the backbone amide
motion in the µs-ms time scale, in which CPMG relaxation dispersion experiments
were done. The CPMG results indicate a number of residues in SOD1L126Z under-
went conformation exchange in the µs-ms time scale regime (Fig.3.14B); residues in
SOD1L126Z with notable conformation exchange (µs-ms) formed amphiphilic helices
and have reduced motion in the ps-ns timescale regime: A4, L8, V29, T88 and A123.
Similar to SOD1L126Z (Fig.3.14), the hnNOE (ps-ns dynamics) of SOD1WT in solution
and DPC are different (Fig.3.15A). The backbone amides of SOD1WT in solution
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Figure 3.15: NMR dynamic studies of SOD1WT in solution and 200x DPC. (A)
Heterogeneous-nuclear NOE (hnNOE) barplot for SOD1WT in solution (black) and
200x DPC (red). The error bars are illustrated on the top of each bar. (B) Per residue
CPMG differences of R2(τcp) at 80Hz and 960Hz, SOD1
WT in 200x DPC (gray). The
gray curve is set at 1.5, which is an arbitrary indicator for significant conformation
exchanges in the µs-ms timescale. The small insert shows the CPMG curve of residues
with significant conformation exchanges.
are unconstrained as the hnNOEs are narrowly distributed with averaged negative
hnNOE at -0.24 and positive hnNOE at 0.11 (Fig.3.15A). On the other hand, except
the Zn2+-binding loop (E49-D90) and electrostatic loop (H120-S142) in SOD1WT , DPC
constrained the backbone amides in the amphiphilic helices of SOD1WT where the
averaged hnNOE values are larger than 0.50 (Fig.3.15A).
While the hnNOEs of SOD1L126Z (Fig.3.14A) and SOD1WT (Fig.3.15A) are quite
similar in magnitude, only A4 and T88 showed significant µs-ms conformation changes
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(CPMG relaxation dispersion) in both SOD1L126Z (Fig.3.14B) and SOD1WT (Fig.3.15B).
Most CPMG values of SOD1WT (Fig.3.15B) are generally smaller than that of SOD1L126Z
(Fig.3.14A), which indicates SOD1WT in DPC has a slower tumbling time or larger
molecular size than SOD1L126Z . These results suggest under in-vivo conditions, mem-
brane vesicles containing SOD1 WT and WT-like mutants are significantly larger than
those containing truncated SOD1 mutants, and may limit their ability to further in-
teract with membrane system once membrane-bound unlike truncated SOD1. Because
it may be easier for SOD1L126Z to hijack smaller but “aberrant”-shaped vesicles to
severely impair the vesicular ER-Golgi transport system and accelerating apoptosis
onset in motor neurons (Stieber et al., 2000). This molecular pathogenesis can ac-
count partially why truncated SOD1 mutants elicit more severe ALS symptoms than
full-length SOD1 point mutants.
3.1.3.7 SSP comparison of SOD1L126Z and SOD1WT
Chemical shifts differences can be used to predict secondary structure propensity (SSP)
of residues (Marsh et al., 2006) in SOD1 (Fig.3.16). In DPC, α-helical SSP scores of
two regions (V14-E21, S34-L38) in SOD1L126Z (Fig.3.16A) are slightly higher (about
0.1-0.2) than SOD1WT (Fig.3.16B). The higher α-helical tendency in SOD1L126Z sug-
gests increased propensity for backbone hydrogen bonds in its amphiphilic regions to
stabilize its lipid partitioning and compensate for reduced positive energetics due wa-
ter molecules competing for hydrogen bonds with backbone amides (White & Wimley,
1999; Ladokhin & White, 1999) as compared with SOD1WT in DPC. Two regions in
Zn2+-binding loop (A60-F64 and K70-G73) appeared to be more extended in both
SOD1L126Z (Fig.3.16A) and SOD1WT (Fig.3.16B) in DPC. This result indicates the
Zn2+-binding loop became slightly extended after interacting with the DPC molecules.
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Figure 3.16: SSP score comparison of (A) SOD1L126Z and (B) SOD1WT in solution
(black) and DPC (red). SSP score is calculated from the chemical shifts of Cα, Cβ ,
Hα, NH (backbone amide nitrogen) and H (backbone amide proton) (Marsh et al.,
2006). +1 indicates 100% α-helix, and -1 indicates 100% β-sheet.
However in DPC, part of Zn2+-binding loop (A60-F64) in SOD1L126Z (Fig.3.16A) ap-
pears to more extended than in SOD1WT (Fig.3.16B). This observation can be ratio-
nalized as the protein length increases in SOD1WT , backbone and sidechains atoms
from the additional residues can compete with DPC for hydrogen-bonding with the
Zn2+-binding loop, which makes the Zn2+-binding loop slightly less extended in the
SOD1WT .
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Figure 3.17: Amphiphilic helices found for SOD1WT in DPC and its electrostatic
potential surface (left), and 180◦ rotation view (right): (A) V5-K9; (B) V14-S25; (C)
V30-K37; (D) L39-E49; (E) V81-D92; (F) A95-D125; (G) R143-Q152. Color code for
electrostatic surface: red is negatively charged, blue is positively charged and white
is hydrophobic or uncharged.
3.1.4 MD simulation results
Figure 3.17 shows the vacuum electrostatic potential surface of the amphiphilic helices
of SOD1WT in DPC. As molecular dynamics can provide useful molecular details that
cannot be afforded by other biophysical techniques, we used MD simulation is to un-
derstand how unstructured peptides containing either with or without significant am-
phiphilicity gets partitioned to the DPC micelle. The N’ fragment (SOD1npep) contains
the sequence of several amphiphilic helices (V5-H43) as illustrated in Fig.3.17A-C, but
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due to the practicality and limitation of MD simulation box size, the starting structure
of this unstructured amphiphilic region was truncated at H43. The middle fragment
(SOD1midPep) contains the sequence of Zn2+-binding loop (F45-L84) and has no am-
phiphilic region. The last set of MD simulation is done with the NMR structures of
SOD1L126Z in DPC, which can provide us the molecular insights on how the different
regions of SOD1L126Z orientate themselves around the DPC micelle, particularly the
Zn2+-binding loop.
3.1.4.1 MD behavior of SOD1npep with DPC
Figure 3.18: MD simulated behavior of 2 independent sets of N’ fragment (V5-H43)
in SOD1 (SOD1npep) with randomly positioned DPC. (A) RMSD of SOD1npep: red
is the 1st set, and black is 2nd set. (B) RMSF of SOD1npep: red is the 1st set, and
black is 2nd set.
First we evaluated the force-field ability to capture the molecular events of an un-
folded amphiphilic peptide partitioning to the DPC interface. An unstructured peptide
(SOD1npep) with SOD1 sequence of V5-H43 has several amphiphilic regions (Fig.3.3B),
with both its N’ end capped with acetyl and C’ capped with N-methyl. While the root
mean square deviation (RMSD) indicates most conformation changes were stabilized
within 30ns for the both MD simulation sets of SOD1npep (Fig.3.18A), SOD1npep un-
derwent further but less drastic conformation changes after the first 30ns. The root
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Figure 3.19: MD Snapshots of SOD1npep in DPC. (A) First MD set. (B) Second MD
set. Color code: red is MD snapshot at 150ns; blue is MD snapshot at 200ns; orange
is DPC molecules and orange sphere is the phosphate in DPC. Each sub-diagram is
not in the same scale as the others.
Figure 3.20: Time evolution of secondary structure conformation in SOD1npep using
the program DSSP. (A) First MD set. (B) Second MD set. Color code: black is
unstructured; red is β-bridge; green is β-sheet; blue is α-helix; dark yellow is 310-
helix; purple is π-helix; brown is turn; cyan is loop; gray is bend or coil.
mean squared fluctuations (RMSF) values (Fig.3.18B) suggests other than the N’ and
C’ residues, the region between E22 and G26 fluctuated a lot. This E22-G26 region
has several charged residues (E22, K24, E25) making it rather hydrophilic (Fig.3.3A),
and may have electrostatic interaction with the phosphocholine of DPC which renders
this region to be relatively unstructured (Fig.3.20).
Several additional backbone-backbone hydrogen bonds were formed towards the later
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Figure 3.21: Time evolution for (A) first MD set and (B) second MD set of SOD1npep
in terms of total hydrogen bonds mediated between atoms of: backbone and backbone
(red); sidechain and sidechain (blue); backbone and sidechain (green); DPC and pro-
tein backbone (pink); DPC and protein sidechain (black). Hydrogen bond stability
or occupancy (in the last 50ns of MD simulation) between backbone/sidechain and
DPC for (C) first MD set and (D) second MD set. Color code: black for first DPC,
red for second DPC, blue for third DPC, green for fourth DPC and pink for the fifth
DPC.
half of the MD simulation (Fig.3.21A-B), which indicates backbone hydrogen bonds of
amphiphilic helices formed during the MD simulation. The formation of these backbone
hydrogen bonds is needed to stabilize partitioning of the peptide to the lipid interface
(White & Wimley, 1999; Ladokhin & White, 1999). While the amphiphilic character
of S34-E40 is larger in magnitude than V29-S34 (Fig.3.3B), the only α-helical region
formed in both MD sets is between V29 and S34 (Fig.3.20A-B). The general topology of
this α-helical region at 150ns and 200ns are quite similar (Fig.3.19A-B) which indicates
the partitioned α-helices had been stable for the last 50ns of the MD simulation.
Interestingly, one MD simulation set captured the formation of an amphiphilic helix
between K36 and E40 (Fig.3.20A) from 100ns to 200ns. Thus in both MD simulation,
the proclivity for region between V29 and S34 to form amphiphilic helix instead of K36
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and E40 is likely due to the C’ termini flexibility effect (K36-E40) and the insufficient
MD sampling.
Overall, the MD simulation observations here suggested as the unfolded amphiphilic
regions of SOD1WT partitioned to the phospholipid interface, these amphiphilic re-
gions form backbone-backbone hydrogen bonds to stabilize the partitioning, which
was previously proposed by White (Ladokhin & White, 1999; White & Wimley, 1999).
In addition, transient backbone-DPC and sidechain-DPC hydrogen bonds may be an
important source of initial anchoring the unstructured amphiphilic regions as they
partitioned to the membrane interface (Fig.3.21C-D).
3.1.4.2 MD behavior of SOD1midpep with DPC
Figure 3.22: MD simulated behavior of 2 independent sets of middle fragment (F45-
L84) in SOD1 (SOD1midpep) with DPC. (A) RMSD of SOD1midpep: red is the 1st set,
and black is 2nd set. (B) RMSF of SOD1midpep: red is the 1st MD set, and black is
2nd MD set.
SOD1midpep is an unstructured peptide containing the sequence of the Zn2+-binding
loop region (F45-L84) which is highly hydrophilic (Fig.3.3B), with both its N’ end
capped with acetyl and C’ capped with N-methyl. The RMSD plots suggested SOD1midpep
underwent more conformation changes (Fig.3.22A) than SOD1npep (Fig.3.18A). How-
ever there was no region with outstanding RMSF values in SOD1midpep (Fig 3.22B)
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Figure 3.23: MD Snapshots of SOD1midpep with the formed DPC micelle during
the MD simulation. (A) First MD set. (B) Second MD set. Color code: red is MD
snapshot at 150ns; blue is MD snapshot at 200ns; orange is DPC molecules and orange
sphere is the phosphate in DPC. Each sub-diagram is not in the same scale as the
others.
Figure 3.24: Time evolution of secondary structure conformation in SOD1midpep
with DPC using the program DSSP. (A) First MD set. (B) Second MD set. Color
code: black is unstructured; red is β-bridge; green is β-sheet; blue is α-helix; dark
yellow is 310-helix; purple is π-helix; brown is turn; cyan is loop; gray is bend or coil.
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Figure 3.25: Time evolution for (A) first MD set and (B) second MD set of
SOD1midpep interacting with DPC in terms of total hydrogen bonds mediated be-
tween atoms of: backbone and backbone (red); sidechain and sidechain (blue); back-
bone and sidechain (green); DPC and protein backbone (pink); DPC and protein
sidechain (black). Hydrogen bond stability or occupancy (in the last 50ns of MD sim-
ulation) between backbone/sidechain and DPC for (C) first MD set and (D) second
MD set. Color code: Black for first DPC, red for second DPC, blue for third DPC,
green for fourth DPC and pink for the fifth DPC.
unlike that in SOD1npep (Fig 3.18B). No further information can be obtained on which
regions in SOD1midpep is more dynamic. Interestingly, SOD1midpep is intercalated be-
tween two irregular-sized DPC micelle (Fig.3.23A), which was unseen in SOD1npep
(Fig.3.19A-B).
During the course of MD simulation, SOD1midpep showed no significant backbone-
backbone hydrogen bonds (Fig.3.25A-B) unlike SOD1npep (Fig.3.21A-B). There was
no consistent secondary structure conformation in the two independent MD sets of
SOD1midpep (Fig.3.24A-B) unlike SOD1npep (Fig.3.20A-B). SOD1midpep adopted mainly
unstructured conformation as seen in the MD snapshots (Fig.3.23A-B). This MD obser-
vation is consistent with the NMR-determined structures of SOD1L126Z and SOD1WT ,
where the Zn2+-binding loop region is unstructured and unable to form α-helices in
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the presence of DPC.
Interestingly during the two MD simulation sets, SOD1midpep showed several backbone-
and sidechain- mediated hydrogen bonding with phosphate groups of DPC (Fig.3.25C-
D), and hydrogen bond per DPC molecule of these residues are quite relatively stable
(≥50% hydrogen bond occupancies). These regions of SOD1midpep forming stable hy-
drogen bond with DPC adopted mainly turn or 310-helix conformation (Fig.3.24A-B).
As the Zn2+-binding loop is a highly hydrophilic stretch in SOD1 (Fig.3.3A) due to its
enrichment of residues with hydrogen bond donors and acceptors (Asn, Asp, Ser, Gln,
Glu, Lys and Arg), the unstructured SOD1midpep (or Zn2+-binding loop) may sandwich
itself in between membrane vesicles where the sidechains of these residues engage in hy-
drogen bonds with the phosphate group in phospholipids, while the other amphiphilic
regions of SOD1 can partition themselves to the phospholipid membrane interface.
However as the SOD1midpep is an isolated fragment, it may not reflect the molecular
events of this Zn2+-binding loop in the protein context which have amphiphilic se-
quences. As such, we are interested to study the properties of Zn2+-binding loop in
the context of other amphiphilic helices, thus we studied the MD simulation behavior
of NMR-derived structure of SOD1L126Z in DPC, which is covered in the next section.
3.1.4.3 MD behavior of SOD1L126Z with DPC
As for the MD simulation of SOD1L126Z , the ends were not capped. Three NMR
structures of SOD1L126Z in DPC with the lowest Cyana target function values were
used (Fig.3.12A), and 150 DPCmolecules were randomly placed around NMR structure
of SOD1L126Z in DPC. 150 DPC molecules is the DPC molar ratio in which 2D-
HSQC of SOD1L126Z in DPC showed saturated peak shifts. The RMSF and RMSD
of SOD1L126Z indicated great dynamic changes from the initial NMR conformation
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Figure 3.26: MD simulated behavior of 3 independent MD sets of SOD1L126Z with
randomly positioned DPC molecules. (A) Root mean square deviation of Cα (RMSD).
(B) Root mean square fluctuation of Cα (RMSF). Color code: red is the first set; black
is second set; green is third set.
(Fig.3.26A-B). The topology of α-helices in SOD1L126Z are heterogeneous in terms of
their orientation around clusters of DPC molecules (Fig.3.27A-C), which are consistent
with the absence of long-range NOEs for SOD1L126Z in DPC.
The time evolution of secondary structures shows only the amphiphilic helical regions
of E14-S25 (Fig.3.17B) and E40-F45 (Fig.3.17C) in SOD1L126Z remained α-helical
throughout the MD simulation (Fig.3.28). Other amphiphilic helical regions alternate
between α-helix and 310-helix through the turn conformation (Fig.3.28), which suggest
amphiphilic helical regions are still intact. On the other hand, Figure 3.28A-C indicate
the Zn2+-binding loop and part of β5 region experienced more structural changes
than the other regions of SOD1L126Z . Although the general topology of amphiphilic
helices in SOD1L126Z remains the same in the last 50ns for each MD simulation, the
intercalated conformation of Zn2+-binding loop in SOD1L126Z varied around clusters
of DPC molecules (Fig.3.27A-C), which is also seen for SOD1midpep (Fig.3.23A-B);
interestingly, the Zn2+-binding loop in SOD1L126Z is less extended than in SOD1midpep.
The hydrogen bond analysis shows two interesting observations (Fig.3.29). First, a
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Figure 3.27: MD Snapshots of SOD1L126Z with DPC micelle formed during MD
simulation. (A) First MD set. (B) Second MD set. (C) Third MD set. Color code: red
is MD snapshot at 150ns; blue is MD snapshot at 200ns; orange is DPC molecules and
orange sphere is the phosphate in DPC. The unstructured loop is the Zn2+-binding
loop. Each sub-diagram is not in the same scale as the others.
number of hydrogen bonds between the backbone and phosphate of DPC are medi-
ated from β1 (T2-L8), Zn2+-binding loop (H48-H80) and β5 (L84-A89) (Fig.3.29D-F).
Second, as the MD simulation progressed, there was an increasing number of sidechain-
mediated hydrogen bonds with phosphate group of DPC molecules (Fig.3.29A-C). In-
terestingly, many of the sidechain-mediated and several backbone-mediated hydrogen
bonds with DPC are from the Zn2+-binding loop (Fig.3.29D-F). But unlike SOD1midpep,
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Figure 3.28: Time evolution of secondary structure conformation in SOD1L126Z in
DPC using the program DSSP. (A) First MD set. (B) Second MD set. (C) Third
MD set. Color code for: black is unstructured; red is β-bridge; green is β-sheet; blue
is α-helix; dark yellow is 310-helix; purple is π-helix; brown is turn; cyan is loop; gray
is bend or coil.
many of backbone and sidechain-mediated hydrogen bonds (per DPC molecule) by
Zn2+-binding loop in SOD1L126Z are relatively weaker (Hbond occupancy ≤ 50%)
(Fig.3.29D-F) than SOD1midpep (Fig.3.25C-D). This observation reflects as the pro-
tein length increases from SOD1midpep to SOD1L126Z , there is increased propensity
for other SOD1 regions to compete with DPC for hydrogen bonding to Zn2+-binding
loop. Thus as the protein length increases to SOD1WT , Zn2+-binding loop becomes
less extended than SOD1L126Z and has lesser ability to be intercalated between DPC
micelle/molecules (Fig.3.16). Nonetheless, this phospholipid intercalating ability of
Zn2+-binding loop should be transient because conformation exchange is absent in this
Zn2+-binding loop (Fig.3.14B, Fig.3.15B), its low hnNOE values (Fig.3.14A, 3.15A)
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Figure 3.29: Time evolution of total hydrogen bonds mediated in SODL126Z in
DPC. (A-C) Time evolution of total hydrogen bonds mediated between atoms of:
backbone and backbone (red); sidechain and sidechain (blue); backbone and sidechain
(green); DPC and protein backbone (pink); DPC and protein sidechain (black). (D-F)
Hydrogen bond stability or occupancy (in the last 50ns of MD simulation) between
backbone/sidechain and DPC for the three MD set. Color code: Black for first DPC,
red for second DPC, blue for third DPC, green for fourth DPC and pink for the
fifth DPC. Asterisks marked residues from the Zn2+-binding loop. (A-C) and (D-F)
corresponds to first, second and third MD set respectively.
indicated highly unconstrained motion in DPC and its varied conformation throughout
the MD simulation (Fig.3.28).
Collectively, the MD simulation results of SOD1midpep and SOD1L126Z here suggest the
Zn2+-binding loop may transiently stabilize the initial partitioning of the unstructured
amphiphilic regions of SOD1L126Z or SOD1WT to the phospholipid interface. As the
Zn2+-binding loop is enriched with residues having hydrogen bond donors and accep-
tors (Asn, Asp, Glu, Gln, Arg, Ser and Lys), this lipid partitioning is meditated through
the extensive sidechain-mediated and (smaller extent) backbone-mediated hydrogen
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bonds of Zn2+-binding loop with phosphate group of DPC. The heterogeneous, tran-
sient conformations of the Zn2+-binding loop region in the MD simulation (Fig.3.28)
also reflects how the Zn2+-binding loop adapt to the changing milieu of lipid environ-
ment while maintaining its transient anchor of SOD1 onto the membrane surface.
3.1.5 Discussion
SOD1 is an ubiquitous, cytosolic β-barrel enzyme which reduces cytoplasmic superan-
ion oxide generated from aerobic metabolism. Internal β-sheet regions in SOD1WT
are either amphiphilic or hydrophobic, which are characteristics of β-sheet rich pro-
teins (Monsellier & Chiti, 2007). Exposure of these internal regions may allow these
internal amphiphilic regions to partition to lipid membranes interface, where it is ener-
getically favorable through forming backbone hydrogen bonds of amphiphilic α-helices
(White & Wimley, 1999; Ladokhin & White, 1999). On the other hand, exposure
of hydrophobic regions under physiological conditions (high ionic concentration) may
trigger the aggregation of proteins (Li et al., 2006; Song, 2009). The hydrophobicity
propensity analysis of SOD1WT sequence indicates several amphiphilic regions in the
β-sheet regions of SOD1WT : N26-H46, D93-S105 and E121-K136 (Fig.3.3B). Several
of its predicted disordered regions are: first ten residues at N’, Zn2+-binding loop,
electrostatic loop and last ten resides at C’ (Fig.3.2).
Truncation SOD1 mutants like SOD1L126Z is unable to fold correctly which exposes its
internal amphiphilic regions naturally. In the absence of Zn2+, SOD1WT is unstruc-
tured conformation (Fig.3.4A) as it cannot fold correctly. Using biophysical methods
like CD (Fig.3.4B,D) and NMR (Fig.3.5), we showed these unstructured amphiphilic
regions of truncated SOD1L126Z and full-length SOD1WT interacted phospholipids
mimetics like DPC and formed α-helices with an overall amphiphilic profile (Fig.3.17).
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To augment missing atomistic details, we used MD simulation to simulate partition
behavior of DPC molecules with peptide fragments which contain amphiphilic regions
(SOD1npep), without amphiphilic regions (SOD1midpep) and the NMR structure of
SOD1L126Z in DPC. The MD simulation results of SOD1npep (V5-H43) showed as
the unstructured amphiphilic regions came in contact with the phospholipid interface
of DPC micelle, these unstructured regions had increased backbone hydrogen bonds
(Fig.3.21A-B) and the formed amphiphilic α-helices were from either 310-helix or turn
conformation (Fig.3.20A). This MD observation is line with the protein-phospholipid
partition concept proposed by White & Wimley (1999). In addition, the MD results
suggested backbone or sidechains atoms of unstructured SOD1 amphiphilic regions
can initiate hydrogen bonds with phosphate group of DPC to stabilize the protein-
phospholipid partitioning (Fig.3.21C-D).
While there is a general lack of tertiary packing for amphiphilic helices in proteins
(White & Wimley, 1999; Ladokhin & White, 1999), the topology of amphiphilic α-
helices in protein is dependent on the overall conformation of lipid environment (Qin
et al., 2013a; Ulmer et al., 2005; Mazumder et al., 2013; Bussell et al., 2005). Thus
amphiphilic regions of proteins in micelle system tend to have heterogeneous topology
(Ulmer et al., 2005; Mazumder et al., 2013; Bussell et al., 2005) as the conformation of
micelle is more dynamic than a bilayer system because the motion of lipids in a micelle
is typically less than 1ns (Tieleman et al., 2000). Indeed, this topology variety is seen
for the MD simulated amphiphilic helices of SOD1L126Z in DPC for (Fig.3.27A-C), and
also the lack of experimental long-range NOEs in both SOD1L126Z and SOD1WT in
DPC. Such conformational diversity may allow proteins like SOD1 to fit or adapt their
amphiphilic regions to different lipid milieu which can perturb the native membrane
structure, function or dynamics.
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The MD observations here suggest the hydrophilic Zn2+-binding loop may transiently
anchor unstructured amphiphilic regions of SOD1 to the phospholipid interface, whilst
these amphiphilic α-helices are being formed. SOD1midpep makes up the Zn2+-binding
loop (F45-L84) which is enriched with residues having hydrogen bond donors and ac-
ceptor (Asn, Asp, Ser, Gln, Glu, Lys and Arg) and also residues responsible for Zn2+
and Cu2+ binding (H46, H48, H71, H80 and D83). During the MD simulation, the
Zn2+-binding loop showed enhanced interaction (via backbone and sidechain medi-
tated hydrogen bonding) with the phosphate group of DPC molecules, in the peptide
(SOD1midpep, Fig.3.25C-D) and protein context (SOD1L126Z , Fig.3.29D-F). Further-
more, the MD simulation results showed Zn2+-binding loop intercalated between DPC
molecules in both SOD1midpep (Fig.3.23A) and SOD1L126Z (Fig.3.27A-C). However,
how extended Zn2+-binding loop is in DPC may depend on length of SOD1, as the
Zn2+-binding loop hydrogen bonding with DPC is competed with other fragments of
the longer SOD1: in MD simulation, Zn2+-binding loop in the shorter SOD1midpep
(Fig.3.25C-D) had more stable hydrogen bonds per DPC than the longer SOD1L126Z
(Fig.3.29D-F); in NMR experiment, Zn2+-binding loop of shorter SOD1L126Z in DPC
(Fig.3.16A) more extended than longer SOD1WT in DPC (Fig.3.16B). Nonetheless, the
heterogeneous, transient conformations of the Zn2+-binding loop region in MD sim-
ulation (Fig.3.28), and its experimentally determined unconstrained motion in DPC
(Fig.3.14A, 3.15A) reflects the conformational adaptiveness of Zn2+-binding loop to
the changing conformation of lipid environment, while maintaining its transient an-
chor onto the membrane surface.
In an overall scheme, our NMR and MD simulation results suggest the hydrophilic
Zn2+-binding loop may be important in SOD1 interaction with membrane systems.
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The first important role is form transient hydrogen bonds with phospholipids and an-
chor unstructured SOD1 to the heterogeneous conformations of the plasma membrane
surface, and shortening time needed for unstructured and amphiphilic regions of SOD1
to partition onto the membrane surface. The second important role is once SOD1 is
membrane-bound, Zn2+-binding loop of SOD1 may become solvent-exposed due to its
transient nature to interact with phospholipids, and is able to recruit other unstruc-
tured proteins or SOD1 in the cytoplasm onto the membrane surface. As this process
progresses as meditated by the Zn2+-binding loop of SOD1, more extensive membrane-
remodelling and damage may occur to accelerate the apoptotic onset. This scenario
could be a possible SOD1-dependent ALS molecular pathogenesis.
Important human diseases involving partially soluble proteins may involve partitioning
their internal amphiphilic regions to the lipid membrane, which include: α-synuclein
of Parkinson’s disease (Ulmer et al., 2005; Mazumder et al., 2013), amyloid β-peptides
of Alzheimer’s disease (Elfrink et al., 2008), islet amyloid polypeptide of type II di-
abetes (Kegel et al., 2005), huntingtin of Huntington’s disease (Ku¨nze et al., 2012).
Jiang et al. (2013b) proposed a weak interaction between α-synuclein and lipid mem-
brane is sufficient to remodel the membrane shape. Thus when these amphiphilic
regions of proteins interact with lipid membrane, the native structure and dynamics
of membrane-bounded organelles or vesicles become seriously compromised: the for-
mation of non-native membrane channels, pores, or aggregates (Ulmer et al., 2005;
Mazumder et al., 2013; Kegel et al., 2005; Ku¨nze et al., 2012); disruption of membrane
meditated signaling pathways (Homma et al., 2013) or machineries (Homma et al.,
2013); compromised native membrane remodelling such as vesicle fusion and fission
(Auluck et al., 2010; Kagan et al., 2011). In conclusion, prolonging the presence of
unstructured SOD1 increases the likelihood of native membrane structure (organelles
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or vesicles) are comprised which may accelerate cellular apoptosis in neurons.
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3.2 Metal ions interaction with SOD1
3.2.1 Introduction
SALS development is closely associated with occupational exposure (agricultural work,
machinery assembler, leather workers) to heavy metals are such as Al, Cd, Co, Cr,
Cu, Fe, Hg, Mg, Mn, Ni, Pb, Se and Zn (M Roos, 2013); ALS patients with such
occupational exposure showed about 20% to 30% increase of such heavy metal ions
in their cerebral spinal fluid (M Roos, 2013). Increasing accumulation of such heavy
metal ions may correlate with ALS pathogenic severity (Oba et al., 1993; Ignjatovic´
et al., 2013) and other neurodegenerative diseases (Schipper, 2012). In particular,
Cu, Fe and Zn are enriched in the insoluble protein aggregates in patients suffering
from other neurodegenerative diseases besides FALS and SALS (Ayton et al., 2013).
Iron and copper are proposed to accelerate ALS pathogenesis through their oxidative
catalysis (aberrant Fenton’s chemistry) of ROS to more potent ones (Rivera-Manc´ıa
et al., 2010; Barnham et al., 2004). Recent evidence shows cytoplasmic accumulation
of iron (Fe) in the neurons triggered the early ALS onset in SOD1G93A mice model after
the breakdown of its blood spinal cord barrier (Winkler et al., 2014), through increased
cellular oxidative stress by aberrant Fenton’s chemistry and accelerating apoptotic
onset in the motor neurons (Rivera-Manc´ıa et al., 2010; Barnham et al., 2004). In
addition, several of these heavy metal ions can substitute Zn2+ in the native dimeric
SOD1 (Ming & Valentine, 2014; Bertini et al., 1998, 1994), which may affect SOD1
structural stability in-vivo as these heavy metal accumulates in the motor neurons.
But no study has been done to show whether these metal ions can interact unstructured
SOD1 to affect its folded conformation by Zn2+ and subsequent maturation. Thus in
this section, SOD1 structural behavior was assessed with a list of divalent and trivalent
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metal ions (including heavy metals) and we found beside Zn2+, only Cu2+ and Fe2+ are
able to trigger folding of SOD1. However, only Fe2+ can induce the folding of SOD1 to
the same extent as Zn2+. Several mutants were generated to mimic naturally occurring
ALS mutants (SOD1G93A, SOD1L126Z), disrupted copper-binding (SOD1H46R,H48Q)
and disrupted zinc-binding (SOD1H80S,D83S). Their structural folding ability with
Zn2+ and Fe2+ were assessed. In the presence of Fe2+ ions, the ability of Zn2+ to
induce folding of SOD1 ALS mutants is severely reduced as compared to the SOD1WT .
However, Zn2+,Fe2+-bound SOD1WT have some structural differences as compared
to Zn2+-bound SOD1WT . These results imply Zn2+,Fe2+-bound SOD1WT may not
be effectively recognized by the hCCS in-vivo, and thus under high concentration of
cytoplasmic ferric ions in ALS pathological conditions, the maturation rate of SOD1
WT and ALS mutants may reduce drastically. This situation creates the cytoplasmic
accumulation of toxic forms of Fe2+-bound SOD1 which increases oxidative stress via
aberrant Fenton’s chemistry. The proposed ALS molecular pathogenesis here is a novel
SOD1-dependent mechanism.
3.2.2 Experimental Results
3.2.2.1 Zn2+ interaction with SOD1
Without metalation and formation of the native disulfide bond (C57-C146), SOD1WT
in solution is highly disordered as it had narrow-dispersed 2D-HSQC (Fig.3.30C). Ad-
dition of Zn2+ showed a set of well-dispersed peaks in the 2D-HSQC which indicates a
well folded structure (Fig.3.30A,C). While bound to Zn2+, SOD1WT adopted 2 confor-
mations: folded and unfolded, with the unfolded population appearing more because of
its more intense 2D-HSQC peaks (Fig.3.30A). The presence of well-folded SOD1WT is
also evident by the upfield 1D-1H NMR peaks (Fig.3.31A). Incremental Zn2+ addition
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Figure 3.30: 2D-HSQC spectra of (A) 50µM of SOD1WT (black) with 40x molar
ratio of Zn2+ (red). (B) 50µM of SOD1WT with 40x molar ratio of Zn2+ (red) after
the addition of 2mM EDTA (blue). (C) 50µM of SOD1WT (black). (D) 2mM EDTA
added after 50µM of SOD1WT with 40x molar ratio of Zn2+ (blue).
increased the well-folded population in SOD1WT and became saturated at 18x-20x
molar ratio of Zn2+ to SOD1WT (Fig.3.31A). The mixture of unfolded and folded
population of SOD1WT remained unchanged even at higher molar ratio of 40x Zn2+,
which is also evident by the presence of two HSQC peaks of the only Trp32 sidechain
(1H at about 10.1ppm) (Fig.3.30A): one corresponded to the unfolded and the other
corresponded to the folded population.
Although excess Zn2+ supplementation was unable to shift the unfolded ensemble of
Zn2+-bound SOD1WT to well-folded ensemble, this experimental observation here is
consistently found with other in-vivo (Banci et al., 2013; Luchinat et al., 2014) and
in-vitro studies (Banci et al., 2012; Lim et al., 2015). Interestingly, when the equimolar
of EDTA (40x) is added to SOD1WT with 40x Zn2+, all the well-dispersed peaks disap-
peared (Fig.3.30B,D). These experimental observations further support Zn2+ caused
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Figure 3.31: 1D spectra of 50µM of SOD1 with titration of Zn2+SO2−4 :
(A) SOD1WT ; (B) SOD1G93A. Text in green indicate the molar ratio of
Zn2+ to SOD1G93A; (C) SOD1H80S,D83S which has disrupted Zn2+ binding; (D)
SOD1H46R,H48Q which has disrupted Cu2+ binding; (E) SOD1L126Z . The values: 2x,
10x, ... 80x, indicate the molar ratio of Zn2+ added.
the shift of unfolded ensemble to a mixture of unfolded and unfolded ensemble in
SOD1WT , and Zn2+ is not tightly bound to SOD1.
Next we asked how residues of zinc and copper binding site contribute to SOD1 folding
after Zn2+ binding. Thus two mutants were generated: SOD1H80S,D83S which has
abolished Zn2+-binding (Roberts et al., 2007) and SOD1H46R,H48Q which has abolished
copper-binding and enzymatic activity (Winkler et al., 2009). In addition, we used
two other SOD1 ALS mutants to mimic naturally-occurring ALS mutants: SOD1G93A
(Siddique & Deng, 1996) and SOD1L126Z (Zu et al., 1997).
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Figure 3.32: 2D-HSQC spectra of free 50µM SOD1WT (black in Fig 3.32.A,C,E,G)
superimposed against free 50µM SOD1 mutants, and 50µM SOD1WT with 20xZn2+
(black in Fig 3.32.B,D,F,H) against 50µM SOD1 mutants with Zn2+. (A)
Free SOD1H80S,D83S (red). (B) SOD1H80S,D83S with 40xZn2+ (red) and free
SOD1H80S,D83S (blue). (C) Free SOD1H46R,H48Q (red). (D) SOD1H46R,H48Q with
40xZn2+ (red) and free SOD1H46R,H48Q (blue). (E) Free SOD1G93A (red). (F)
SOD1G93A with 80xZn2+ (red) and free SOD1G93A (blue). (G) SOD1L126Z (red).
(H) SOD1L126Z with 80xZn2+ (red) and free SOD1L126Z (blue).
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Figure 3.33: 2D-HSQC spectra superimposition of SOD1WT (blue) and SOD1G93A
(red) in the absence of metalation and the native disulfide bridge. Color code for
residues with significant shifts in SOD1G93A: Magenta are residues within mutation
site. Green are residues far from the mutation site.
Free SOD1H80S,D83S showed a narrow-dispersed 2D-HSQC spectrum, and most of its
2D-HSQC peaks were superimposable to SOD1WT except for residues near the muta-
tion sites (Fig.3.32A). Upfield 1D-1H peaks of Zn2+-bound SOD1H80S,D83S exhibited
minor changes at 1:10 molar ratios of Zn2+, and the characteristic 1D-1H upfield peaks
of Zn2+-bound SOD1WT were absent in 40x-Zn2+-bound SOD1H80S,D83S (Fig.3.31C).
While SOD1H80S,D83S with 40x Zn2+ showed a well-folded population (Fig.3.32B), sev-
eral well-dispersed peaks from Zn2+-bound SOD1WT were missing in SOD1H80S,D83S .
Thus while the H80S,D83S mutation reduced Zn2+-binding ability of SOD1 (Roberts
et al., 2007), excess supplementation of Zn2+ may push the SOD1 folding to a well-
folded conformation but not to the same extent as in Zn2+-bound SOD1WT . These
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observations illustrate Zn2+ induce partial folding of SOD1H80S,D83S and also the fold-
ing specificity of Zn2+-induced folding in SOD1.
Interestingly, free or unbound SOD1H46R,H48Q showed a mixture of well-folded and
unfolded ensemble, though the intensity of well-folded peaks in 2D-HSQC were rela-
tively quite weak (Fig.3.32C). Zn2+ titration to SOD1H46R,H48Q showed an increase
in its well-folded ensemble (Fig.3.32D), and is evident by more intense upfield 1D-
1H NMR peaks which became saturated at 20x Zn2+ (Fig.3.31D). Most of 2D-HSQC
peaks in Zn2+-bound SOD1H46R,H48Q are quite superimposable to that of Zn2+-bound
SOD1WT , which suggest the overall structural similarity in the well-folded population
adopted by Zn2+-bound SOD1H83S,D83S , SOD1H46R,H48Q and SOD1WT .
SOD1G93A was chosen as it is a popular SOD1 mutant and studied extensively both
in-vivo and in-vitro. Thus, this mutant was used here as a proxy to study the Zn2+-
binding mechanism in SOD1 WT-like mutants. In the absence of Zn2+, SOD1G93A
was unstructured but several residues had significant shifts as compared to SOD1WT
(Fig.3.32E); these shifted peaks were near (D92, V94 and A95) and far from (Q22,
E24, D101 and D103) the mutation site (Fig.3.33). At same molar ratio of Zn2+,
SOD1G93A showed less intense upfield 1D-1H NMR peaks than SOD1WT (Fig.3.31B).
At higher molar ratio of 80x Zn2+, well-folded ensemble of Zn2+-bound SOD1G93A
remained unsaturated as its upfield 1D-1H NMR peaks were less intense than those 20x-
Zn2+ bound SOD1WT (Fig.3.31B). However, further addition of Zn2+ to SOD1G93A
resulted in significant broadening of its 2D-HSQC peaks (Fig.3.32F), and visible white
aggregates formed subsequently which limited further NMR experiments.
SOD1L126Z is a naturally occurring ALS mutation which is truncated at residue 126,
and most of its residues are superimposable to SOD1WT , and the missing 28 residues in
Figure 3.32G are those truncated residues . Although at high concentration of 80x Zn2+
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to SOD1L126Z had a few but very weak 2D-HSQC well-dispersed peaks (Fig.3.32H),
no upfield 1D-1H NMR peak was seen in Zn2+-bound SOD1L126Z (Fig.3.31E). This
experiment result also indicates the last 28 residues (last β-sheet) are crucial for the
dynamic stabilization of the β-sheet folding induced by Zn2+.
Experimental observations here also reflected the different intrinsic folding capability
of each unique SOD1 mutant as Zn2+ is unable to saturate the folding of SOD1G93A
but is able to saturate the folding of SOD1H80S,D83S and SOD1H46R,H48Q (Fig.3.31),
and unbound SOD1H80S,D83S shows a pre-existing of folded and unfolded ensemble.
More importantly, the results here generally imply the induced folding by Zn2+ is
significantly reduced in SOD1 mutants, which meant reduced maturation rate of these
SOD1 mutants in-vivo and increased propensity for other non-native toxic functions
of partially-folded SOD1 such as perturbation of membrane-bound organelles (Son &
Elliott, 2014).
3.2.2.2 Backbone assignment of Zn2+-bound SOD1WT
Backbone sequential assignment of 500µM double-labeled (15N and 13C) SOD1WT was
done at pH3.5 with 5x Zn2+; higher molar ratio of Zn2+ triggered the aggregation of
the 500µM SOD1WT . Most 2D-HSQC peaks in the folded ensemble of 5x-Zn2+-bound
SOD1WT are superimposable to their cognate 2D-HSQC peaks of 40x-Zn2+-bound
SOD1WT . Figure 3.34A shows chemical shifts of unfolded and folded population of
SOD1WT in the presence of 5x Zn2+. 13C CSI values of most β-sheet regions in folded
population of Zn2+-bound SOD1WT here were similar to that of 2AF2 (Zn2+-bound,
super-stable SOD1C6A,C111S mutant with BMRB Entry 6821 from Banci et al. (2006)),
but the main CSI differences are in the Zn2+-binding loop region (F45-L84) (Fig.3.34B).
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Figure 3.34: CSI of 500µM SOD1WT in solution of pH3.5, with 5x Zn2+, 25 ◦C. (A)
Chemical shifts of folded (red) and unfolded (gray) population of 500µM SOD1WT
in solution of pH3.5, with 5xZn2+. (B) Chemical shifts of folded population (red)
of 500µM SOD1WT with 5xZn2+, against folded population (gray) of SOD1 Cys
mutant (C6A,C111S) with PDB code: 2AF2 (Banci et al., 2006). (C) Chemical
shifts of unfolded population (red) of 500µM SOD1WT with 5x Zn2+ against unfolded
population of SOD1WT in milli-Q water (gray).
94
Metal ions and SOD1 95
Figure 3.34C shows some residues with substantial chemical shifts differences for the
unfolded population of SOD1WT in the presence and absence of Zn2+. The unfolded
ensemble of Zn2+-bound SOD1WT showed some β-sheet character for several residues:
E21 (-1.58), E49 (-1.25), E121 (-0.91) (values in parentheses are CSI), but the CSI of
these residues are not negative for the unfolded and unbound SOD1WT (Fig.3.34C).
Interestingly both CSI of H48 and H120 of unfolded SOD1WT are quite similar in bound
and unbound forms (Fig.3.34C), which implied Zn2+ in the unstructured population of
Zn2+-bound SOD1WT only influenced the conformation propensity of residues around
the Zn2+/Cu2+-binding residues: H48 and H120.
In addition, we collected 15N-NOESY spectra for 500µM SOD1WT with 5x Zn2+
to determine the exchange kinetics of the folded and unfolded ensemble using the
longitudinal relaxation (R1). However no exchange peak was found for well-dispersed
peaks in the 2D-HSQC of unfolded ensemble and vice versa. This observation implies
the conformation exchange rate between the folded and unfolded ensemble of Zn2+-
bound SOD1WT is in the ms to mins timescale.
3.2.2.3 Other metal ions interaction with SOD1WT
As occupational exposure of heavy metal ions and their presence in insoluble protein
aggregates are associated with neurodegenerative diseases (M Roos, 2013; Oba et al.,
1993; Ignjatovic´ et al., 2013; Schipper, 2012), these heavy metal ions may also trigger
some structural changes in the free, unstructured SOD1WT . Beside Zn2+, we tested
the binding of SOD1WT with the following metal sulphates (SO2−4 ): Al
3+, Ca2+, Co2+,
Cd2+, Cu2+, Fe2+, Mg2+, Mn2+ and Ni2+. Most of the metal ions: Al3+, Cd2+, Co2+,
Ni2+, Mg2+ triggered minor shift in a few 2D-HSQC peaks in SOD1WT (Fig.3.35).
These experimental observations indicate these heavy metal ions do not influence the
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Figure 3.35: 2D-HSQC spectra of 50µM SOD1WT with 2mM of metal SO2−4 . Black
is the unstructured SOD1WT in milli-q water, pH3.5, 25◦C. Red is SOD1WT incu-
bated with 2mM metal SO2−4 .
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conformation of unstructured SOD1. At higher molar ratios of these heavy metal ions,
the 2D-HSQC peaks of SOD1WT broadened and white insoluble precipitates formed.
Only Cu2+ and Fe2+ are found to trigger substantial upfield 1D-1H NMR changes
and formation of well-dispersed 2D-HSQC peaks, which are covered in the subsequent
sections.
3.2.2.4 Cu2+ interaction with SOD1WT
Figure 3.36: NMR spectra of 50µM of SOD1WT with Cu2+ SO2−4 : (A) 1D spectra
of SOD1WT ; the values: 2x, 6x, 10x indicate the molar ratio of Cu2+ added. (B)
2D-HSQC NMR spectra of SOD1WT (blue) with 10xCu2+ (red). Red arrows indicate
well-resolved peaks of SOD1WT in Cu2+, and blue arrow indicate the only Trp32 in
unfolded state of SOD1WT .
The binding affinity of Cu2+ to unfolded SOD1WT is higher than that of Zn2+ as
the upfield 1D changes reached saturation point at 6x Cu2+ (Fig.3.36A), and Cu2+
has the ability to trigger greater shifts of HSQC peaks in SOD1WT (Fig.3.36B) than
Zn2+ (Fig.3.30A). But Cu2+-bound SOD1WT is a partially-folded form, as most of
the well-dispersed HSQC peaks in Zn2+-bound SOD1WT were absent in the 2D-HSQC
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spectra of Cu2+-bound SOD1WT ; the well-dispersed peaks in Cu2+-bound SOD1WT
are demarcated by the red arrows in Figure 3.36B. We tried using more NMR scans to
capture other possible well-dispersed but less intense peaks in Cu2+-bound SOD1WT ,
but we found no notable difference. Thus the strong binding of Cu2+ to SOD1 and
its induction of unfolded SOD1 to a partially folded form (not to the same extent as
Zn2+-bound SOD1) may rationalize the evolutionary need for hCCS-meditated copper
loading into pre-folded, Zn2+-bound SOD1 (Banci et al., 2012, 2013; Luchinat et al.,
2014).
3.2.2.5 Fe2+ interaction with SOD1
As Fe2+ is paramagnetic (Otting, 2010), more NMR scans were needed to capture
the well-dispersed HSQC peaks in Fe2+-bound SOD1 (Fig.3.37A). Many 2D-HSQC
peaks in the folded ensemble of Fe2+-bound SOD1WT can be overlaid to those in
the Zn2+-bound SOD1WT (Fig.3.37B). As with the Zn2+-bound SOD1WT , the addi-
tion of equimolar EDTA abolished the well-dispersed 2D-HSQC peaks of Fe2+-bound
SOD1WT (Fig.3.37C-D), which indicate structural changes of Fe2+-bound SOD1WT is
entirely due to the ferric ion. The upfield 1D-1H NMR changes also confirmed Fe2+
has the ability to trigger the β-folding of unstructured SOD1WT (Fig.3.38A), which
became saturated at 20x Fe2+.
As paramagnetic Fe2+ causes enhanced magnetization relaxation and pseudo-contact
shift in NMR (Otting, 2010), it is not suitable to compare directly the intensities and
chemical shifts of SOD1WT induced by Fe2+ against those induced by Zn2+. Nonethe-
less these experimental observations here implied the structural fold of Fe2+ and Zn2+-
bound SOD1WT are quite similar in terms of the β-barrel region (Fig.3.39A). Residues
in the Fe2+ binding site may be a subset of Cu2+ and Zn2+ binding pocket residues
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Figure 3.37: 2D-HSQC spectra of free 50µM SOD1WT with Fe2+. (A) Free
SOD1WT (black) against SOD1WT with 20x Fe2+ (red). (B) SOD1WT with 20x
Fe2+(red) against SOD1WT with 20x Zn2+ (black). (C) SOD1WT with 20x Fe2+(red)
against 20x EDTA treatment of SOD1WT with 20x Fe2+ (green). (D) Free SOD1WT
(black) against 20x EDTA treatment of SOD1WT with 20x Fe2+ (green).
(Fig.3.39B). Many of the unaffected residues in Fe2+-bound SOD1WT are spatially far
away from the Cu2+ and Zn2+ pocket (Fig.3.39B).
For the Zn2+-binding mutant SOD1H80S,D83S , Fe2+ induced its folding but to a smaller
degree vis-a-vis SOD1WT as seen with the smaller upfield 1D-1HNMR changes (Fig.3.38C)
and less intense widely-dispersed 2D-HSQC peaks (Fig.3.40B) from unstructured, un-
bound SOD1H80S,D83S (Fig.3.40A). The upfield 1D-1HNMR changes induced in SOD1H80S,D83S
were saturated at around 20x Fe2+ (Fig.3.38C), similar to SOD1WT (Fig.3.38A). As
for the Cu2+-binding mutant SOD1H46R,H48Q, the upfield 1D-1H NMR changes were
saturated at around 20x Fe2+ (Fig.3.38D). As unbound SOD1H46R,H48Q showed a
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Figure 3.38: 1D NMR spectra of 50µM of SOD1 with titration of Fe2+: (A) WT; (B)
G93A ALS mutant; (C) H80S,D83S mutant which mimics abolished Zn2+ binding;
(D) H46R,H48Q mutant which mimics abolished Cu2+ binding. The values: 2x, 10x,
... 80x, indicate the molar ratio of Fe2+ added.
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Figure 3.39: Mapping of residues in SOD1WT with significant differences in Fe2+
and Zn2+. (A) 2D-HSQC spectra of SOD1WT being superimposed in Zn2+ (blue) and
Fe2+ (red). Well-resolved HSQC peaks which are superimposable (green) and those
with significant shift (pink) in Zn2+ and Fe2+. Red arrows indicate well-resolved
peaks of SOD1WT in Fe2+, and blue arrow indicate the only Trp32 in unfolded state
of Zn2+-bound SOD1WT . (B) Monomeric SOD1WT (1PU0) (DiDonato et al., 2003) is
shown with residues experiencing significant shift in Zn2+-and Fe2+-forms are labeled
pink, and residues in both Zn2+-and Fe2+-forms having no changes are labeled green.
preexistence of folded and unfolded ensemble (Fig.3.40C), Fe2+ merely increased the
intensity of the well-folded ensemble in SOD1H46R,H48Q (Fig.3.40D), but most of its
2D-HSQC peaks can be overlaid to Zn2+-bound SOD1WT . Collectively, the results
indicate Fe2+ binding site are mainly residues from the Zn2+-binding site and several
residues from the Cu2+-binding site.
Interestingly, Fe2+ was unable to trigger SOD1G93A folding even at 80x Fe2+ (Fig.3.38B).
Likewise, no widely-dispersed 2D-HSQC peak was visible for Fe2+-bound SOD1G93A
(Fig.3.40F) from the unstructured and unbound SOD1G93A (Fig.3.40E). But Fe2+ was
able to cause significant residual peaks shifts of SOD1G93A in the Cu2+ and Zn2+-
binding sites (Fig.3.41), which indicated Fe2+ can mimic Zn2+-binding to these residues
even in SOD1 ALS mutants. However Fe2+-induced folding capability of SOD1 is
severely reduced in the presence of naturally-occurring ALS mutations.
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Figure 3.40: 2D-HSQC spectra of free 50µM SOD1WT (black in Fig 3.32.A,C,E)
superimposed against free 50µM SOD1 mutants, and 50µM SOD1WT with 20xFe2+
(black in Fig 3.32.B,D,F) against 50µM SOD1 mutants with Fe2+. (A) free
SOD1H80S,D83S (red). (B) free SOD1H80S,D83S (blue), SOD1H80S,D83S with
20xFe2+ (red). (C) free SOD1H46R,H48Q (red). (D) free SOD1H46R,H48Q (blue),
SOD1H46R,H48Q with 20xFe2+ (red). (E) free SOD1G93A (red), (F) free SOD1G93A
(blue), SOD1G93A with 80xFe2+ (red).
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Figure 3.41: 2D HSQC spectra of SOD1G93A in presence of Fe2+. 2D-HSQC spectra
superimposition of SOD1G93A in the absence (blue) and in 80x Fe2+ (red). Residues
with significant 2D-HSQC shifts are labeled in the figure.
3.2.2.6 Fe2+-bound SOD1 interaction with Zn2+
We preincubated SOD1 with Fe2+ and subsequently monitored upfield 1D-1H NMR
changes and 2D-HSQC peaks shifts, upon further titration of Zn2+. This approach
allowed us to evaluate how binding of Zn2+ and its induction of SOD1 folding are
affected in Fe2+-bound SOD1.
Even after titration to 40x Zn2+, the intensity changes of upfield 1D-1H NMR in
20x Fe2+-bound SOD1WT remained minor, although its overall lineshape was similar
to 20x Zn2+-bound SOD1WT (Fig.3.42A). This observation was mirrored in the 2D-
HSQC peaks, where Zn2+ addition to 20x Fe2+-bound SOD1WT showed many super-
imposable peaks to the ones of Zn2+-bound SOD1WT (Fig.3.43A-B). Fe2+,Zn2+-bound
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Figure 3.42: 1D spectra of 50µM of SOD1WT preincubated with Fe2+ and titrated
with Zn2+. (A) SOD1WT with: 20x Zn2+ (green), 20x Fe2+ (blue), preincubated 20x
Fe2+ and added with 10x Zn2+ (black), preincubated 20xFe2+ and added with 20x
Zn2+ (red). Red arrow is the upfield 1H NMR which indicates the well-folded form
of Zn2+-bound SOD1WT . (B) SOD1G93A with: 40x Zn2+ (blue), 25x Fe2+ (black),
preincubated 10x Fe2+ and added with 40x Zn2+ (green), preincubated 25x Fe2+ and
added with 10x Zn2+ (brown), preincubated 25x Fe2+ and added with 10x Zn2+ (red).
SOD1WT showed several reminiscent 2D-HSQC peaks of Fe2+-bound form (arrows in
Fig.3.43A-B), which indicated a partial overlap of residues involved in Fe2+ and Zn2+
binding. Upon further Zn2+ addition, dynamic aggregation of SOD1WT occurred as
2D-HSQC peaks broadened and subsequently visible aggregates formed which limited
further NMR studies. The results here indicate the ferric ion in Fe2+-bound SOD1
is less amenable to be replaced by Zn2+ despite of excessive Zn2+supplementation.
Thus Fe2+-bound SOD1 may not be effectively recognized by hCCS, which meant the
maturation rate of SOD1 may reduced drastically in high concentration of cytoplasmic
ferric ions during ALS pathogenesis (Winkler et al., 2014).
Structural effects of Zn2+ titration under Fe2+-bound SOD1G93A were evaluated at the
pre-existing molar ratio of 10x and 25x Fe2+. The mere presence of 10x Fe2+ reduced
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Figure 3.43: 2D spectra of 50µM of SOD1WT preincubated with Fe2+ and sub-
sequent titration with Zn2+: (A) SOD1WT with 20x Zn2+ (blue) 20x Fe2+ (green),
with preincubated 20x Fe2+ and added with 10x Zn2+ (red). (B) SOD1WT with
20x Zn2+ (blue) 20x Fe2+ (green), with preincubated 20x Fe2+ and added with 20x
Zn2+ (red). Red arrows indicate Fe2+ specific peaks. Blue arrows indicate Zn2+ spe-
cific peaks. (C) SOD1G93A with 10x Zn2+ (blue), preincubated 25x Fe2+ and added
10x Zn2+ (red). (D) SOD1G93A with 40x Zn2+ (blue), preincubated 10x Fe2+ and
added 40x Zn2+ (red). Red arrows indicate well-dispersed peaks not detected for
Zn2+,Fe2+-bound SOD1G93A.
the intensity of upfield 1D-1H peaks in SOD1G93A induced by 40x Zn2+ (Fig.3.42B).
Although the overall intensity of 2D-HSQC peaks was reduced in the 10x Fe2+-bound
SOD1G93A as compared to 40x Zn2+-bound SOD1G93A, these 2D-HSQC peaks can be
superimposed to those of 40x Zn2+-bound SOD1G93A (Fig.3.43C). However at higher
pre-existing molar ratio of 25x Fe2+-bound SOD1G93A, Zn2+ titration between 10x and
40x was unable to trigger substantial upfield 1D-1H NMR changes (Fig.3.43B), and
instead induced limited number of widely-dispersed 2D-HSQC peaks (Fig.3.43C-D).
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Even at lower molar ratio of 10x Fe2+ and excessive 40x Zn2+, the folding of SOD1G93A
was not saturated (Fig.3.42B), which indicates Fe2+ radically reduce the Zn2+ induced
folding in SOD1 ALS mutants. As molar ratio of Zn2+ reached about 80x, visible white
aggregates of SOD1G93A were observed with the eventual disappearance of most 2D-
HSQC peaks limited further NMR experiments. The results here indicate SOD1 ALS
mutants are more susceptible to be in unstructured conformation when they are Fe2+-
bound, as the number of well-dispersed NMR peaks (which indicated the structured
population) and their peaks intensity of Zn2+,Fe2+-bound SOD1G93A are lesser and
less intense than Zn2+,Fe2+-bound SOD1WT . The results here also imply SOD1 ALS
mutants have drastically reduced maturation rate as compared to SOD1WT in the
presence of high cytoplasmic concentration of ferric ions.
During neurodegeneration and aging, breakdown of the blood-spinal cord barrier can
lead to increased accumulation of cytoplasmic ferric ions in the neurons, which is
seen in SOD1G93A mouse model, where the ferric concentration in neurons was about
800ng per mg of cytoplasmic protein, or approximately 3mM of cytoplasmic Fe2+
(Winkler et al., 2014). The results here suggest during ALS pathogenesis, gradual
increase in cytoplasmic ferric ions creates strong competition between Fe2+ and Zn2+
for SOD1 binding, and Fe2+ can retard significantly the maturation rate of SOD1WT
and drastically for naturally-occurring SOD1 WT-like mutants such as SOD1G93A.
3.2.3 Discussion
Metal ions are involved in the pathology of important neurodegeneration diseases by
modulating the aggregation process of the associated mutant proteins. In Alzheimer’s
disease, Cu2+ or Zn2+ accelerated the aggregation of Aβ aggregation in-vitro (Atwood
et al., 1998; Curtain et al., 2001; Kozin et al., 2001; Danielsson et al., 2007). In
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Parkinson’s disease, Cu2+ triggered α-synuclein aggregation (Jackson & Lee, 2009),
but is reversed upon EDTA addition (Rasia et al., 2005). In TypeII diabetes, Zn2+
accelerated aggregation of IAPP (human islet amyloid polypeptide) (Brender et al.,
2010, 2013; Salamekh et al., 2011). While these proteins don’t require metal ions for
its folding or structural stability, Zn2+ is essential for both the folding and structural
stability of SOD1 (Crow et al., 1997; Liu et al., 2000; Banci et al., 2006).
Removing Zn2+ from native SOD1WT increases its structural disorder or partial un-
folding, and was proposed as one main cause for SOD1 aggregation in-vivo (Banci
et al., 2008). Furthermore, SOD1 mutations are believed to increase the dissocia-
tion constant (KD) of SOD1 to Zn
2+ (Crow et al., 1997; Liu et al., 2000), which
implies SOD1 ALS mutants are less properly folded as compared to SOD1WT in
the presence of Zn2+ . Thus we first tested Zn2+ binding properties with several
SOD1 mutants: SOD1H46R,H48Q which disrupts Cu2+-binding (Winkler et al., 2009);
SOD1H80S,D83S which disrupts Zn2+-binding (Roberts et al., 2007); SOD1G93A which
is a widely studied SOD1 mutant with patients having less than a mean lifespan of 3.1
years (Siddique & Deng, 1996); SOD1L126Z which is a naturally occurring C’-truncated
SOD1 mutant (Zu et al., 1997). At pH3.5, SOD1 WT (Fig.3.30C) and ALS mutants
are unstructured (Fig.3.32A,E,G); only unbound SOD1H46R,H48Q shows a mixture of
folded and unfolded ensemble (Fig.3.32C). While Zn2+ had negligible structural effects
on SOD1L126Z (truncated SOD1 mutant) (Fig.3.32H), Zn2+ induced significant con-
formation changes in SOD1WT (Fig.3.30A) and the other full-length SOD1 mutants
(Fig.3.32B,D,F). Although these Zn2+-bound SOD1 mutants displayed the hybrid pop-
ulation of folded and unfolded ensemble similar to Zn2+-bound SOD1WT , their folding
were not saturated at higher molar ratio of Zn2+ which indicated they had markedly
reduced folding capacity after Zn2+ binding (Fig.3.32B,D,F), especially for SOD1G93A
107
Metal ions and SOD1 108
(Fig.3.32F).
Maturation rate of Zn2+-bound SOD1 is reduced or even abolished if the Zn2+-bound
SOD1-hCCS complex is as stable as SOD1H46R,H48Q (Winkler et al., 2009). Thus Zn2+
is loosely bound to SOD1WT as seen by the folded and unfolded population (Fig.3.30A-
B). Zn2+-induced ‘loose’ folding of SOD1 is sine qua non for SOD1 interaction with
hCCS and its maturation processes (Banci et al., 2012, 2013; Luchinat et al., 2014). Our
experimental observations here imply SOD1 mutants undergo reduced maturation rate
because they may require higher Zn2+ molar ratio to fold and become recognizable by
hCCS. This situation may increased propensity for these immature SOD1 ALS mutants
to have other non-native toxic functions such as perturbation of membrane integrity
in membrane-bound organelles, which are covered in the previous section.
Many types of heavy metal ions are routinely found in ALS patients (M Roos, 2013),
particularly in the protein aggregates in the neurons of ALS patients (Ayton et al.,
2013). Thus we evaluated how SOD1WT interact with these heavy metal ions (SO2−4 ):
Al3+,Ca2+, Co2+,Cd2+, Cu2+, Fe2+, Mg2+, Mn2+ and Ni2+. Most of these metal ions
cannot induce β-sheet folding of SOD1WT (Fig.3.35) like that of Zn2+, except Cu2+
and Fe2+. Cu2+ binding to SOD1WT saturated at a lower molar ratio than Zn2+
but it elicited partial folding of SOD1WT as there were only a few well-dispersed 2D-
HSQC peaks (Fig.3.36B). These structural effects of Cu2+ on SOD1 may necessitate
the evolutionary need for hCCS meditated copper loading into pre-folded, Zn2+-bound
SOD1 (Banci et al., 2012, 2013; Luchinat et al., 2014).
Only Fe2+ could induced large-scale folding of SOD1H80S,D83S (Fig.3.38C) and SOD1H46R,H48Q
mutants (Fig.3.38D) and SOD1WT (Fig.3.38A) to a similar extent like Zn2+ (Fig.3.31).
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However, Fe2+ is unable to induce folding in SOD1G93A (Fig.3.38B), indicating Fe2+-
induced folding in naturally-occurring ALS mutants is severely reduced. The Fe2+-
binding site may be a subset of Cu2+and Zn2+ binding site residues (Fig.3.39B). Al-
though the folded architecture of Fe2+-bound SOD1 is quite similar to Zn2+-bound
SOD1, further Zn2+ addition does not fully restore the folded architecture of Fe2+-
bound SOD1 to a pure Zn2+-bound conformation for SOD1 WT and ALS mutants
(Fig.3.42, 3.43); this effect is more pronounced in the naturally-occurring ALS SOD1G93A
mutant (Fig.3.42B, 3.43C-D).
While there is no in-vivo study done on Fe2+-bound SOD1, large amounts of ferric
(Fe2+) ions are associated with ALS pathogenesis: protein inclusion bodies (Jeong
et al., 2009); blood serum of human ALS patients (Veyrat-Durebex et al., 2014); mice
models of SOD1 mutants (Abel et al., 2012; Wang et al., 2010; Hadzhieva et al., 2013).
Furthermore under enhanced oxidative stress in ALS, unfolded SOD1 WT and WT-like
mutants are frequently translocated to the inner membrane space (IMS) of mitchon-
dria (Vehvila¨inen et al., 2014) by hCCS (Kim et al., 2011), which contains ferric ions
bound by ferritin (Mackenzie et al., 2008). During aging or ALS neurodegeneration,
elevated cytoplasmic Fe2+ concentration in neurons (Oba et al., 1993; Mitchell et al.,
2011; Ignjatovic´ et al., 2013; Winkler et al., 2014) may significantly inhibit the first
maturation step of unfolded SOD1. One implication is this hybrid Fe2+,Zn2+-bound
SOD1 (especially naturally-occurring ALS mutants like SOD1G93A) may not be effec-
tively recognized by the hCCS and cannot undergo the necessary maturation steps.
Without structural integrity imparted by the formation of the native disulfide bridge
(Valentine et al., 2005; Winkler et al., 2009; Sheng et al., 2014), SOD1 WT and ALS
mutants including SOD1G93A (Galaleldeen et al., 2009) and SOD1H46R,H48Q (Winkler
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et al., 2009) may have non-native toxic functions such as interaction with membranes-
bound organelles (Liu et al., 2004), or act as an active conduit for aberrant Fenton’s
chemistry through its bound Fe2+ (Liochev & Fridovich, 1999; Dixon & Stockwell,




4.1 TDP43prion interaction with phospholipids
4.1.1 Introduction
Figure 4.1: Primary sequence of TDP43prionWT . Dashes indicate residues not in
TDP43prion domain. Residues in blue indicate the hydrophobic residues.
The C’ end of TDP43 is a prion-like domain (TDP43prion) enriched in prion-like
residues (Gly, Ser, Gln and Asn) and is the nexus for most of the ALS mutations
(Hasegawa et al., 2011; Wang et al., 2012; King et al., 2012; Ling et al., 2013; Lee
et al., 2012; Polymenidou & Cleveland, 2011). TDP43prion liaises the formation of
soluble, reversible, high-order oligomers or granules through either self-association or
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complexing with other hnRNPs, which are important for its transcriptional and RNA
splicing duties (Wang et al., 2012, 2002). But these reversible structures of TDP43
may become the nucleus for subsequent TDP43 pathological or irreversible aggregation
seen in ALS and FTLD patients (Ling et al., 2013; Li et al., 2013; Kato et al., 2012).
Recent studies demonstrated insoluble inclusion of TDP43 perturb or impair membrane
dynamics of membrane-bound organelles such as mitochondria (Wang et al., 2013;
Magrane´ et al., 2013) and ER (Stoica et al., 2014). Furthermore TDP43 insoluble
aggregates can form pore-like oligomers on the plasma membrane surface (Couthouis
et al., 2011), similar to proteins involved in other neurodegeneration diseases such as
Alzheimer’s (Lashuel et al., 2002; Ashley et al., 2006), Huntington’s (Kagan et al.,
2001; Kegel et al., 2009), Parkinson’s (Lashuel et al., 2002). The formation of such
pore-like aggregates increases the perturbation and pathological remodelling of the
cellular membranes and the chance for cellular apoptosis.
Neurons have higher density requirement of mitochondria, which is needed to satisfy
the huge ATP demand from the transportation of synaptic vesicles at the pre-synaptic
and post-synaptic area (Sheng & Cai, 2012). Pathological perturbation to neuronal
mitochondria can impart long-lasting physiological changes to the neurons and accel-
erate the onset of neuron degeneration or apoptosis (Sheng & Cai, 2012). Further-
more, over-expressed TDP43 WT and ALS mutants are known to impair dynamics
of mitochondria membrane (Wang et al., 2013; Stoica et al., 2014), which resulted in
abnormal mitochondrial morphology (Magrane´ et al., 2013). Interestingly, peptides
designed based on sequences of TDP43prion can form both amyloid fibers and perturb
the membrane integrity of liposomes (Liu et al., 2013; Sun et al., 2014). These obser-
vations indicate the possibility TDP43prion has the potential to perturb the membrane
integrity of membrane-bound organelles.
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On closer inspection of its primary sequence, there is a highly hydrophobic region
in the center of TDP43prion (Fig.4.1) which is flanked by a few relatively weak hy-
drophilic regions (Fig.1.4B,C). We hypothesize by the virtue of this hydrophobic re-
gion in TDP43prion, TDP43 has the ability to associate with membrane-bound or-
ganelles. This section aims to explore this possibility. The results of NMR struc-
tural studies on TDP43prion show although the highly hydrophobic central region of
TDP43prion remains helical in both solution and membrane environment, its helical
population increases in the membrane environment. Interestingly in the lipid envi-
ronment, TDP43prion adopted a Ω-loop-helix conformation between M313 and Q343,
which is an essential region for TDP43 neurotoxicity (Cragnaz et al., 2014; Mompea´n
et al., 2014). Interestingly, three selected TDP43prion ALS mutants studied here with
the bicelle system showed ALS mutations predispose TDP43prion towards forming ir-
reversible aggregates, and thus suggesting ALS mutations in TDP43prion prompt the
irreversible aggregation propensity of TDP43prion.
4.1.2 Experimental results
4.1.2.1 CD studies of TDP43prionWT with phospholipids
Figure 4.2: CD spectra of TDP43prionWT with titration of (A) DPC micelle and (B)
DHPC/DMPC bicelle. The numbers 50x, 100x, ... refers to the molar ratio of DPC
or bicelle to protein.
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We first evaluated the conformational properties of TDP43prionWT in pH5, 1mM phos-
phate at 298K using DPC micelles and DMPC/DHPC bicelle system (molar ratio of
DMPC:DHPC is 4:1). Both phosphocholine systems were also in pH5, 1mM phosphate.
In solution, TDP43prionWT is intrinsically disordered (Fig.4.2A) because of the character-
istic CD negative maxima at 199nm, but it has a small population of α-helices as
indicated by another negative CD maximal at 222nm (Fig.4.2A). Gradual titration of
DPC increased the population of α-helical conformations as seen with the appearance
of a more negative CD maxima at 222nm (Fig.4.2A).
The DMPC/DHPC bicelle system is disc-shaped with a flatter surface which mimics
better the plasma membrane bilayer. Similar to DPC titration, DHPC/DMPC bicelle
titration to TDP43prionWT gave rise to a more negative CD maxima at 222nm which
indicated enhanced α-helical conformation in TDP43prionWT (Fig.4.2B). The similar CD
spectra of TDP43prionWT in both micelle and bicelle system suggest a particular region in
TDP43prionWT may have an existing α-helical conformation, and interaction with phos-
pholipids increases the stability or propensity of this α-helical region in TDP43prionWT .
4.1.2.2 NMR structural studies of TDP43prionWT in solution and DPC
Both 2D-HSQC NMR spectra of TDP43prionWT in solution and DPC showed a narrow dis-
persion of backbone amide which imply it has no tertiary packing and is predominantly
unstructured (Fig.4.3). However, the Trp sidechains of TDP43prionWT in DPC showed 2
peaks which indicates the Trp are exposed to different chemical environment: one is
solvent exposed and the other in the lipid environment of DPC (Fig.4.3). In solution,
the hydrophobic region of TDP43prionWT in solution showed lesser helical propensity as
implied by the smaller CSI (Fig.4.4A-B) and SSP scores (Fig.4.4C). In contrast, the
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Figure 4.3: 2D-HSQC of TDP43prionWT in solution (black) and 200x DPC (red). The
right insert is the Trp sidechains.
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Figure 4.4: Structural properties of TDP43prionWT in solution (black) and 200x DPC
(red). (A) shows the chemical shift differences of ∆Cα - ∆Cβ, where ∆Cα/β is the
difference between the observed chemical shift and that of the random coil. (B) shows
the chemical shift differences of ∆Hα which is the difference between observed Hα
and the random coil. (C) shows the SSP score calculated from the chemical shifts of
Cα, Cβ , Hα, NH (backbone amide nitrogen) and H (backbone amide proton) (Marsh
et al., 2006). +1 indicates 100% α-helix, and -1 indicates 100% β-sheet.
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Figure 4.5: NOE plot of TDP43prionWT in (A) solution and (B) 200x DPC. NOEs
includes intra, sequential (i,i+1) and short-range NOEs (i, i+2 → i+4).
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Figure 4.6: Illustration of detected long-range NOEs for TDP43prionWT in 200x DPC.
(A) Slices of 3D,15N-NOESY for M311 and M323 illustrates the detected long-range
NOEs. Intra and ambiguous long-range NOEs are not illustrated for clarity. (B)
NOE connectivities of M311-A325 with long-range NOEs between residues adopting
the Ω-loop.
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CSI of TDP43prionWT in DPC is significantly higher for the hydrophobic region (Fig.4.4A-
B), and the SSP score for this region (Fig.4.4C) indicate this α-helical propensity for
region ranges from 90% to 100%, which is consistent with CD results of DPC titration
(Fig.4.2A).
In solution, this hydrophobic region of TDP43prionWT showed lower helical propensity
which is line with the absence of NOE typical of α-helices: dαN (i,i+3) and dαN (i,i+4)
NOEs (Fig.4.5A). In contrast, TDP43prionWT in DPC showed higher helical propensity
in its hydrophobic region as implied by increased NOE found for NOE typical of
α-helices: dαN (i,i+2), dαN (i,i+3) and dαN (i,i+4) (Fig.4.5B). But unlike TDP43
prion
WT
in solution, several long-range NOEs were detected for TDP43prionWT in DPC. These
long-range NOEs are localized within the N312-M322 region which is upstream of the
hydrophobic helical region and are illustrated in Figure 4.6A-B.
4.1.2.3 NMR structure of TDP43prionWT in DPC
Cyana software package (Gu¨ntert, 2004b) was used to calculate 50 NMR structures of
region (M307-S347) in TDP43prionWT in DPC. 46 dihedral angle 328 distance restraints
were used: 132 sequential, 76 medium and 9 long-range NOEs. Five NMR structures
with the lowest target functions values are shown in Figure 4.7A; their NMR statistics
are listed in (Table.4.1). While the hydrophobic region between M322 and Q344 adopts
an α-helical conformation (Fig.4.7A), residues upstream of hydrophobic region (M311-
N319) adopted a defined but irregular loop structure (Fig.4.7B). Long-range NOEs
in TDP43prionWT (Fig.4.6B) were isolated within this irregular-shaped loop, and this
loop is characterized as a Ω-loop in the literature (Fetrow, 1995; Falls et al., 2001).
In this Ω-loop, M311, F313, F316 and I318 form an exposed hydrophobic surface
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Figure 4.7: Calculated NMR structure of TDP43prionWT in 200x DPC. (A) The Ω-
loop-helix with hydrophobic region, from M307 to S347. The five structures have the
lowest target function values, as calculated by Cyana (Gu¨ntert, 2004b); green, cyan,
magenta, yellow and pink correspond to structures with the lowest to the fifth lowest
target value. (B) The annotated Ω-loop-helix of the structure with lowest target value.
(C) Vacuum electrostatic surface map of the hydrophobic Ω-loop (M311-N319) (front;
same view as (B)), and the lateral view of hydrophobic helix (left and right). Color
code for electrostatic surface: red is negatively charged, blue is positively charged and
white is hydrophobic or uncharged.
which is orthogonal to the hydrophobic surface of the hydrophobic helix (M322-Q344)
(Fig.4.7C).
Irregular-shaped Ω-loop is also found in the γ-carboxyglutamic acid (GLA) domain
of human pro-thrombin, where the exposed hydrophobic residues in the Ω-loop pene-
trate and anchor the human pro-thrombin to the plasma membrane surface to capture
and complex with other clotting proteins needed for its physiological function (Falls
et al., 2001; Huang et al., 2003). Interestingly, cellular studies using TDP43prion pep-
tides without the Ω-loop (Q331-M369) showed little neurotoxic manifestation (Cragnaz
et al., 2014), but peptides with just the sequence of Ω-loop (M311-N319) in TDP43prion
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Distance violation > 0.5 A˚ 0
Angle violation > 5.0◦ 0
CYANA target function 6.3
Deviations from ideal geometry
Bond length 0.020 ± 0.006 A˚
Angles 1.995 ± 0.866 ◦






RMSD for Ω-loop and helix (311-344) (A˚)
All atoms 1.11 ± 0.34
Heavy atoms 0.91 ± 0.25
Backbone atoms 0.35 ± 0.11
triggered neurotoxic effects (Zhu et al., 2014). Furthermore TDP43prion peptides with
just the Ω-loop sequence (M307-M322) can cause the leakage of liposomes, but remov-
ing the Ω-loop portion (M307-M311) in the peptide abolishes its liposome perturbation
ability (Liu et al., 2013). These other experimental findings indicated the Ω-loop is im-
portant for anchoring the hydrophobic region of TDP43prion to the membrane interface
and may be membrane perturbation.
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4.1.2.4 NMR studies of TDP43prionWT in bicelle
Figure 4.8: 2D-HSQC NMR spectrum of free TDP43prionWT (blue) and in presence of
200x DHPC/DMPC bicelle (red), 1mM phosphate buffer at pH5. Right insert shows
Trp sidechains of TDP43prionWT .
DMPC/DHPC bicelle system is disc-shaped with a flatter surface which mimics the
plasma membrane bilayer better. A number of 2D-HSQC peaks of TDP43prionWT in the
bicelle system (DHPC/DMPC) had either shifted or disappeared; most of disappeared
2D-HSQC peaks were from the Ω-loop and hydrophobic helical regions of TDP43prionWT
(Fig.4.8). The disappeared peaks also indicated the Ω-loop and hydrophobic helix
in TDP43prionWT were embedded deeply into the larger DHPC/DMPC bicelle, as the
disappearance of 2D-HSQC peaks is due to the shortening of their T2 rate, which
is inversely proportional to the molecular size of complex these backbone amide are
embedded into (Prosser et al., 2006; Durr et al., 2012).
Three Trp sidechains of TDP43prionWT can be seen in the bicelle (Fig.4.8) which suggest
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each of the Trp sidechain experiences different chemical environment. The disappeared
2D-HSQC peaks of TDP43prionWT in DHPC/DMPC bicelle correlate with a systematic
conformational shift towards increased α-helical conformation as shown by its CD
spectra (Fig.4.2B). The results here indicate M311-L340 in TDP43prionWT is the main
region responsible for TDP43 interaction with both micelle (DPC) and bilayer (bicelle)
membrane systems. More importantly, the upstream Ω-loop in TDP43prionWT is shown
to be embedded into the flatter DHPC/DMPC bicelle system. It is likely the Ω-loop
is responsible for anchoring the hydrophobic helix in TDP43prionWT onto the surface
of phospholipid membrane. As the local concentration of TDP43 on the membrane
surface increases, membrane integrity of membrane-bound organelles may gradually
become severely perturbed (Wang et al., 2013; Stoica et al., 2014)
4.1.2.5 NMR dynamic studies of TDP43prionWT in DPC
Figure 4.9: Heterogeneous-nuclear NOE (hnNOE) bar plot for TDP43prionWT in solu-
tion (black) and 200x DPC (red). The error bars are illustrated on the top of each
bar. A gray bar of 0.5 is drawn to denote regions of dynamic rigidity in the ps-ns
time range.
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Heteronuclear NOEs (hnNOEs) indicate dynamic motion of backbone amide in the ps-
ns timescale. hnNOEs of TDP43prionWT in both solution and DPC are presented in Figure
4.9. Most residues of TDP43prionWT in solution or DPC are flexible in the ps-ns timescale
as their hnNOEs show minor positive or negative hnNOEs with averages at about
±0.07. Figure 4.9 also indicates beside the Ω-loop and hydrophobic helix, most residues
remains unconstrained in the lipid environment of DPC. This phenomenon is expected
as these regions are enriched in polar residues (G, S, Q, N) that are characteristic of
prion or prion-like protein which lacks stable secondary structure (Ross & Toombs,
2010).
In solution, hnNOEs of hydrophobic region in TDP43prionWT are larger than 0.25 (Fig.4.5A)
which indicated the hydrophobic region had restricted backbone motions and probably
reflect its preexisting α-helical conformation. In DPC, the Ω-loop and hydrophobic he-
lix of TDP43prionWT between M311 and A341 are more constrained because they showed
notable increase in positive hnNOE as compared those in solution (Fig.4.9); the average
hnNOE is 0.53 in DPC, while the average is about 0.30 in solution.
Although several residues in the C’ of TDP43prionWT have increased hnNOEs (S403, D406
and G411-M414), these residues are not very hydrophobic (Fig.1.4B) nor do they pos-
sess notable amphiphilicity (Fig.1.4C). The increased hnNOEs of the C’ residues in
TDP43prionWT (G411-M414) indicate these residues are constrained in the lipid envi-
ronment of DPC (Fig.4.9). It is possible the C’ end of TDP43prionWT has additional
contribution to membrane interaction ability of TDP43prionWT besides the Ω-loop and
hydrophobic helix; the C’ end of TDP43prionWT alone can interact with hydrocarbon
chains of phospholipids (Killian & von Heijne, 2000). Interestingly, residues before
the Ω-loop (S292-G309) of TDP43prionWT in DPC show more negative hNOEs (Fig.4.9)
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which indicate these residues in TDP43prion have more flexibility upon their interac-
tion with DPC. This result suggests upstream residues of Ω-loop in TDP43prion may
enhance the interaction and aggregation with other membrane-bounded TDP43, and
amplify its membrane perturbation ability of membrane-bound organelles or vesicles
(Liu et al., 2013; Sun et al., 2014).
4.1.2.6 Paramagnetic Gd3+ interaction of TDP43prionWT in DPC
Figure 4.10: Relative intensity ratio of 2.0mM Gd3+ against TDP43prionWT in DPC.
A red horizontal line is drawn at 0.59; values above 0.59 indicate backbone amides
of residues which are solvent inaccessible. Green arrows indicate the start and end of
solvent inaccessible regions.
Paramagnetic probes such as Gd3+ andMn2+ are used in liquid NMR to probe solvent
exposure of peptides and proteins in membrane mimetics. These paramagnetic ions
cause line-broadening of 2D-HSQC peaks and the extent of line-broadening depends on
the proximity of backbone amides to these paramagnetic ions. While Mn2+ showed
specific interaction with both protein backbone and sidechains amide atoms, Gd3+
does not have any specific interaction with TDP43prionWT . Thus Gd
3+ titration will be
most accurate in reflecting the solvent exposure of TDP43prionWT in DPC.
The Gd3+ titration indicates that several regions in Ω-loop (M311-N319), hydrophobic
regions (M323-A325, A328-A329, S332-W335, M336-M337) and C’ end (G411-M414)
of TDP43prion are embedded in the hydrocarbon chain phase of DPC, while the rest of
protein are highly exposed to the solvent (Fig 4.10). The results here are in-line with
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the hnNOEs results (Fig.4.9) which show residues in the Ω-loop, hydrophobic region
and C’ end of TDP43prion are constrained by the DPC molecules.
4.1.2.7 Interaction of three TDP43prion ALS mutants in micelle and bicelle
phospholipid system
We chose several point ALS mutations in TDP43prion to study the effects of these ALS
mutations in the membrane perturbation ability of TDP43prion: A315E in the Ω-loop
(TDP43prionA315E), Q331K (TDP43
prion
Q331K) and M337V (TDP43
prion
M337V ) in the hydropho-
bic helix (Fig.4.7A-B). In solution at pH4, the conformation of TDP43prion mutants
are similar to TDP43prionWT , which is monomeric and mainly disordered (Fig.4.11A).
Though the CD spectrum of TDP43prionQ331K differs slightly from the other two mutants
(Fig.4.11A), all their HSQC spectra are superimposable to the TDP43prionWT except for
residues near the mutated residue and the mutated residue themselves (Fig.4.11B-D).
Interestingly, the TDP43prionQ331K showed the most extensive local changes in neighbor-
ing residues (Fig.4.11C): A324, A326, Q327, A328, A329, L330, S333, S334, G335, and
M337.
Likewise in the 1mM phosphate buffer at pH5, the conformation of TDP43prion ALS
mutants in DPC micelle environment are similar to TDP43prionWT as seen with their
similar CD spectrum (Fig.4.11E) and their superimposable 2D-HSQC to TDP43prionWT
(Fig.4.11F-H). Even after 1 month of incubation at pH5, there was no significant change
in the CD and 2D-HSQC spectra of TDP43prion WT and three mutants.
Interestingly in the DMPC/DHPC bicelle system, the three TDP43prion mutants be-
haved quite differently from TDP43prionWT . Although the conformation of these three
TDP43prion ALS mutants are similar to TDP43prionWT immediately after the addition
of bicelle as seen by their similar CD spectra (Fig.4.11I) and their superimposable
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Figure 4.11: Conformation of TDP43prion WT and three ALS mutants in solu-
tion at pH4 (A-D), 200x DPC micelle (E-H) and 200x DMPC/DHPC bicelle (I-L)
in 1mM phosphate buffer, pH5. (A) CD spectra of TDP43prion WT and mutants in
solution at pH4; the corresponding 2D-HQSC of (J) TDP43prionA315E , (K) TDP43
prion
Q331K ,
(L) TDP43prionM337V in solution at pH4. (E) CD spectra of TDP43
prion WT and mu-
tants with 1:200x DPC molar ratio; the corresponding 2D-HQSC of (F) TDP43prionA315E ,
(G) TDP43prionQ331K , (H) TDP43
prion
M337V with 1:200x DPC molar ratio. (I) CD spec-
tra of TDP43prion WT and mutants with 1:200x DMPC/DHPC molar ratio (solid
lines are the 5mins CD spectra, dotted lines are CD spectra after 1 day incubation;
the corresponding 2D-HQSC spectrum of (J) TDP43prionA315E , (K) TDP43
prion
Q331K , (L)
TDP43prionM337V with 1:200x DMPC/DHPC molar ratio. The DPC and DMPC/DHPC
titration experiments were conducted in 1mM phosphate buffer at pH5. Color code
for 2D-HSQC: blue is the TDP43prionWT , red is the corresponding TDP43
prion mutant.
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HSQC peaks to TDP43prionWT (Fig.4.11J-L), the CD spectra of three TDP43
prion mu-
tants shifted towards β-rich conformation after one day of incubation (Fig.4.11I). In
particular, the conformation of TDP43prionA315E and TDP43
prion
M337V had changed to one that
reflects β-rich oligomers just after one day of incubation (Fig.4.11I); β-rich conforma-
tion transitioning of TDP43prionQ331K in bicelle is more tamed. Although no new peak
or peak shift was seen in the 2D-HSQC spectra of three TDP43prion mutants after
one day of incubation, the general peak intensity of their 2D-HSQC spectrum reduced
significantly. After several days, visible white aggregates were seen in the CD cuvette
and NMR tubes of these three TDP43prion ALS mutants but not for TDP43prionWT .
TDP43prionWT remained a clear but viscous hydrogel.
As the DPC micelle system is smaller and has higher curvature stress (Durr et al.,
2012), the number of TDP43prion molecules associating with DPC is limited and thus
the self-oligomerization process is limited for TDP43prion. However, the relatively
larger and flatter DMPC/DHPC bicelle system (Durr et al., 2012) can host more
TDP43prion molecules. Thus the flatter bicelle system indirectly serves as a platform for
increasing significantly the local concentration of the TDP43prion and enhancing their
self-oligomerization. The experimental observations here indicate in the flatter phos-
pholipid system, three TDP43prion ALS mutants have enhanced self-oligomerization
rate and is inclined towards the irreversible self-aggregation.
4.1.3 Discussion
The C’ end (K263-M414) of TDP43 (TDP43prion) is the nexus of ALS-relevant muta-
tions (Hasegawa et al., 2011; Wang et al., 2012; King et al., 2012; Ling et al., 2013;
Lee et al., 2012; Polymenidou & Cleveland, 2011). While TDP43prion can initiate the
formation of soluble, reversible high-order oligomers (Wang et al., 2012, 2002), these
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reversible structures of TDP43 become centers for irreversible aggregation of TDP43
under ALS pathological conditions (Ling et al., 2013; Li et al., 2013; Kato et al., 2012).
Recent studies also demonstrated TDP43 aggregates perturb membrane integrity of
membrane-bound organelles (Wang et al., 2013; Magrane´ et al., 2013; Stoica et al.,
2014).
In this section, the CD spectrum shows TDP43prionWT in solution is disordered (Fig.4.2)
with unconstrained backbone motion in the ps-ns timescale (Fig.4.9). TDP43prion
contains a membrane-interacting element which is the central hydrophobic region
(Fig.1.4B). This region and the upstream residues (Ω-loop) consistently show inter-
action with phospholipids in both micelle (Fig.4.3) and bicelle (Fig.4.8) systems. In-
terestingly, the essential region (M307-N319) for TDP43 neurotoxicity (Zhu et al.,
2014) is an irregular-shaped Ω-loop (Fig.4.7B) when TDP43prion gets embedded into
lipid environment of DPC. The hnNOEs (Fig.4.9) and solvent accessibility experiments
(Fig.4.10) indicate in addition to the Ω-loop (upstream of hydrophobic region) and
hydrophobic region, C’end (G411-M414) of TDP43prion are constrained by the lipid
environment. But more surprisingly, the residues upstream of the Ω-loop became more
flexible when TDP43prion is embedded in DPC (Fig.4.9). Thus when TDP43prion as-
sociates with phospholipids, certain unique dynamic changes may occur in TDP43prion
where upstream residues of Ω-loop, Ω-loop and the C’-end may act synergistically to
enhance the interaction or self-oligomerization of TDP43prion with other membrane-
bounded TDP43prion. Such enhanced oligomerization of membrane-bounded TDP43
may speed up the perturbation of membrane integrity in membrane-bound organelles
or vesicles which eventually lead to neurotoxicity in ALS patients (Liu et al., 2013; Sun
et al., 2014).
TDP43prion with ALS mutations are more susceptible to form irreversible aggregates.
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We found three ALS TDP43prion mutants (one in the Ω-loop and two in the hy-
drophobic region) showed enhanced irreversible self-oligomerization of TDP43prion
when these three TDP43prion ALS mutants were embedded into the membrane surface
of bicelle system as compared to the TDP43prionWT (Fig.4.11I). This observation implies
TDP43prion ALS mutants are more prone to form larger insoluble aggregates of TDP43
near membrane-bound organelles or vesicles (Ling et al., 2013; Li et al., 2013; Kato
et al., 2012). Thus as the concentration of membrane-bounded TDP43 increases due to
the membrane-interaction of TDP43prion, N’-domain of TDP43 may become unfolded
(Qin et al., 2014) which may accelerate the shift of TDP43 from forming dynamic
oligomers to irreversible aggregates. Furthermore, irreversible aggregation of TDP43
may indirectly contribute to the neuronal toxicity because the aggregated TDP43 can-
not inhibit or regulate other hnRNPs essential for normal cellular RNA metabolism
(Suzuki et al., 2014). As several other human diseases are also caused by proteins with
membrane-interactions domains (Liu et al., 2013, 2015; Michalek et al., 2013; Safar
et al., 1991; McLean et al., 2000), the presented results here implicate TDP43prion
membrane interaction as a relevant molecular pathogenesis in ALS and also in other
neurodegeneration diseases. Thus one therapeutic strategy for ALS treatment could





In the previous section, we found three TDP43prion ALS mutants (TDP43prionA315E , TDP43
prion
Q331K
and TDP43prionM337V ) in the membrane interacting domain (hydrophobic region) had ac-
celerated rate of self-oligomerization rate (β-rich oligomers) when they are anchored
onto the surface DMPC/DHPC bicelle system. As self-oligomerization is an integral
part of TDP43 physiological function (Da Cruz & Cleveland, 2011), we first assessed
the structural differences in the self-oligomerization of the three TDP43prion mutants
against TDP43prionWT near physiological pH (pH6.8). Quite remarkably, the visible fluo-
rescence and NMR evidence indicate the three TDP43prion ALS mutants exhibit unique
structural differences in their self-oligomeric states as compared to TDP43prionWT , al-
though their self-oligomeric state were generally β-rich and amyloid fibril-like.
Freibaum et al. (2015) had found expansion mutations in C9orf72 (commonly found in
ALS and FTLD patients) resulted in impaired nuclear trafficking of proteins, and thus
generating an overwhelming accumulation of RNA. Furthermore, TDP43prion is known
to interact with the other domains of TDP43 in the presence of nucleic acid (Kato et al.,
2012). Therefore there is a possibility TDP43 might self-oligomerize in the presence of
overwhelming concentration of nucleic acid under pathological ALS conditions. Thus
we assessed the structural properties of TDP43prion in presence of single-stranded DNA
(ssDNA) which mimics RNA. Surprisingly in the presence of ssDNA at pH5 in 1mM
phosphate buffer, the three TDP43prion mutants showed the same unique structural
differences (seen in their self-oligomerization at pH6.8) as compared to TDP43prionWT .
We had found a plausible mechanism to explain the self-oligomerization tendency of
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TDP43prion at neutral pH (pH6.8). Incredibly, most of backbone amide peaks in 2D-
HSQC NMR spectra of TDP43prionWT at pH4, pH5, pH6 and pH6.8 are quite superim-
posable. Using the backbone amide temperature coefficient, we found TDP43prion WT
has an extensive network of intra-molecular hydrogen bonding involving the backbone
amide protons. However at higher pH, the backbone amide has lesser propensity to
engage in the intra-molecular hydrogen bonding which mean these exposed backbone
amides are readily engaging in inter-molecular hydrogen bonding, which is manifested
as self-oligomerization of TDP43. We found temperature factors of the three ALS
mutants can rationalize the differences in their irreversible aggregation rate at neu-
tral pH. The general higher temperature factors of faster aggregating ALS mutants
TDP43prionA315E and TDP43
prion
M337V indicated lower stability in their intra-molecular hy-
drogen bond network, while the general lower temperature factors of slower-aggregating
TDP43prionQ331K indicated more stable intra-molecular hydrogen bond network. Collec-
tively, the results here indicate the folding landscape of TDP43prion is changed in the
presence of ALS mutations which favor irreversible aggregation of TDP43 functional
oligomers, and each ALS mutation has different influence on this folding landscape
that determines their different aggregation rate.
4.2.2 Experimental Results
4.2.2.1 CD and NMR characterization of self-oligomerization of TDP43prion
WT and three ALS mutants
By using CD, we found TDP43prionWT had quite similar conformations or secondary
structures below 40◦C at: pH4 (Fig.4.12A), pH5 (Fig.4.12B) and pH6 (Fig.4.12C).
By using NMR, most of the other peaks in the 2D-HSQC spectrum of TDP43prionWT at
pH5, pH6 and pH6.8 were superimposable to their cognate peaks at pH4 (Fig.4.13),
132
TDP43prion self-oligomerization 133
Figure 4.12: CD spectrum of TDP43prionWT at various pH and temperatures. (A)
TDP43prionWT in aqueous solution at pH4. (B) TDP43
prion
WT in 1mM phosphate buffer
at pH5. (C) TDP43prionWT in aqueous solution in 1mM phosphate buffer at pH6. The
various curves in each graph corresponds to different temperatures from 20◦C to 90◦C.
although residues at the N’ and C’ (including His-tag) had either shifted or disappeared
at higher pH. The NMR results support the CD observations and indicate no significant
structural or conformational differences of TDP43prion at various pH. However as time
progress, the peak intensity of most 2D-HSQC peaks of TDP43prionWT gradually decreased
and disappeared at neutral pH (pH6.8) (Fig.4.13D). These experimental observations
were observed for the other three TDP43prion ALS mutants, which reflected the general
propensity for TDP43prion to undergo self-oligomerization at neutral pH.
Despite at a low concentration of 20 µM, TDP43prion WT and three mutants were able
to self-oligomerize in 1mM phosphate buffer at pH6.8 as time lapsed. For TDP43prionWT ,
its CD spectrum showed gradual reduction in intensity and, its CD spectrum after 4
days (Fig.4.14A) changed to one that reflects soluble β-stranded oligomers (Jiang et al.,
2013a; Zhu et al., 2014; Mompea´n et al., 2014). But no further conformation change
was observed after 8 days (Fig.4.14A). CD deconvolution analysis of the TDP43prionWT
spectrum at day 8 showed it contained approximately: 3% α-helical, 25% random
coil, 72% β-sheet and β-turn. This deconvolution analysis illustrated the propensity




Figure 4.13: 2D-HSQC spectrum of 100µM of TDP43prionWT at different pH. (A)
TDP43prionWT in solution (Milli-Q water) at pH4 (black) and in 1mM phosphate buffer
at pH5 (red). (B) TDP43prionWT in solution (Milli-Q water) at pH4 (black) and in
1mM phosphate buffer at pH6 (green). (C) TDP43prionWT in 1mM phosphate buffer at
pH5 (black) and in 1mM phosphate buffer at pH6 (green). (D) TDP43prionWT in 1mM




Figure 4.14: CD spectrum of time course TDP43prion WT and three ALS mutants
for self-oligomerization in 1mM phosphate buffer at pH6.8, for 20µM: (A) TDP43prionWT ,
(B) TDP43prionA315E , (C) TDP43
prion
Q331K , (D) TDP43
prion
M337V . D indicates number of days,
e.g. 1D means one day.
Figure 4.15: 1D 1H NMR spectra (0.60ppm-0.96ppm) of time course for the
self-oligomerization of TDP43prion WT and three ALS mutants, under 25◦C in
1mM phosphate buffer at pH6.8, for 40µM: (A) TDP43prionWT , (B) TDP43
prion
A315E , (C)
TDP43prionQ331K , (D) TDP43
prion
M337V . Arrows indicate the manifested upfield 1D NMR
peaks during the self-oligomerization; these upfield peaks are seen only in TDP43prionWT .
But unlike TDP43prionWT , the CD spectra of all three TDP43
prion ALS mutants at neu-
tral pH (Fig.4.14) eventually changed to a conformation that reflected β-rich amy-
loid oligomeric fibrils (Jiang et al., 2013a; Zhu et al., 2014; Mompea´n et al., 2014).
Interestingly, the complete self-oligomerization of the three TDP43prion mutants var-
ied. Fast aggregating ones are TDP43prionA315E (Fig.4.14B) which finished at 18hrs and





(Fig.4.14C) which finished at around 9-10 days.
We tried using NMR to follow the time course of structural changes in TDP43prion
WT and three ALS mutants at a higher protein concentration of 100µM after di-
luting them into 1mM phosphate buffer at pH 6.8. However, at this higher protein
concentration, their self-oligomerization rate were faster and many 2D-HSQC peaks
broadened. Within the first day, the intensity of most peak became too weak and are
undetectable. This tendency was accentuated with a higher TDP43prionWT concentration
such as 200µM, which had complete self-oligomerization at neutral pH within a couple
of hours .
Thus in order to use NMR to characterize the self-oligomerization process of TDP43prion
WT and three mutants in a similar way to the CD experiments, we chose to study
them at 40µM. Figure 4.15 shows the time course of 1D-1H NMR spectrum of their
self-oligomerization process after dilution into 1mM phosphate buffer at pH 6.8; the
upfield 1H range (0.60ppm-0.96ppm) reflects structural changes from the non-labile
methyl protons and some form of tertiary packing. TDP43prionWT at pH4 showed no
upfield peak (Fig.4.15A) which reflects it is highly disordered in solution and is consis-
tent with its CD spectrum (Fig.4.14A). Interestingly, right after its dilution into 1 mM
phosphate buffer at pH 6.8, TDP43prionWT showed two upfield
1H peaks at 0.681 and 0.689
ppm right till 14 hours when their intensity were the highest (Fig.4.15A); thereafter, the
intensity of these two 1H peaks reduced and disappeared after 24 hours of incubation
(Fig.4.15A). Such upfield 1H peaks are due to methyl protons having aromatic-stacking
interaction, and reflects some tertiary packing in the dynamic oligomers of TDP43prionWT .
As no new peak was seen in the corresponding 2D-HSQC spectra of TDP43prionWT during
the time course of this incubation, these two upfield 1H peaks reflected TDP43prionWT
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was forming dynamic oligomers with some tertiary packing which cannot be captured
by its 2D-HSQC spectrum.
Interestingly, the three ALS mutants showed no such upfield 1D-1H NMR peaks during
their self-oligomerization process at neutral pH (Fig.4.15B-D), which indicates the
dynamic oligomers formed by TDP43prion WT and the three ALS mutants have subtle
structural or conformational differences. Their 1D-1H NMR results are also consistent
with CD results where the complete self-oligomerization of TDP43prionA315E (Fig.4.14B)
and TDP43prionM337V (Fig.4.14D) were completed within a day, while TDP43
prion
Q331K took
approximately 8 days (Fig.4.14C). Another interesting observation here is the self-
oligomerization rate of TDP43prionQ331K was less sensitive to concentration changes. At
higher protein concentrations used in NMR (40µM), TDP43prionA315E and TDP43
prion
M337V
experienced faster self-oligomerization than at lower concentration used in the CD
experiments (20µM). This tendency was not seen in TDP43prionQ331K .
4.2.2.2 Fluorescence spectra of TDP43prion WT and three ALS mutants
Fluorescence spectroscopy was used to study the time course of self-oligomerization in







The time-evolution of the self-association process was done with: intrinsic UV (emission
spectra with excitation at 280nm), visible fluorescence (emission spectra with excita-
tion at 375nm) and induced fluorescence by binding to Thioflavin T (ThT) (emission
spectra with excitation at 440nm) (Nilsson, 2004; Shukla et al., 2004; Guptasarma,
2008; Chan et al., 2013; del Mercato et al., 2007; Westermark et al., 2000).
TDP43prion contains three Trp residues (W334, W385, W412) which contribute to the
highly observable intrinsic UV fluorescence signal in TDP43prion (Nilsson, 2004). Fig-
ure 4.16A-D shows TDP43prionWT in pH4 had similar emission intrinsic UV280nm spectrum
137
TDP43prion self-oligomerization 138
Figure 4.16: Fluorescence spectra of self-oligomerization process in TDP43prion
WT and three ALS mutants at neutral pH, 1mM phosphate buffer. (A-D) Emis-
sion spectrum of intrinsic UV fluorescence with excitation wavelength at 280nm for
(A) TDP43prionWT , (B) TDP43
prion
A315E , (C) TDP43
prion
Q331K and (D) TDP43
prion
M337V . (E-H)
Emission spectrum of induced fluorescence by ThT binding with excitation wave-
length at 440nm for (E) TDP43prionWT , (F) TDP43
prion
A315E , (G) TDP43
prion
Q331K and (H)
TDP43prionM337V . (I-L) Emission spectrum of visible fluorescence with excitation wave-
length at 375nm for (I) TDP43prionWT , (J) TDP43
prion




prion in water is at pH 4.0, and the time course of 40µM
TDP43prion being incubated in 1mM phosphate buffer at pH 6.8, under 25◦C. D
indicates number of days, e.g. 1D means one day.
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to the other three ALS mutants in pH4.0 which indicates similar chemical exposure
or environment of three Trp residues in the TDP43prionWT and the other three mutants;
the slight intensity differences reflected minor or local differences in chemical environ-
ments due to the mutations (Nilsson, 2004). However, right after diluting the protein
into 1mM phosphate buffer at pH 6.8, TDP43prionWT showed the largest blue-shift of
the emission maximum from 351 to 347 nm (Figure 4.16A). This blue-shift of emission
maximum was sustained through the course of the next 8 days where the emission max-
imum moved to 339nm and thereafter there was no more significant change (Fig.4.16A).
This phenomenon was observed for three ALS mutants (Fig.4.16B-D). The results here
indicate as TDP43prion self-assemble into oligomers, the Trp residues more buried and
become isolated from the bulk solvent (Nilsson, 2004)
ThT binding is a popular tool to detect β-rich amyloid structures in which the fluores-
cence increases when ThT binds to these β-rich amyloid structures, however the exact
molecular details remain unclear (Nilsson, 2004). Figure 4.16E-H shows TDP43prion
WT and three ALS mutants have the ability to form β-rich amyloid structures af-
ter being diluted into the 1mM phosphate buffer at pH6.8. The intensity of emission
maximum of TDP43prionWT reached the highest after 2 days and thereafter it declined
(Fig.4.16E). This pattern was observed for TDP43prionA315E (Fig.4.16F) and TDP43
prion
M337V
(Fig.4.16H) but the intensity of emission maximum of TDP43prionQ331K (Fig.4.16G) reached
the highest only after 4 days. Generally after prolonged incubation, the fluorescence
intensity from ThT binding assay typically decreased; this phenomenon had has been
widely observed as the more condensed protein fibrils have reduced the surface area
that ThT can bind to (Nilsson, 2004; Westermark et al., 2000).
A recent discovery shows intrinsic visible fluorescence (with excitation at 370nm) may
develop during the aggregation of β-rich protein fibril such as tau protein, lysozyme,
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amyloid-β protein fragments (residue 1-40 and 1-42) (Chan et al., 2013). Because of the
extensive network of hydrogen bonds between backbone carbonyl and amide peptidyl
bonds in β-rich protein fibril, the electron delocalization become extensive in these
peptidyl bonds and thus allowing lower energy electronic transitions which gives rise
to this intrinsic visible fluorescence; this effect is independent of aromatic side-chain
residues (Guptasarma, 2008; Chan et al., 2013; del Mercato et al., 2007).
Figure 4.16I shows the phosphate buffer does not have any detectable visible fluores-
cence. Interestingly at pH4, this intrinsic visible fluorescence is detected for a low
concentration of 40µM TDP43prionWT (Fig.4.16I) and three ALS mutants (Fig.4.16J-
L); they show similar emission maxima: 446nm for TDP43prionWT (Fig.4.16I), 447nm for
TDP43prionA315E (Fig.4.16J), 446nm for TDP43
prion
Q331K (Fig.4.16K) and 449nm for TDP43
prion
M337V
(Fig.4.16L). Because this visible fluorescence is detectable only for high concentration
of γ-crystallin (emission maximum at 465nm) and lysozyme (emission maximum at
425nm) when they formed β-rich fibrils aggregates (Guptasarma, 2008), this visible
fluorescence observation for a low concentration of TDP43prion suggest in general,
TDP43prion may have extensive network of hydrogen bonds involving the backbone
carbonyl and amide in solution.
This intrinsic visible fluorescence of TDP43prionWT increased by approximately 2-fold
after five mins of its dilution into 1mM phosphate buffer of pH6.8 (Fig.4.16I); the
emission maximum was maintained in the range of 446nm to 450nm throughout,
but the fluorescence intensity gradually increased after two days (Fig.4.16I). In con-
trast, the intrinsic visible fluorescence of three ALS mutants showed a different pat-
tern from TDP43prionWT (Fig.4.16J-L). One day after their dilution into 1mM phos-
phate buffer of pH6.8, the emission maximum of three TDP43prion experienced a red-
shift gradually till the sixth day in which the fluorescence intensities is the highest:
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479nm for TDP43prionA315E (Fig.4.16J), 476nm for TDP43
prion
Q331K (Fig.4.16K) and 479nm
for TDP43prionM337V (Fig.4.16L). A correlation for this red-shift of emission maxima of this
intrinsic visible fluorescence has been established where the larger the red-shift is, the
more hydrogen bonds are found to be involved with the β-rich amyloid-like structures
(Nilsson, 2004; Shukla et al., 2004; Guptasarma, 2008; Chan et al., 2013; del Mercato
et al., 2007; Westermark et al., 2000).
When forming amyloid nanofibrils, the poly(ValGlyGlyLeuGly) peptide showed a red-
shift of this intrinsic fluorescence emission to approximately 468nm; this nanofibril is
also electricity-conductive because of its amyloid β-structures is believed to have an ex-
tensive hydrogen bond network to allow extensive electron delocalization for electrical
conductivity (del Mercato et al., 2007). The three TDP43prion mutants showed greater
red-shift of this intrinsic fluorescence (Fig.4.16J-L) than TDP43prionWT (Fig.4.16I) and
the poly(ValGlyGlyLeuGly) peptide, which indicated these three TDP43prion mutants
acquired β-amyloid rich structures that have more extensive intra-molecular hydrogen
bond than TDP43prionWT . Thus the intrinsic fluorescence results here further support
the 1D-1H NMR observations (Fig.4.15) that dynamic oligomers of TDP43prionWT have
subtle conformational or structural differences than the three ALS mutants.
4.2.2.3 Transmission electron microscopy imaging of protein fibers formed
by TDP43prion WT and three ALS mutants
Transmission electron microscope (EM) was used to visualize the morphology of oligomer-
ization for the TDP43prion WT and three ALS mutants after being incubated at 1mM
phosphate buffer at 25◦C. We observed high concentration of approximately 200µM
TDP43prionWT resulted in amorphous aggregates with varying physical dimensions shortly
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Figure 4.17: EM images of 200µM TDP43prionWT incubated immediately after di-
luting into 1mM phosphate buffer at pH 6.8, under 25◦C. Left figures are of lower
magnification (scale bar of 1 µm), and right figures are of higher magnification (scale
bar of 200 nm).
Figure 4.18: EM images of the samples incubated for 1 week in 1mM phosphate
buffer at pH 6.8, under 25◦C for (A) TDP43prionWT , (B) TDP43
prion
A315E , (C) TDP43
prion
Q331K
and (D) TDP43prionM337V . Left figures are of lower magnification (scale bar of 1 µm),
and right figures are of higher magnification (scale bar of 200 nm).
after it was diluted into 1mM phosphate buffer at pH6.8 (Fig.4.17). At lower concen-
tration of 40µM at physiological pH under 25◦C, we observed similar fibril morphology
for the self-oligomers of TDP43prion WT and three ALS mutants for one (Fig.4.18) and
two weeks (Fig.4.19) of incubation. Right after one week of incubation, TDP43prion
WT and three ALS mutants formed amyloid fibrils with thickness range between 15nm
and 30nm (Fig.4.18), and these fibrils showed similar structural morphology to the fib-
ril found in ALS patients (Thorpe et al., 2008). The amyloid fibrils of TDP43prionWT and
the three mutants appeared similar after two weeks of incubation, but the fibrils after
two weeks appeared more condensed and larger (Fig.4.19).
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Figure 4.19: EM images of the samples incubated for 2 week in 1mM phosphate
buffer at pH 6.8, under 25◦C for (A) TDP43prionWT , (B) TDP43
prion
A315E , (C) TDP43
prion
Q331K
and (D) TDP43prionM337V . Left figures are of lower magnification (scale bar of 1 µm),
and right figures are of higher magnification (scale bar of 200 nm).
4.2.2.4 TDP43prion WT and three ALS mutants aggregation with nucleic
acid (ssDNA)
Figure 4.20: Far-UV CD spectra of ssDNA titration for (A) TDP43prionWT , (B)
TDP43prionA315E , (C) TDP43
prion
Q331K and (D) TDP43
prion
M337V . Experiments were done at
25◦C in 1mM phosphate buffer at pH5. The numbers represent the molar ratio of
ssDNA added to protein.
The low complex sequence of TDP43prion domain is highly homologous to regions
of other DNA/RNA-binding proteins which tend to form oligomers and bind to a
large repertoire of single/double-stranded DNA/RNA (Kato et al., 2012). Such low-
complex domains in DNA/RNA-binding proteins (including FUS and TDP43) do not
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Figure 4.21: 1D 1H NMR spectra of ssDNA titration with (A) TDP43prionWT (green
lines indicate the upfield 1D 1H NMR); (B) TDP43prionA315E ; (C) TDP43
prion
Q331K ; (D)
TDP43prionM337V . Color code for various molar ratios of protein:ssDNA : 1:0 (black),
1:0.25 (red), 1:0.50 (blue) and 1:1 (pink) at 25◦C.
have specific RNA-binding motifs but is demonstrated to assemble into dynamic β-
dominant oligomers in presence of nucleic acids (Kato et al., 2012). Therefore CD
and NMR spectroscopy were used to study the structural consequences in TDP43prion
WT and three mutants in the presence of single-stranded DNA (ssDNA). The ssDNA
(TG)6 used here bind to N’ domain of TDP43 (Qin et al., 2014).
To avoid self-oligomerization of TDP43prion at pH6.8, the ssDNA binding experi-
ments were done in 1 mM phosphate buffer at pH5 in which both TDP43prion WT
and three mutants showed no self-oligomerization after one week of incubation. In-
deed, ssDNA was able to bind and trigger the significant conformational changes
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Figure 4.22: 2D-HSQC spectra are superimposed for 40µM TDP43prionWT at different
ssDNA molar ratio. Color code for protein to ssDNA molar ratios of 1:0 (blue), 1:0.5
(red) and 1:1 (green). Experiments were done in 1 mM phosphate buffer at pH 5.0,
temperature at 25◦C. Labeled residues are residues which have insignificant 2D-HSQC
peak shifts at protein to ssDNA molar ratio of 1:0.5.
for the TDP43prion WT (Fig.4.20A) and three mutants (Fig.4.20B-D). Interestingly,
TDP43prionWT showed no visible aggregate and the sample became a clear but viscous
hydrogel after molar ratio of protein to ssDNA reaches 1:1, but this effect mitigated
further titration experiments of ssDNA. In contrast, the three ALS mutants under-
went irreversible aggregation (forming white precipitates) at smaller ratio of ssDNA as
compared to TDP43prionWT (Fig.4.20). Interestingly, the faster aggregating ALS mutants
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Figure 4.23: 2D-HSQC spectra of (A) TDP43prionA315E , (B) TDP43
prion
Q331K , (C)
TDP43prionM337V at different titration points of ssDNA. Color code for protein to ss-
DNA molar ratios of 1:0 (blue), 1:0.5 (red) and 1:1 (green). Experiments were done
in 1 mM phosphate buffer at pH 5.0, temperature at 25◦C.
at neutral pH also required lesser ssDNA molar ratio to self-oligomerize: 0.3x-0.4x for
TDP43prionA315E (Fig.4.20B) and TDP43
prion
M337V (Fig.4.20D). On the other hand, the slower
self-oligomerized at neutral pH TDP43prionQ331K required higher ssDNA ratio of 0.5x-0.6x
to self-oligomerize (Fig.4.20C). The results here also indicate ALS point mutations of
TDP43prion reduce the barrier of irreversible aggregation upon interaction with nu-
cleic acid, but each ALS mutation have different influence on the folding landscape of
TDP43prion.
We used 1D-1H NMR to study the interaction of ssDNA with TDP43prion WT and
three ALS mutants (Fig.4.21). Surprisingly, TDP43prionWT showed two upfield
1H peaks
upon ssDNA addition (Fig.4.21A). These two upfield 1D-1H peaks of TDP43prionWT with
ssDNA had strikingly similar chemical shifts (at 0.683ppm and 0.690ppm) (Fig.4.21A)
to those seen in the self-oligomerization of TDP43prionWT at pH6.8 (at 0.681ppm and
0.689ppm) (Fig.4.15A). In contrast, the two upfield 1H peaks were absent in all three
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ALS mutants when interacting with ssDNA (Fig.4.22B-D), which again demonstrated
ALS mutations cause TDP43prion to have a different oligomeric structure that is more
susceptible to irreversible aggregation.
We also used 2D-HSQC NMR to study the interaction of ssDNA with TDP43prionWT
(Fig.4.22) and the three TDP43prion mutants (Fig.4.23). At ssDNA to protein molar
ratio of 1:0.5, many 2D-HSQC peaks in TDP43prionWT became too broad to be detectable
(Fig.4.22), which indicated these residues were involved in forming large oligomers. The
broadening of 2D-HSQC peaks was also seen in the three ALS mutants as they inter-
acted with ssDNA (Fig.4.23). Interestingly, a subset of these 2D-HSQC NMR peaks
in TDP43prionWT remained detectable and are largely superimposable to their cognate
2D-HSQC peaks in the unbounded state (Fig.4.22). Most of the remaining unaffected
peaks are from the C-terminal residues: Q343-M414 (Fig.4.22). This experimental
observation suggests the C’ residues do not participate in DNA binding and remain
unbounded when ssDNA triggers the self-oligomerization of TDP43prionWT .
4.2.2.5 Mechanism for self-oligomerization in TDP43prion
Interestingly TDP43prionWT between pH4.0 and pH6.8 shows insignificant shifts in their
2D-HSQC NMR peaks (Fig.4.13), which was also observed for the three ALS mutants.
This phenomenon is unexpected as the backbone amide of disordered proteins are
usually exposed to bulk solvent, which make them quite sensitive to pH changes and
one should observe significant shifts of 2D-HSQC peaks with pH changes (Dyson &
Wright, 2004). Temperature factors of backbone amides are used as a sensitive probe
for backbone amide protons involved in hydrogen bonding and involves measuring the
extent of 2D-HSQC peak shifts at varying temperatures (Baxter & Williamson, 1997;
Cierpicki & Otlewski, 2001).
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Figure 4.24: Residue specific temperature factor (coefficient) for TDP43prion WT
in solution (Milli-Q water) at pH4 (black), in 1mM phosphate buffer at pH5 (red),
and in 1mM phosphate buffer at pH6 (cyan-green). The horizontal line is set at 4.5
ppb/K, an indicator for well-protected or hydrogen bonded backbone amide.
Figure 4.25: Residue specific temperature coefficient (factor) for TDP43prion WT
and three ALS mutants in solution (Milli-Q water): TDP43prionA315E at (A) pH4, (B)
pH5; TDP43prionQ331K at (C) pH4, (D) pH5; TDP43
prion
M337V at (E) pH4, (F) pH5. Dark





The NMR temperature factor (coefficients) of backbone amide protons in TDP43prionWT
at pH 4.0, in 1 mM phosphate buffers at pH 5.0 and pH 6.0 are presented in Figure
4.24, which indicates the backbone amide protons of most residues in TDP43prionWT at
pH4.0 show small temperature coefficients (averaged at 4.3), which are smaller than 4.5
ppb/K (an indicator for hydrogen bonded backbone amide protons in well-folded pro-
teins) (Baxter & Williamson, 1997; Cierpicki & Otlewski, 2001). This result indicates
many backbone amides of TPD43prionWT are hydrogen bonded. But this hydrogen bonds
network in TDP43prion is likely to be intra-molecular. This hydrogen bond network is
unlikely to be inter-molecular as we collected the CPMG experiments of TDP43prionWT
and found no chemical exchange. The lack of chemical exchange indicated there is
no protein oligomerization in TDP43prionWT as protein association occurring in µs-ms
timescale can be captured by the CPMG experiments. Thus most backbone amide
protons of TDP43prionWT at pH4 are engaged in intra-molecular hydrogen bonding with
either backbone atoms or sidechains, as TDP43prion is enriched in Asn, Gln, Ser and
the sidechains of these residues are known to form hydrogen bonds with the backbone
atoms in both short peptides and folded proteins (Cierpicki & Otlewski, 2001; Eswar
& Ramakrishnan, 2000).
At pH5, the averaged temperature factor in TDP43prionWT became larger with an average
of 4.7 (Fig.4.24). At pH6, the averaged temperature factor increased further with an
average of 5.2 (Fig.4.24). Interestingly, residues between S369 and N378 showed the
most significant increase in the temperature factor at higher pH (Fig 4.24). The general
but significant increase of temperature factor at pH6 is a reflection of increased disso-
ciation of the backbone amide protons from the network of extensive intra-molecular
hydrogen bonds, which may involve the sidechains of Ser, Gln and Asn. The ex-
posed protons from the backbone and sidechains may then initiate inter-molecular
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hydrogen bonding and subsequently self-oligomerization of TDP43prion, similar to how
poly-Gln(Q) sequences of proteins in other neurodegenerative diseases initiate self-
oligomerization through forming inter-molecular hydrogen bonds between backbone
and sidechain atoms (Stott et al., 1995; Perutz et al., 1994). This self-oligomerization
process of TDP43prion is seen with the disappearance of many 2D-HSQC peaks just
after one day of incubating TDP43prionWT in 1mM phosphate at pH6.8 (Fig.4.13C-D).
We evaluated how this extensive network of intra-molecular hydrogen bond in TDP43prion
is affected by ALS mutations. But a number of 2D-HQSC peaks were too broad for
detection for TDP43prionA315E and TDP43
prion
M337V mutants at pH6 and 30
◦C. Therefore we
will limit our temperature factors comparison of three ALS mutants to pH4 and pH5
here (Fig.4.25). Many of TDP43prionA315E (Fig.4.25A-B) and TDP43
prion
M337V (Fig.4.25E-
F) residues have higher averaged temperature coefficients than TDP43prionM337V , which
indicated less stability in their network of intra-molecular hydrogen bonds, more sus-
ceptibility to pH changes, and thus their faster complete self-oligomerization rate at
neutral pH which finished within a day (Fig.4.14B,D). However, many of TDP43prionQ331K
residues had similar or slightly smaller temperature coefficient factor than TDP43prionWT
(Fig.4.25C-D), and required a longer time of 9 days for complete self-oligomerization of
TDP43prionQ331K (Fig.4.14C) as compared to TDP43
prion
A315E (Fig.4.14B) and TDP43
prion
M337V
(Fig.4.14D). These results here suggest the rate of complete self-oligomerization is
correlated to overall stability of the intra-molecular hydrogen bond network in these
TDP43prion ALS mutants, but the final conformation of self-oligomerized complex





Proteinaceous inclusions of TDP43 are found in approximately 97% ALS and 45%
FTLD patients regardless of being genetics-inherited or sporadic mutated (Ling et al.,
2013). TDP43prionWT is aggregation-prone because it has to undergo reversible oligomer-
ization for its physiological functions (Wang et al., 2012, 2002). However ALS patho-
genesis starts when reversible oligomerization of TDP43 shifts towards irreversible
aggregation. Interestingly Alzheimer’s patients with these TDP43 proteinaceous inclu-
sions suffer from enhanced cognitive impairment (Josephs et al., 2014). While both the
N’ (Zhang et al., 2013) and C’ (Hasegawa et al., 2011; Ling et al., 2013) of TDP43prion
demonstrated intrinsic aggregation propensity, aggregation alone is insufficient to be
neurotoxic because aggregation prone peptides designed with TDP43prion sequence
(Q331-S369) mitigated TDP43 neurotoxicity (Cragnaz et al., 2014). Experimental
results here demonstrate although TDP43prionWT is aggregation prone, ALS mutations




M337V ) significantly shift the
soluble self-oligomerization process of TDP43prion towards irreversible aggregation at
neutral pH.
Although the solution conformation at pH4 of TDP43prionWT (Fig.4.13A) and three
mutants are unstructured, these three mutants in 1mM phosphate buffer at pH6.8
are able to transform into well-formed β-rich amyloid oligomers as demonstrated by
their CD (Fig.4.14B-D) and induced visible fluorescence spectra (Fig.4.16F-H), which
are unlike TDP43prionWT (Fig.4.14A,4.16E respectively); interestingly the complete self-
oligomerization of three mutants are different: TDP43prionQ331K (Fig.4.14C,4.15C) took 7
days, while TDP43prionA315E (Fig.4.14B,4.15B) and TDP43
prion
M337V (Fig.4.14D,4.15D) just
took about 1 day. Through visualization with TEM imaging in 1mM phosphate
buffer at pH6.8, the physical morphology of amyloid fibrils formed by TDP43prionWT
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(Fig.4.18A,4.19A) are quite similar to the three TDP43prion ALS mutants (Fig.4.18B-
D,4.19B-D). But the secondary structures of self-oligomers formed TDP43prionWT are
different from the three TDP43prion mutants as the self-oligomerization of TDP43prionWT
at pH6.8 showed 2 characteristic upfield 1D-1H NMR peaks (Fig.4.15A) which are
absent in the 1D-1H NMR spectrum of three TDP43prion mutants (Fig.4.15B-D). Fur-
thermore, the intrinsic visible fluorescence also shows unique structural differences
between TDP43prion WT (Fig.4.16I) and three ALS mutants (Fig.4.16J-L).
As the prion-like domain in TDP43 triggers the functional oligomerization of these
DNA/RNA binding protein in the presence of nucleic acids (Kato et al., 2012), we
provided in-vitro evidence which shows ssDNA trigger different self-oligomerization
process in TDP43prionWT and the other three ALS mutants. In the presence of ssDNA,
TDP43prionWT became hydrogel-like with 2 characteristic upfield
1H peaks (Fig.4.21A),
while the three TDP43prion mutants formed irreversible, white aggregates with no char-
acteristic upfield 1H peaks (Fig.4.21B-D). Interestingly the complete self-oligomerization
of three ALS mutants in the presence of ssDNA is strikingly similar to their self-
oligomerization at neutral pH: TDP43prionQ331K (Fig.4.20C,4.21C) requires a higher ssDNA
molar ratio than TDP43prionA315E (Fig.4.20B,4.21B) and TDP43
prion
M337V (Fig.4.20D,4.21D).
To explain the pH-invariant backbone conformation of TDP43prionWT between pH4 and
pH6.8 (Fig.4.13A-C), we measured temperature factor of TDP43prion WT (Fig.4.24)
and three mutants (Fig.4.25) at various pH. The temperature factors of TDP43prionWT at
pH4 suggest many backbone amide protons are engaged in extensive intra-molecular
hydrogen bonding with either themselves or sidechains atoms of Asn, Gln and Ser
(Fig.4.24). Averaged residual temperature factors of TDP43prionWT increases with in-
creasing pH (Fig.4.24) which indicated the backbone amide protons are less involved
in the extensive, intra-molecular hydrogen bond network. Indeed in 1mM phosphate
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buffer at pH6.8, TDP43prion started to aggregate and by the end of 1 week, the disap-
pearance of most 2D-HSQC peaks indicate the formation of larger oligomers or aggre-
gates (Fig.4.13D). At near neutral pH (pH6.8), backbone amides protons and sidechain
protons of Asn, Gln and Ser in TDP43prion are freed from the intra-hydrogen bond
network and engage in inter-molecular bonding which trigger the self-oligomerization
of TDP43prion, similar to how prion-like proteins aggregate (Michelitsch & Weissman,
2000; Song et al., 2010; Nelson et al., 2005; Stott et al., 1995; Perutz et al., 1994). We
also examined the temperature factor of three mutants. Interestingly, the temperature
factors of fast-aggregating TDP43prionA315E (Fig.4.25A-B) and TDP43
prion
M337V (Fig.4.25E-
F) mutants are higher than TDP43prionWT , while temperature factor of slow aggregating
TDP43prionQ331K is quite similar to TDP43
prion
WT (Fig.4.25B-C). These results indicate the
intra-molecular hydrogen bond network in TDP43prionA315E and TDP43
prion
M337V are less




M337V are more sus-
ceptible to pH changes and forming insoluble aggregates.
The strikingly similar results of the self-oligomerization process at pH6.8 and ssDNA
interaction support the notion that ALS point mutations in TDP43prion changed its
folding landscape to favor irreversible aggregation as seen by faster self-oligomerization
process at pH6.8 in the three TDP43prion ALS mutants (Fig.4.14B-D) as compared to
TDP43prion WT (Fig.4.14A), and also lower ssDNA ratio requirement for irreversible
aggregation in the three ALS mutants (Fig.4.20B-D and Fig.4.21B-D). The differences
in self-oligomerization rate of three ALS mutants is rationalized by the stability of their
intra-molecular hydrogen bond network. Thus in the presence of these ALS mutations,
TDP43 is more susceptible to irreversible aggregation and thus depleting “normally
functioning” TDP43 in stress granules and hastening the apoptotic onset in neurons
(McDonald et al., 2011; Liu-Yesucevitz et al., 2014).
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Chapter 5
Conclusion and future directions
5.1 General remarks
Amyotrophic lateral sclerosis (ALS) was first mentioned in 1869 and is a progressive
motor neuron degenerative disorder that is intensively researched on for the past three
decades. Approximately 1 in 100,000 people may develop ALS during their lifetime
(Ferraiuolo et al., 2011; Andersen & Al-Chalabi, 2011). Interestingly, ALS patients
may show overlapping clinical symptoms that are characteristic of other non-motor
neuronal diseases such as FTLD, Parkinson, and etc (Ferraiuolo et al., 2011; Ander-
sen & Al-Chalabi, 2011). The complexity of clinical diagnosis is further compounded
by the indistinguishable clinical symptoms of both inherited (FALS) and acquired
form (SALS) (Ferraiuolo et al., 2011; Robberecht & Philips, 2013). While the pool
of ALS-causative genes are growing and accounts for approximately 90% of all ALS
cases (Ferraiuolo et al., 2011; Robberecht & Philips, 2013), the underlying molecular
mechanisms remain poorly understood. As both FALS and SALS show indistinguish-
able clinical manifestations, many research studies also show molecular pathogenesis
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of FALS and SALS are similar.
We picked two proteins (SOD1 and TDP43) to study in this project; these two pro-
teins received major ALS research efforts and are implicated in both FALS and SALS
(Ling et al., 2013). We had employed various complementary biophysical studies to
understand how these two proteins contribute to ALS manifestation. The common
ALS pathogenesis of SOD1 (Liu et al., 2004; Jonsson et al., 2004; Velde et al., 2008;
Israelson et al., 2010) and TDP43 (Wang et al., 2013; Magrane´ et al., 2013; Stoica
et al., 2014) is their purported ability to interact with membrane systems (vesicular
or membrane-bound organelles), which remains under-explored in the field. Prolonged
interaction with membrane systems may lead to perturbation of membrane-bound or-
ganelles, interruption of cellular vesicular transport and enhanced apoptosis signaling
in motor neurons. In addition, other plausible ALS pathogenesis of SOD1 and TDP43
are also explored in this project.
The findings from this project indicate ALS mutations have more profound effects
on a protein which may allow the protein to participate in several ALS molecular
pathogenesis under appropriate cellular conditions. How proteins with ALS mutations
behave under different conditions to trigger a particular ALS pathogenesis is unclear
and cannot be rationalized easily. Thus there may be novel ALS pathogenesis waiting
to be unraveled in the near future. As more ALS pathogenesis are unraveled, the
future therapeutic research should first focus in improving the understanding of how
different ALS molecular pathogenesis complement each other to accelerate ALS onset.
The next research direction is to find ways to modulate this interplay or constellation
of different ALS pathogenesis to slow down ALS onset.
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5.2 SOD1
SOD1 is a dimeric, β-barrel enzyme which reduces cellular oxidative stress by removing
the cytosolic superoxide anion (ROS). Elevated, cellular oxidative stress due to the lack
of functional SOD1 (Shibata et al., 2001; Ferrante et al., 1997; Saccon et al., 2013) or
“aberrant” Fenton’s reaction (Este´vez et al., 1999; Wiedau-Pazos et al., 1996; Liochev
& Fridovich, 2000) is believed to trigger ALS onset. The first critical maturation step
is Zn2+ binding to unstructured SOD1 which catalyzes its proper folding. But with-
out finishing the maturation process by hCCS which catalyzes the disulphide formation
and Cu2+ insertion, Zn2+-bounded SOD1WT adopts both unstructured and structured
conformation in vivo (Luchinat et al., 2014). In contrast, naturally-occurring truncated
SOD1 mutants such as SOD1L126Z innately lacks the capacity to fold properly even
in the presence of excessive Zn2+ supplementation. Recent studies show unstructured
SOD1 may have the ability to perturb dynamics of membrane organelles (Liu et al.,
2004; Jonsson et al., 2004; Velde et al., 2008; Israelson et al., 2010), but the biophysical
evidence behind this phenomenon is lacking. Thus we pursued the biophysical inves-
tigation of how unstructured SOD1 (using the truncated SOD1L126Z and SOD1WT )
interact with phospholipids (phosphocholine).
First, we observed unstructured SOD1 mutant and WT interacted with phospholipid
mimetics (DPC), where unstructured amphiphilic regions of SOD1 developed into am-
phiphilic α-helices. Only Zn2+-binding loop does not form amphiphilic α-helices. Sec-
ond, we found SOD1L126Z in DPC may be markedly smaller than that of SOD1WT
in DPC. This tendency can correlate to the more severe ALS pathology in truncated
SOD1L126Z because truncated SOD1L126Z have increased chances to interact and per-
turb smaller vesicles in cellular transport system than the longer SOD1WT . Third, MD
simulation results show unstructured N’ region of SOD1 (SOD1npep) adopted several
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regions of amphiphilic α-helices, while Zn2+-binding loop (SOD1midpep) did not adopt
any helices. Instead, Zn2+-binding loop was seen to intercalate between DPC micelles
in varying conformations, which also suggest the conformational adaptiveness of Zn2+-
binding loop to the changing conformation of lipid environment. In the presence of
amphiphilic helices, the Zn2+-binding loop also meditated many transient hydrogen-
bonds with the phospholipids. These two features of hydrophilic Zn2+-binding loop
suggest it has two roles in SOD1 interaction with membrane systems: the initial an-
choring of unstructured SOD1 and recruiting other unstructured proteins or SOD1 in
the cytoplasm onto the membrane surface. As this molecular process progresses, more
extensive membrane-remodelling and damage may occur to accelerate the apoptotic
onset.
The results here provide some biophysical basis of unstructured SOD1 insert into
membrane-bound organelle, and rationalized how unstructured SOD1 is potentially
key player in ALS pathogenesis (Velde et al., 2008; Israelson et al., 2010; Urushitani
et al., 2008; Atkin et al., 2014). However we used only phospholipids with choline
headgroups experimentally and in MD simulation. One future research direction is to
use other types of headgroups and understand how the interaction of Zn2+-binding
loop with different lipids types affect lipid-partitioning of unstructured SOD1 such as
negatively charged lipids like cardiolipins in mitochondria. These experiments can also
be extended to different lipid systems to mimic different membrane-bound organelles
with different composition of lipids and sterols. Such experiments may provide in-
sights on how SOD1 interact with different organelles. If there are positive findings
from this in-vitro research, the next research step is to see whether SOD1 can localize
to a particular membrane system (vesicles or cellular organelle) in-vivo; this experi-
ment can be ideally done with fluorescence-labeled truncated SOD1 as it is unable to
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fold with excess Zn2+ supplementation. The gleaned insights from these research aims
will advance our understanding in the molecular pathogenesis of ALS and other human
diseases.
Accumulation of heavy metal ions in motor neurons correlates with the SALS devel-
opment (M Roos, 2013), and several metal ions can substitute Zn2+ in the native
dimeric SOD1 (Ming & Valentine, 2014; Bertini et al., 1998, 1994) which may affect
its structural stability in-vivo and increase SOD1 ability to conduct “aberrant” Fen-
ton’s chemistry, raise cellular oxidative stress and accelerate the activation of cellular
apoptosis. As no metal-ion interaction with unstructured SOD1 studies have been
done before, we assessed a list of 12 metal ions with unstructured SOD1 WT and ALS
relevant mutants. We found that beside Cu2+ and Zn2+, only Fe2+ has the ability
to trigger the folding of unstructured SOD1 and resulted in two conformation popula-
tions: structured and unstructured. Interestingly, Cu2+ can only trigger partial folding
of unstructured SOD1WT which has slight structural differences from the Zn-bounded
SOD1WT . This result also rationalize the evolutionary need of SOD1 maturation
through Cu2+ loading by hCCS.
Pathological ALS conditions may be correlated to progressive increase in the concen-
tration of cytoplasmic ferric ions (Jeong et al., 2009; Veyrat-Durebex et al., 2014;
Winkler et al., 2014), because excessive ferric ions can increase cellular oxidative stress
(Rivera-Manc´ıa et al., 2010; Barnham et al., 2004). While no report had shown direct
implication of cytoplasmic ferric ions in targeting SOD1, our results show Fe2+ trigger
folding of SOD1 and its binding site is an overlap of both Cu2+ and Zn2+ binding sites.
Although Fe2+-bound and Zn2+-bound SOD1 adopt similar structural conformations,
there are some notable structural differences in their metal-binding site. However, we
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found that excessive Zn2+ supplementation may not be able to induce the correct fold-
ing of Fe2+-bound SOD1WT and ALS mutant SOD1G93A. These experimental findings
suggest as ALS progress, increasing amount of cytoplasmic Fe2+ (Winkler et al., 2014)
may increase its binding with unstructured SOD1 WT and ALS mutants, prevent the
correct folding of SOD1 by Zn2+, increase the pool of immature, Fe2+-bound SOD1 to
conduct ‘aberrant’ Fenton’s chemistry and accelerate apoptosis onset in motor neurons
just like copper-bound and zinc-deficient SOD1WT (Este´vez et al., 1999).
The first relevant direction is to solve the X-ray crystal structures of Fe2+-bound
SOD1WT , Zn2+-Fe2+-bound SOD1WT and possibly their complexes with hCCS. There
is an in-vivo possibility that Zn2+-Fe2+-bound SOD1 may form very stable complex
with hCCS, which may deplete the pool of cellular hCCS needed to mature SOD1. Such
X-ray crystal structures may also provide atomic insights to design new inhibitors
to modulate molecular contacts between metal-binding residues and Fe2+ in Fe2+-
bound SOD1 so that SOD1 can adopt a structural fold for proper maturation by
hCCS. The next relevant step is to establish whether oxidative stress can be increased
due to aberrant Fenton’s chemistry from ferric-bound SOD1 in cell-based models and
animal models. If this relationship can be established, and then we can further explore
therapeutic-oriented research on this ALS pathogenesis. For example, as iron-specific
chelators are shown to slow down the progress of neurodegeneration in mice and other
animal models (Petri et al., 2007; Kupershmidt et al., 2009; Wang et al., 2010), we can
explore whether the use of iron-specific chelators or Zn2+ supplementation in animal
model with later ALS stages can improve the endogenous maturation of SOD1 and
ALS symptoms or prognosis. If such positive findings can be obtained, therapeutic
approaches based on this principle can be developed to improve ALS prognosis.
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5.3 TDP43
TDP43 is a hnRNP protein involved a large repertoire of RNA metabolism duties, by
forming large molecular complexes with other hnRNPs either in the nucleus or cyto-
plasm to perform its roles (Verma & Tandan, 2013; Da Cruz & Cleveland, 2011; Udan
& Baloh, 2011). Interestingly, TDP43 was found to be the main component of insoluble
aggregates in ALS and FTLD patients (Ling et al., 2013); its irreversible aggregates
are found in approximately 97% ALS and 45% FTLD patients (Ling et al., 2013). It is
found TDP43 is an intrinsically aggregation-prone (Wang et al., 2012, 2002), and can
disrupt cellular vesicular transport and perturbing membrane-bound organelles such
as ER (Stoica et al., 2014; Soo et al., 2015), Golgi apparatus (Fujita et al., 2008; Soo
et al., 2015) and mitochondria (Wang et al., 2013; Magrane´ et al., 2013). Although
TDP43 has four domains, its C’ end (prion-like domain) is the nexus of ALS mutations
and meditates TDP43 interaction with other hnRNPs (Hasegawa et al., 2011; Wang
et al., 2012; Ling et al., 2013). While this prion-like domain (TDP43prion) is enriched
with residues such as Gly, Ser, Asn and Gln, TDP43prion has a hydrophobic region
(A321-A341) surrounded by relatively weak hydrophilic regions. More importantly,
peptides based on TDP43prion was shown to perturb and cause the leakage of lipo-
somes (Liu et al., 2013; Sun et al., 2014) and thereby providing important biophysical
basis on how TDP43 may perturb membrane bound organelles. However as there re-
mains much paucity in biophysical evidence to support how TDP43prion interact with
membrane bound organelles, we explored this possibility in this project.
First we had showed that while TDP43prion in solution is disordered, the nascent
α-helix propensity (hydrophobic region) is enhanced dramatically in phospholipid en-
vironment such as DPC micelle or DMPC/DHPC bicelle. Second we found residues
upstream of TDP43prion hydrophobic helices adopted an irregular loop structure that
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we termed as Ω-loop. Interestingly, this membrane-interacting region of TDP43prion
(especially Ω-loop) is essential for neurotoxicity of the TDP43 (Liu et al., 2013; Jiang
et al., 2013a; Zhu et al., 2014). Third, we assessed the interaction properties of three
ALS TDP43prion mutants (in the membrane-interacting domain) with phospholipids
and found these ALS mutants self-oligomerized into irreversible β-rich fibrils whereas
TDP43prion WT remained soluble. Furthermore, at neutral pH or in the presence of
nucleic acid, these three ALS TDP43prion mutants self-oligomerize faster towards ir-
reversible β-rich fibrils, whereas TDP43prion WT remained relatively soluble. Fourth,
we found TDP43prion has an unusual pH invariant conformation from pH4 to pH7,
which can be rationalized with an extensive intra-molecular hydrogen network involv-
ing backbone amides and the sidechains of Asn, Gln and Ser. But as the pH increases,
the backbone amides are exposed and able to engage with intermolecular hydrogen
bonding, which is manifested as accelerated self-oligomerization at neutral pH. Lastly,
we found the intra-molecular hydrogen networking of TDP43prion ALS mutants are less
stable than TDP43prion WT. These differences illustrate ALS mutations affected the
folding landscape of TDP43prion to increases its membrane interaction and aggregation,
which may partly account for enhanced neurotoxicity of TDP43 ALS mutants.
Because how TDP43prion interact with other TDP43 domains remains unknown, the
first step is to understand how TDP43prion interact with these domains such as TDP43RRM1
and TDP43RRM2. The next investigation stage is the self-oligomerization process of
TDP43prion in the context of other TDP43 domains, using bicelle systems and in neu-
tral pH. Because the results here show conformation of self-oligomers of TDP43prion
WT is quite different than the ALS mutants in the initial stages of TDP43prion self-
assembly, we need thorough investigation on whether the capacity of TDP43prion ALS
mutants to form β-rich oligomers is enhanced in the presence of other TDP43 domains
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and full-length context. Findings from such studies will further our limited molecular
understanding on how the TDP43prion domain behaves. Another relevant research di-
rection is to understand how self-oligomerization of TDP43prion WT and ALS mutants
is affected in the presence of other hnRNPs and nucleic acid of different lengths and
sequences. Findings from such investigation may provide new insights on drug design
to slow down the formation of irreversible β-amyloid aggregates of TDP43prion.
We only used phosphocholine to explore the interaction of lipids with TDP43prion in
this project. One future research direction is to explore how different composition of
phospholipids, sterols and lipopolysaccharides (in the lipid systems) affect the inter-
action of TDP43prion WT and ALS mutants with the membrane surface. Another
important direction is to establish the relevance of phospholipid membrane interaction
to the physiological functions of TDP43 in-vivo, and whether TDP43prion interaction
with phospholipid membrane differs in the nucleus and cytoplasm. This research inves-
tigation should eventually be extended to include the effects of other TDP43 domains,
nucleic acid of different lengths and sequences, and different hnRNPs. These research
findings may help to decouple the effects of irreversible aggregation from membrane-
interaction of TDP43 and provide insights on how to conduct future ALS therapeutic
research.
We also found the existence of intrinsic visible fluorescence in β-amyloid fibers of
TDP43prion WT, and the three ALS TDP43prion mutants suggest there exists an ex-
tensive delocalization of electrons in peptidyl hydrogen bonds in TDP43prion; this
intrinsic fluorescence is rationalized by the extensive delocalization of electrons in pep-
tidyl hydrogen bonds (del Mercato et al., 2007; Xu et al., 2010; Shlizerman et al.,
2010). Such amyloid fibers of peptides (del Mercato et al., 2007; Xu et al., 2010) and
even β-rich proteins (Shlizerman et al., 2010) are shown to conduct electricity. As
162
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we had demonstrated here β-fibrils of TDP43prion are shown to interact with lipid
membrane and may have extensive electrons delocalization, the formation of these β-
fibrils of TDP43prion on the membrane surface of motor neurons may adversely affect
the electrical conductivity properties of motor neurons and the propagation of action
potential along the motor neurons which are manifested as ALS symptoms. One imme-
diate research direction is to establish any differences in electric conductivity of motor
neurons with aggregates of TDP43prion WT and ALS mutants and whether these elec-
tric conductivity differences can rationalize the pathological severity of different ALS
mutations in-vivo. Positive findings from these research endeavors may spring forth
future ALS therapeutic means by exploring ways to modulate electrical conductivity
properties of TDP43prion β-fibrils on the membrane surface of motor neurons.
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